
<SEC-DOCUMENT>0001477932-16-011975.txt : 20160816
<SEC-HEADER>0001477932-16-011975.hdr.sgml : 20160816
<ACCEPTANCE-DATETIME>20160816095335
ACCESSION NUMBER:
CONFORMED SUBMISSION TYPE:
PUBLIC DOCUMENT COUNT:
CONFORMED PERIOD OF REPORT:
FILED AS OF DATE:
DATE AS OF CHANGE:
10-Q
41
20160630
0001477932-16-011975
20160816
20160816
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME:
CENTRAL INDEX KEY:
STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000]
IRS NUMBER:
FISCAL YEAR END:
Madison Ventures Inc.
0001575975
000000000
0331
FILING VALUES:
FORM TYPE:
SEC ACT:
SEC FILE NUMBER: 333-188753
FILM NUMBER:
10-Q
1934 Act
161835013
BUSINESS ADDRESS:
STREET 1:
STREET 2:
CITY:
STATE:
ZIP:
BUSINESS PHONE:
1810 E SAHARA AVE.
SUITE 583
LAS VEGAS
NV
89104
866-239-0577
MAIL ADDRESS:
STREET 1:
STREET 2:
CITY:
STATE:
ZIP:
1810 E SAHARA AVE.
SUITE 583
LAS VEGAS
NV
89104
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mdsv_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<html><head><title>mdsv_10q.htm</title><!--Document Created by EDGARMaster--
></head><BODY style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN; MARGIN: 
0px 7%" scroll="yes"><p style="MARGIN: 0px">&nbsp;</p><div style="FONT-SIZE: 
1px; WIDTH: 100%; BORDER-BOTTOM: #000000 4px solid; MARGIN: 0px"></div><div 
style="FONT-SIZE: 1pt; WIDTH: 100%; MARGIN-TOP: 2px; BORDER-BOTTOM: #000000 1px 
solid"></div><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><b><font size="3">UNITED STATES</font></b></p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b><font 
size="3">SECURITIES AND EXCHANGE COMMISSION</font></b></p><p style="MARGIN: 0px;
TEXT-INDENT: 0px" align="center"><b><font size="3">Washington, D.C. 
20549</font></b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b><font size="5">FORM 10-Q</font></b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">(MARK 
ONE)&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><b><font face="Wingdings">x 
</font></b><b>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px; TEXT-INDENT: 0px" align="center">For the quarterly period ended <b><u>June
30, 2016</u></b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center">OR</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><b><font face="Wingdings">o 
</font></b><b>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE 
SECURITIES EXCHANGE ACT OF 1934</b></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center">For the transition period 
from ____________ to ___________</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center">Commission File No. <b>333-
188753</b></p><p style="MARGIN: 0px">&nbsp;&nbsp;</p><p style="MARGIN: 
0px"><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cols="2" cellpadding="0" width="50%" align="center" border="0" >
<tr><td style="BORDER-BOTTOM: black 1px solid"><p style="MARGIN: 0px" 
align="center"><font size="5"><strong>MADISON VENTURES 
INC.</strong></font></p></td></tr><tr><td><p style="MARGIN: 0px" 
align="center">(Exact name of registrant as specified in its 
charter)</p></td></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px"><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW 
ROMAN" cellspacing="0" cellpadding="0" width="85%" align="center" border="0" >  
<tr height="15"><td style="BORDER-BOTTOM: 1px solid" valign="top" width="45%"><p
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>Nevada</b></p></td><td 
valign="top" width="10%"></td><td style="BORDER-BOTTOM: 1px solid" valign="top" 
width="45%"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>None</b></p></td></tr><tr height="15"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center">(State or other 
jurisdiction of</p></td><td valign="top"></td><td valign="top"><p style="MARGIN:
0px; TEXT-INDENT: 0px" align="center">(I.R.S. Employer</p></td></tr><tr 
height="15"><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center">incorporation or organization)</p></td><td valign="top"></td><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center">Identification No.)</p></td></tr></table></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>1810 E
Sahara Ave Suite 583</b></p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b><u>Las Vegas, NV 89104</u></b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center">(Address of principal executive offices, zip 
code)</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px" align="center"><b><u>(866) 239-0577</u></b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center">(Registrant's telephone number, including area 
code)</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px">Indicate by check mark whether the issuer (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to such 
filing requirements for the past 90 days. Yes <font face="Wingdings">x </font>No
<font face="Wingdings">o</font></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Indicate by check mark whether the 
registrant has submitted electronically and posted on its corporate Web site, if
any, every Interactive Data File required to be submitted and posted pursuant to
Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 
12 months (or for such shorter period that the registrant was required to submit
and post such files). Yes <font face="Wingdings">o </font>No <font 
face="Wingdings">x</font></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px; TEXT-INDENT: 0px">Indicate by check mark whether the registrant is a large 
accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller 
reporting company. See the definitions of "large accelerated filer," 
"accelerated filer" and "smaller reporting company" in Rule 12b-2 of the 
Exchange Act. (check one):</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN:
0px"><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" width="85%" align="center" border="0" >    <tr 
height="15"><td width="30%"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Large 
accelerated filer</p></td><td width="20%"><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><font face="Wingdings">o</font></p></td><td width="30%"><p style="MARGIN: 
0px; TEXT-INDENT: 0px">Accelerated filer</p></td><td width="20%"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><font 
face="Wingdings">o</font></p></td></tr><tr height="15"><td><p style="MARGIN:
0px; TEXT-INDENT: 0px">Non-accelerated filer</p></td><td><p style="MARGIN: 0px; 
TEXT-INDENT: 0px"><font face="Wingdings">o</font></p></td><td><p style="MARGIN: 
0px; TEXT-INDENT: 0px">Smaller reporting company</p></td><td><p style="MARGIN: 
0px; TEXT-INDENT: 0px"><font face="Wingdings">x</font></p></td></tr><tr 
height="15"><td colspan="2"><p style="MARGIN: 0px; TEXT-INDENT: 0px">(Do not 
check if a smaller reporting 
company)</p></td><td></td><td></td></tr></table></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">Indicate by check mark 
whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2
of the Exchange Act): Yes <font style="FONT-FAMILY: Wingdings">&#168; </font>No 
<font face="Wingdings">x</font></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>APPLICABLE ONLY TO 
ISSUERS INVOLVED IN BANKRUPTCY </b><b>PROCEEDINGS DURING THE PRECEDING FIVE 
YEARS:</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px">Indicate by check mark whether the registrant has filed all 
documents and reports required to be filed by Sections 12, 13 or 15(d) of the 
Securities Exchange Act of 1934 subsequent to the distribution of securities 
under a plan confirmed by a court. Yes <font face="Wingdings">o </font>No <font 
face="Wingdings">o</font></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px; TEXT-INDENT: 0px" align="center"><b>APPLICABLE ONLY TO CORPORATE 
ISSUERS</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px">As of August 12, 2016, there were 28,400,000 shares of common 
stock, $0.001 par value per share, outstanding.</p><p style="MARGIN: 
0px">&nbsp;</p><div style="FONT-SIZE: 1pt; WIDTH: 100%; BORDER-BOTTOM: #000000 
1px solid; MARGIN: 0px"></div><div style="FONT-SIZE: 1pt; WIDTH: 100%; MARGIN-
TOP: 2px; BORDER-BOTTOM: #000000 4px solid"></div><p style="MARGIN: 0px"><table 
class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" border="0" >    <tr><td 
class="hpbhr">&nbsp;</td></tr><tr><td>&nbsp;</td></tr><tr></tr><tr><td><div 
style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 
0px"></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p style="MARGIN: 0px" 
align="center">&nbsp;<b>MADISON VENTURES INC.</b></p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>QUARTERLY REPORT ON FORM 10-Q</b></p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>FOR THE PERIOD ENDED 
JUNE 30, 2016</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b><a name="Toc">INDEX</a></b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><table style="TEXT-ALIGN: 
justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
width="100%" border="0" >    <tr height="15"><td style="BORDER-BOTTOM: 1px 
solid" valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><b>Index</b></p></td><td valign="bottom"></td><td valign="bottom"></td><td 
style="BORDER-BOTTOM: 1px solid" valign="bottom" colspan="2"><p style="MARGIN: 
0px; TEXT-INDENT: 0px" align="center"><b>Page</b></p></td><td 
valign="bottom"></td></tr><tr height="15"><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom" 
colspan="2"></td><td valign="bottom"></td></tr><tr height="15"><td 
valign="bottom" colspan="2"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b><a 
href="#Part1">PART I. FINANCIAL INFORMATION</a></b></p></td><td 
valign="bottom"></td><td valign="bottom" colspan="2"></td><td 
valign="bottom"></td></tr><tr height="15"><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom" 
colspan="2"></td><td valign="bottom"></td></tr><tr height="15" 
bgcolor="#cceeff"><td valign="bottom"><p style="MARGIN:
 0px; TEXT-INDENT: 0px"><a href="#Item1">Item 1.</a></p></td><td 
valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#Item1">Consolidated Financial Statements.</a></p></td><td 
valign="bottom"></td><td valign="bottom" colspan="2"><p style="MARGIN: 0px" 
align="right">4</p></td><td valign="bottom"></td></tr><tr height="15" 
bgcolor="#ffffff"><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom" colspan="2"></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#cceeff"><td valign="bottom" 
width="9%"></td><td valign="bottom" width="79%"><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><a href="#BS">Condensed Consolidated Balance Sheets as of June 30, 
2016 (unaudited) and March 31, 2016.</a></p></td><td valign="bottom"
width="1%"></td><td valign="bottom" width="1%"></td><td valign="bottom" 
width="9%"><p style="MARGIN: 0px" align="right">4</p></td><td valign="bottom" 
width="1%"></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="bottom"></td><td valign="bottom"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#SO">Condensed Consolidated 
Statements of Operations for the Three Months ended June 30, 2016 and 2015 
(unaudited).</a></p></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"><p style="MARGIN: 0px" align="right">5</p></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="bottom"></td><td valign="bottom"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#SE">Condensed Consolidated 
Statements of Changes in Stockholders Equity (Deficit) from March 31, 2015 to 
June 30, 2016 (unaudited).</a></p></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"><p style="MARGIN: 0px" 
align="right">6</p></td><td valign="bottom"></td></tr><tr height="15" 
bgcolor="#ffffff"><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#cceeff"><td 
valign="bottom"></td><td valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><a href="#CF">Condensed Consolidated Statements of Cash Flows for the Three
Months ended June 30, 2016 and 2015 (unaudited).</a></p></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"><p 
style="MARGIN: 0px" align="right">7</p></td><td valign="bottom"></td></tr><tr 
height="15" bgcolor="#ffffff"><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td></tr><tr height="15" 
bgcolor="#cceeff"><td valign="bottom"></td><td valign="bottom"><p style="MARGIN:
0px; TEXT-INDENT: 0px"><a href="#NOTES">Notes to the Condensed Consolidated 
Financial Statements (unaudited).</a></p></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"><p style="MARGIN: 0px" 
align="right">8</p></td><td valign="bottom"></td></tr><tr height="15" 
bgcolor="#ffffff"><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#cceeff"><td 
valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ITEM2">Item 
2.</a></p></td><td valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ITEM2">Management's Discussion and Analysis of Financial Condition and 
Results of Operations.</a></p></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"><p style="MARGIN: 0px" 
align="right">15</p></td><td valign="bottom"></td></tr><tr height="15" 
bgcolor="#ffffff"><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#cceeff"><td 
valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ITEM3">Item 
3.</a></p></td><td valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ITEM3">Quantitative and Qualitative Disclosures About Market 
Risk.</a></p></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"><p style="MARGIN: 0px" align="right">17</p></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="bottom"><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><a href="#ITEM4">Item 4.</a></p></td><td valign="bottom"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ITEM4">Controls and 
Procedures.</a></p></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"><p style="MARGIN: 0px" align="right">17</p></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td></tr><tr 
height="15" bgcolor="#ffffff"><td valign="bottom" colspan="2"><p style="MARGIN:
0px; TEXT-INDENT: 0px"><b><a href="#Part2">PART II. OTHER 
INFORMATION</a></b><b></b></p></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td></tr><tr 
height="15" bgcolor="#ffffff"><td valign="bottom" colspan="2"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#cceeff"><td 
valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ITEM1_2">Item
1.</a></p></td><td valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ITEM1_2">Legal Proceedings.</a></p></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"><p style="MARGIN: 0px" 
align="right">18</p></td><td valign="bottom"></td></tr><tr height="15" 
bgcolor="#ffffff"><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#cceeff"><td 
valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ITEM1a_2">Item 1A.</a></p></td><td valign="bottom"><p style="MARGIN: 0px;
TEXT-INDENT: 0px"><a href="#ITEM1a_2">Risk Factors.</a></p></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"><p 
style="MARGIN: 0px" align="right">18</p></td><td valign="bottom"></td></tr><tr 
height="15" bgcolor="#ffffff"><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td></tr><tr height="15" 
bgcolor="#cceeff"><td valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><a href="#ITEM2_2">Item 2.</a></p></td><td valign="bottom"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ITEM2_2">Unregistered Sales of 
Equity Securities and Use of Proceeds.</a></p></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"><p style="MARGIN: 0px" 
align="right">18</p></td><td valign="bottom"></td></tr><tr height="15" 
bgcolor="#ffffff"><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#cceeff"><td 
valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ITEM3_2">Item
3.</a></p></td><td valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ITEM3_2">Defaults Upon Senior Securities.</a></p></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"><p 
style="MARGIN: 0px" align="right">18</p></td><td valign="bottom"></td></tr><tr 
height="15" bgcolor="#ffffff"><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td></tr><tr height="15" 
bgcolor="#cceeff"><td valign="bottom"><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><a href="#ITEM4_2">Item 4.</a></p></td><td valign="bottom"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ITEM4_2">Mine Safety 
Disclosures.</a></p></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"><p style="MARGIN: 0px" align="right">18</p></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="bottom"><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><a href="#ITEM5_2">Item 5.</a></p></td><td valign="bottom"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ITEM5_2">Other 
Information.</a></p></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"><p style="MARGIN: 0px" align="right">18</p></td><td 
valign="bottom"></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="bottom"><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><a href="#ITEM6_2">Item 6.</a></p></td><td valign="bottom"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ITEM6_2">Exhibits.</a></p></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"><p style="MARGIN: 0px" 
align="right">19</p></td><td valign="bottom"></td></tr><tr height="15" 
bgcolor="#ffffff"><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"></td><td 
valign="bottom"></td></tr><tr
height="15" bgcolor="#cceeff"><td valign="bottom" colspan="2"><p style="MARGIN:
0px; TEXT-INDENT: 0px"><b><a href="#sig">Signatures</a></b></p></td><td 
valign="bottom"></td><td valign="bottom"></td><td valign="bottom"><p 
style="MARGIN: 0px" align="right">20</p></td><td 
valign="bottom"></td></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><table 
id="pagebreak5b0c37d3-e23f-458b-8562-bf1f639a7555" class="pagebreak" 
style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
border="0">    <tr><td class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-
BOTTOM: black 1px solid; TEXT-ALIGN: center">2</td></tr><tr></tr><tr><td><div 
style="WIDTH: 100%; PAGE-BREAK-AFTER: always; LINE-HEIGHT: 
0px"></div></td></tr><tr><td>&nbsp;</td></tr></table><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p><p
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN:
0px; TEXT-INDENT: 0px">This Quarterly Report on Form 10-Q of Madison Ventures 
Inc., a Nevada corporation (the "Company"), contains "forward-looking 
statements," as defined in the United States Private Securities Litigation 
Reform Act of 1995. In some cases, you can identify forward-looking statements 
by terminology such as "may", "will", "should", "could", "expects", "plans", 
"intends", "anticipates", "believes", "estimates", "predicts", "potential" or 
"continue" or the negative of such terms and other comparable terminology. These
forward-looking statements include, without limitation, statements about our 
market opportunity, our strategies, competition, expected activities and 
expenditures as we pursue our business plan, and the adequacy of our available 
cash resources. Although we believe that the expectations reflected in the 
forward-looking statements are reasonable, we cannot guarantee future results, 
levels of activity, performance or achievements. Actual results may differ 
materially from the predictions discussed in these forward-looking statements. 
The economic environment within which we operate could materially affect our 
actual results. Additional factors that could materially affect these forward-
looking statements and/or predictions include, among other things: our ability 
to continue licensing and integrate the technology from Ocure Ltd. Into the 
Company's business and the Company's need for and ability to obtain additional 
financing, and other factors over which we have little or no control; and other 
factors discussed in the Company's filings with the Securities and Exchange 
Commission ("SEC").</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">Our management has included projections and estimates in this 
Form 10-Q, which are based primarily on management's experience in the industry,
assessments of our results of operations, discussions and negotiations with 
third parties and a review of information filed by our competitors with the SEC 
or otherwise publicly available. We caution readers not to place undue reliance 
on any such forward-looking statements, which speak only as of the date made. We
disclaim any obligation subsequently to revise any forward-looking statements to
reflect events or circumstances after the date of such statements or to reflect 
the occurrence of anticipated or unanticipated events.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px" ><table id="pagebreakd4236826-5268-4bab-
bbc2-e8bdc8cefce3" class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW 
ROMAN" cellspacing="0" cellpadding="0" border="0">    <tr><td 
class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; 
TEXT-ALIGN: center">3</td></tr><tr></tr><tr><td><div style="PAGE-BREAK-AFTER: 
always; LINE-HEIGHT: 0px"></div><div class="assignanchor"><a href="#Toc">Table 
of Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b><a name="Part1">PART I. FINANCIAL INFORMATION</a></b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b><a 
name="Item1">ITEM 1. FINANCIAL STATEMENTS.</a></b></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Madison Ventures Inc.</b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><b><a name="BS">Condensed Consolidated Balance 
Sheets</a></b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" 
><table style="WIDTH: 100%; TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" width="100%" border="0" >    <tr><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2"
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>June 
30,</b></p></td><td valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" 
valign="bottom" colspan="2" align="center"><p style="MARGIN: 0px; TEXT-INDENT: 
0px" align="center"><b>March 31,</b></p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td></tr><tr><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 1px solid" 
valign="bottom" colspan="2" align="center"><strong>2016</strong></td><td 
style="PADDING-BOTTOM: 1px" valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 1px solid" 
valign="bottom" colspan="2" align="center"><p style="MARGIN: 0px; TEXT-INDENT: 
0px" align="center"><b>2016</b></p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" width="9%" colspan="2" 
align="center"><strong>(Unaudited)</strong></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" width="9%" colspan="2" 
align="center"></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><b>ASSETS</b></p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
colspan="2" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" colspan="2" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">Current assets:</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
colspan="2" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" colspan="2" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 15px">Cash</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%">$</td><td 
id="ffcell" valign="bottom" width="9%" align="right">92,541</td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">66,795</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 15px">Deposit on Technology License</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right">-</td><td valign="bottom" width="1%"><p
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">-</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 15px">Prepaid expenses</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right">2,539</td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">2,100</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p
style="MARGIN: 0px 0px 0px 15px">Miscellaneous receivable</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: 1px solid" 
valign="bottom" width="9%" align="right">2,077</td><td style="PADDING-BOTTOM: 
1px" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN:
 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">4,837</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 30px">Total current assets</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: 1px solid" 
valign="bottom" width="9%" align="right">97,157</td><td style="PADDING-BOTTOM: 
1px" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: 1px solid" 
valign="bottom" width="9%" align="right">73,732</td><td style="PADDING-BOTTOM: 
1px" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr 
bgcolor="#ffffff"><td><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Investment in technology 
license</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">169,606</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">70,998</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 30px">Total assets</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 3px 
double" valign="bottom" width="1%">$</td><td id="ffcell" style="BORDER-BOTTOM: 
3px double" valign="bottom" width="9%" align="right">266,763</td><td 
style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 3px double" valign="bottom" 
width="1%">$</td><td id="ffcell" style="BORDER-BOTTOM: 3px double" 
valign="bottom" width="9%" align="right">144,730</td><td style="PADDING-BOTTOM: 
3px" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr 
bgcolor="#ffffff"><td><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN:
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><b>LIABILITIES AND SHAREHOLDERS' EQUITY 
(DEFICIT)</b></p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Current 
liabilities:</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Accounts payable</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">53,791</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%">$</td><td id="ffcell" 
valign="bottom" width="9%" align="right">19,915</td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Accrued liabilities</p></td><td
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right">25,000</td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right">23,618</td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Due to related 
party</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">213,442</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">213,442</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 15px">Total current liabilities</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: 1px solid" 
valign="bottom" width="9%" align="right">292,233</td><td style="PADDING-BOTTOM: 
1px" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: 1px solid" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: 1px solid" 
valign="bottom" width="9%" align="right">256,975</td><td style="PADDING-BOTTOM: 
1px" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr 
height="15" bgcolor="#cceeff"><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Long-term liabilities:</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Long-term debt</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM:
 1px solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td
id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" 
align="right">110,000</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px 
solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" 
align="right">-</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 30px">Total long-term 
liabilities</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">110,000</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 30px">Total Liabilities</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px 
solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" 
align="right">402,233</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px 
solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" 
align="right">256,975</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr 
bgcolor="#ffffff"><td><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Commitments and Contingencies</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN:
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr 
bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 
0px">Shareholders' equity (deficit):</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr 
bgcolor="#ffffff"><td valign="top"><p style="MARGIN: 0px 0px 0px 15px">Common 
stock: 300,000,000 shares authorized of $0.001 par value; 28,400,000 and 
28,400,000 shares issued</p><p style="MARGIN: 0px 0px 0px 
15px">&nbsp;&nbsp;&nbsp; and outstanding as of June 30, 2016 and March 31, 
2016</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">28,400</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">28,400</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 15px">Additional paid-in capital</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right">54,100</td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right">54,100</td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Accumulated deficit</p></td><td
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right">(218,070</td><td valign="bottom" 
width="1%">)</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">(194,669</td><td valign="bottom" width="1%">)</td></tr><tr 
bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px 0px 0px 
15px">Accumulated other comprehensive income (loss)</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
1px solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" 
align="right">100</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
1px solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%"
align="right">(76</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%">)</td></tr><tr bgcolor="#ffffff"><td valign="top"><p style="MARGIN: 
0px 0px 0px 30px">Total shareholders' equity (deficit)</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" width="9%" align="right">(135,470</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td><td valign="bottom"
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
1px solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" 
align="right">(112,245</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%">)</td></tr><tr bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 
0px 0px 0px 30px">Total liabilities and shareholders' equity 
(deficit)</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 3px double" valign="bottom" 
width="1%">$</td><td id="ffcell" style="BORDER-BOTTOM: black 3px double" 
valign="bottom" width="9%" align="right">266,763</td><td style="PADDING-BOTTOM: 
3px" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td><td 
id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" 
align="right">144,730</td><td style="PADDING-BOTTOM: 3px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center">The accompanying
 notes are an integral part of these condensed consolidated financial 
statements</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" ><table 
id="pagebreak2203cdd7-b5e9-4ac0-98a6-a7c7bd1feede" class="pagebreak" 
style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
border="0">    <tr><td class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-
BOTTOM: black 1px solid; TEXT-ALIGN: center">4</td></tr><tr></tr><tr><td><div 
style="PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div><div 
class="assignanchor"><a href="#Toc">Table of 
Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px" align="center"><b></b>&nbsp;</p><b><b>Madison Ventures 
Inc.</b></b>   <p style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b><a 
name="SO">Condensed Consolidated Statements of Operations 
(Unaudited)</a></b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" 
><table style="WIDTH: 100%; TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" width="100%" border="0" >    <tr><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" colspan="6" align="center"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>Three Months Ended June 30,</b></p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" width="9%" colspan="2" align="center"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>2016</b></p></td><td 
style="PADDING-BOTTOM: 1px" valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 1px solid" 
valign="bottom" width="9%" colspan="2" align="center"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>2015</b></p></td><td style="PADDING-BOTTOM: 
1px" valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
colspan="2" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" colspan="2" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">Operating costs:</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
colspan="2" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" colspan="2" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 15px">Consulting and professional fees</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right">14,885</td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right">15,577</td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Stock based 
compensation</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">1,387</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">6,250</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 15px">Other general &amp; administrative 
expenses</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">3,797</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 30px">Total operating costs</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" width="9%" align="right">20,069</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">21,827</td><td
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Other income 
(expense):</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Foreign exchange 
gain</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(3,332</td><td
valign="bottom" width="1%">)</td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" 
align="right">-</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 30px">Total other income (expense)</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" width="9%" align="right">(3,332</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td><td valign="bottom"
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
1px solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" 
align="right">-</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr 
bgcolor="#cceeff"><td><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
 valign="bottom" width="9%" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Net (loss)</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
3px double" valign="bottom" width="1%">$</td><td id="ffcell" style="BORDER-
BOTTOM: black 3px double" valign="bottom" width="9%" 
align="right">(23,401</td><td style="PADDING-BOTTOM: 3px" valign="bottom" 
width="1%">)</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 3px double" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 3px double" valign="bottom" width="9%" 
align="right">(21,827</td><td style="PADDING-BOTTOM: 3px" valign="bottom" 
width="1%">)</td></tr><tr bgcolor="#cceeff"><td><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Loss per common 
share:</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Basic and diluted</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%">$</td><td 
id="ffcell" style="BORDER-BOTTOM: 3px double" valign="bottom" width="9%" 
align="right">0.00</td><td style="PADDING-BOTTOM: 3px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 3px 
double" valign="bottom" width="1%">$</td><td id="ffcell" style="BORDER-BOTTOM: 
3px double" valign="bottom" width="9%" align="right">0.00</td><td 
style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Weighted average common 
shares outstanding:</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Basic and diluted</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: 3px double" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: 3px double" 
valign="bottom" width="9%" align="right">28,400,000</td><td style="PADDING-
BOTTOM: 3px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 3px double" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 3px double" valign="bottom" width="9%" align="right">28,400,000</td><td 
style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Comprehensive income 
(loss):</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Net (loss)</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">(23,401</td><td valign="bottom" width="1%">)</td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">(21,827</td><td valign="bottom" width="1%">)</td></tr><tr 
bgcolor="#ffffff"><td valign="top"><p style="MARGIN: 0px 0px 0px 15px">Other 
comprehensive income:</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 30px">Foreign currency 
translation</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">176</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 30px">Comprehensive 
(loss)</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 3px double" valign="bottom" 
width="1%">$</td><td id="ffcell" style="BORDER-BOTTOM: 3px double" 
valign="bottom" width="9%" align="right">(23,225</td><td style="PADDING-BOTTOM:
 3px" valign="bottom" width="1%">)</td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 3px double" 
valign="bottom" width="1%">$</td><td id="ffcell" style="BORDER-BOTTOM: 3px 
double" valign="bottom" width="9%" align="right">(21,827</td><td style="PADDING-
BOTTOM: 3px" valign="bottom" width="1%">)</td></tr></table></p><p style="MARGIN:
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" align="center">The 
accompanying notes are an integral part of these condensed consolidated 
financial statements</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" 
><table id="pagebreake42738e9-5ad4-4eb4-b90e-8c72694b40a5" class="pagebreak" 
style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
border="0">    <tr><td class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-
BOTTOM: black 1px solid; TEXT-ALIGN: center">5</td></tr><tr></tr><tr><td><div 
style="PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div><div 
class="assignanchor"><a href="#Toc">Table of 
Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Madison Ventures Inc.</b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><b>Condensed <a name="SE">Consolidated Statements of
Changes in Stockholders' Equity (Deficit)</a></b></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px" ><table style="WIDTH: 100%; TEXT-ALIGN:
justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
width="100%" border="0" >    <tr><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Accumulated</b></p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Common</b></p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Additional</b></p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>other</b></p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Common</b></p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>stock</b></p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>paid-
in</b></p></td><td valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" 
valign="bottom" colspan="2" align="center"><p style="MARGIN: 0px; TEXT-INDENT: 
0px" align="center"><b>Accumulated</b></p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>comprehensive</b></p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN:
0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 1px solid" 
valign="bottom" width="9%" colspan="2" align="center"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>stock</b></p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 1px solid" 
valign="bottom" width="9%" colspan="2" align="center"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>amount</b></p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 1px solid" 
valign="bottom" width="9%" colspan="2" align="center"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>capital</b></p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 1px solid" 
valign="bottom" width="9%" colspan="2" align="center"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>deficit</b></p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 1px solid" 
valign="bottom" width="9%" colspan="2" align="center"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>Income (loss)</b></p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" width="9%" colspan="2" align="center"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>Total</b></p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
colspan="2" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" colspan="2" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" colspan="2" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" colspan="2" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" colspan="2" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" colspan="2" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Balance, March 31, 
2015</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">28,400,000</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">28,400</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td
 id="ffcell" valign="bottom" width="9%" align="right">54,100</td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right">(106,811</td><td valign="bottom" 
width="1%">)</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right">-
</td><td valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right">(24,311</td><td valign="bottom" 
width="1%">)</td></tr><tr bgcolor="#ffffff"><td><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px">Comprehensive loss, March 31, 
2016</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" 
align="right">(87,858</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%">)</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">(76</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td><td valign="bottom"
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
1px solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td
id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" 
align="right">(87,934</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%">)</td></tr><tr bgcolor="#ffffff"><td valign="top"><p style="MARGIN: 
0px 0px 0px 15px">Balance, March 31, 2016</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right">28,400,000</td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%">$</td><td 
id="ffcell" valign="bottom" width="9%" align="right">28,400</td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">54,100</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%">$</td><td id="ffcell" 
valign="bottom" width="9%" align="right">(194,669</td><td valign="bottom" 
width="1%">)</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">(76</td><td valign="bottom" width="1%">)</td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">(112,245</td><td valign="bottom" width="1%">)</td></tr><tr 
bgcolor="#cceeff"><td><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px">Comprehensive loss, June 30, 2016 (unaudited)</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" width="9%" align="right">-</td><td style="PADDING-
BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom"
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td
 id="ffcell" style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="9%" 
align="right">(23,401</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%">)</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">176</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" 
align="right">(23,225</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%">)</td></tr><tr bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 
0px 0px 0px 15px">Balance, June 30, 2016 (unaudited)</p></td><td valign="bottom"
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
3px double" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td
id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" 
align="right">28,400,000</td><td style="PADDING-BOTTOM: 3px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
3px double" valign="bottom" width="1%">$</td><td id="ffcell" style="BORDER-
BOTTOM: black 3px double" valign="bottom" width="9%" 
align="right">28,400</td><td style="PADDING-BOTTOM: 3px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
3px double" valign="bottom" width="1%">$</td><td id="ffcell" style="BORDER-
BOTTOM: black 3px double" valign="bottom" width="9%" 
align="right">54,100</td><td style="PADDING-BOTTOM: 3px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
3px double" valign="bottom" width="1%">$</td><td id="ffcell" style="BORDER-
BOTTOM: black 3px double" valign="bottom" width="9%" 
align="right">(218,070</td><td style="PADDING-BOTTOM: 3px" valign="bottom" 
width="1%">)</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 3px double" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 3px double" valign="bottom" width="9%" align="right">100</td><td 
style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 3px double" valign="bottom" 
width="1%">$</td><td id="ffcell" style="BORDER-BOTTOM: black 3px double" 
valign="bottom" width="9%" align="right">(135,470</td><td style="PADDING-BOTTOM:
3px" valign="bottom" width="1%">)</td></tr></table></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">Note: All share and per 
share information has been restated for all periods presented giving retroactive
effect of the April 11, 2016 approved four to one forward stock split (see note 
8).</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"
align="center">The accompanying notes are an integral part of these condensed 
consolidated financial statements</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px" ><table id="pagebreakb403db52-be78-4400-b10b-10e0750082de" 
class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" border="0">    <tr><td 
class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; 
TEXT-ALIGN: center">6</td></tr><tr></tr><tr><td><div style="PAGE-BREAK-AFTER: 
always; LINE-HEIGHT: 0px"></div><div class="assignanchor"><a href="#Toc">Table 
of Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Madison Ventures Inc.</b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><strong>Condensed </strong><a 
name="CF"><b>Consolidated Statements of Cash Flows</b><b> 
(Unaudited)</b></a></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" 
><table style="WIDTH: 100%; TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" width="100%" border="0" >    <tr><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" colspan="6" align="center"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>Three Months Ended June 30,</b></p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" width="9%" colspan="2" align="center"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>2016</b></p></td><td 
style="PADDING-BOTTOM: 1px" valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: black 1px solid" 
valign="bottom" width="9%" colspan="2" align="center"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>2015</b></p></td><td style="PADDING-BOTTOM: 
1px" valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
colspan="2" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" colspan="2" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><b>Cash flows from operating activities:</b></p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" colspan="2" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" colspan="2" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px">Net (loss)</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">(23,401</td><td valign="bottom" width="1%">)</td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">(21,827</td><td valign="bottom" width="1%">)</td></tr><tr 
bgcolor="#ffffff"><td valign="top"><p style="MARGIN: 0px"><i>Adjustments to 
reconcile net loss to net cash (used in) provided by operating 
activities:</i></p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px">Stock accrued as employee 
compensation<i></i></p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">1,387</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">6,250</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p
style="MARGIN: 0px 0px 0px 15px"><i>Changes in operating assets and 
liabilities:</i></p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 30px">(Increase) in prepaid 
expenses</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">(461</td><td
 valign="bottom" width="1%">)</td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">-</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 30px">Decrease (increase) in miscellaneous 
receivable</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">2,703</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right">-
</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 30px">Decrease (increase) in deposit on technology 
license</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">-</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 30px">Increase in accounts payable</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right">24,338</td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right">7,647</td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 30px">(Decrease) in accrued 
liabilities</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(5</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td><td valign="bottom"
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px 
solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" 
align="right">-</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 45px">Net cash (used in) provided by 
operating activities</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">4,561</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(7,930</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td></tr><tr 
bgcolor="#cceeff"><td><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><b>Cash flows from investing 
activities:</b></p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Acquisition of technology 
license</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(88,827</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td><td valign="bottom"
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px 
solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" 
align="right">-</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 45px">Net cash (used in) investing 
activities</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: 1px solid" valign="bottom" width="9%" align="right">(88,827</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%">)</td><td valign="bottom"
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px 
solid" valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
id="ffcell" style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" 
align="right">-</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr 
bgcolor="#cceeff"><td><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom"
width="9%" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><b>Cash flows from financing 
activities:</b></p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Proceeds from related 
parties</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right">-
</td><td style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">7,930</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Proceeds from non-interest
bearing term-debt</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" 
align="right">110,000</td><td style="PADDING-BOTTOM: 1px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
1px solid" valign="bottom" width="1%"><p
 style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" width="9%" align="right">-</td><td style="PADDING-
BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px">Net cash provided by financing activities</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" width="9%" align="right">110,000</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">7,930</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b>Effect of exchange rate
changes on cash</b></p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">1,012</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Net increase (decrease) in
cash</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">25,746</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right">-
</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Cash, beginning of the period</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" width="9%" align="right">66,795</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><b>Cash, end of the period</b></p></td><td
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td><td 
id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" 
align="right">92,541</td><td style="PADDING-BOTTOM: 3px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
3px double" valign="bottom" width="1%">$</td><td id="ffcell" style="BORDER-
BOTTOM: black 3px double" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b>Non-cash investing and 
financing activities</b></p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%">$</td><td 
id="ffcell" valign="bottom" width="9%" align="right">-</td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%">$</td><td id="ffcell" valign="bottom" width="9%" align="right">-
</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%"
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b>Supplement cash flow 
disclosure:</b></p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 45px">Interest paid</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">-</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%">$</td><td id="ffcell" 
valign="bottom" width="9%" align="right">-</td><td valign="bottom" width="1%"><p
style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 45px">Income tax paid </p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">-</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%">$</td><td id="ffcell" 
valign="bottom" width="9%" align="right">-</td><td valign="bottom" width="1%"><p
style="MARGIN: 0px">&nbsp;</p></td></tr></table></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" align="center">The 
accompanying notes are an integral part of these condensed consolidated 
financial statements</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" 
><table id="pagebreak5e93bf2c-3e63-49cc-a736-d99ce7effd2b"
 class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" border="0">    <tr><td 
class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; 
TEXT-ALIGN: center">7</td></tr><tr></tr><tr><td><div style="PAGE-BREAK-AFTER: 
always; LINE-HEIGHT: 0px"></div><div class="assignanchor"><a href="#Toc">Table 
of Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Madison Ventures Inc.</b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><b><a name="NOTES">Notes to Condensed Consolidated 
Financial Statements (Unaudited)</a></b></p><p style="MARGIN: 0px; TEXT-INDENT: 
0px" align="center"><b>As of June 30, 2016</b></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><b>1.</b>&nbsp;<b>Condensed financial statements</b></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">The accompanying 
unaudited condensed consolidated financial statements are presented in United 
States dollars and are prepared using the accrual method of accounting which 
conforms to generally accepted accounting principles in the United States of 
America ("US GAAP") for interim financial reporting and the instructions for 
Form 10-Q pursuant to the rules and regulations of the Securities and Exchange 
Commission. Accordingly, they do not include all information and footnote 
disclosures necessary for a complete presentation of the financial position, 
results of operations, cash flows, and stockholders equity in conformity with 
generally accepted accounting principles. In the opinion of management, all 
adjustments considered necessary for a fair presentation of the results of 
operations and financial position have been included and all such adjustments 
are of a normal recurring nature.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">The unaudited condensed consolidated 
balance sheet of the Company as of June 30, 2016, and the related consolidated 
balance sheet of the Company as of March 31, 2016, which is derived from the 
Company's audited financial statements, the unaudited condensed consolidated 
statement of operations and cash flows for the Three Months ended June 30, 2016 
and 2015 and the condensed consolidated statement of stockholders equity for the
period of March 31, 2015 to June 30, 2016 and are included in this document. 
These unaudited condensed consolidated financial statements should be read in 
conjunction with the March 31, 2016 audited financial statements and related 
notes included in the Company's most recent Form 10-K as filed with the 
Securities and Exchange Commission on July 18, 2016.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">Operating results for 
the Three Months ended June 30, 2016 are not necessarily indicative of the 
results that can be expected for the year ending March 31, 2017.</p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><b>2.&nbsp;Nature of operations</b></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Madison Ventures Inc. ("Company") was 
incorporated in the State of Nevada as a for-profit company on September 14, 
2009 and established a fiscal year end of March 31. The Company initially was 
engaged in the acquisition, exploration and development of natural resource 
properties. On February 27, 2015, the Company terminated the acquisition of the 
mineral claim and entered into a letter of intent with Ocure Ltd. ("Ocure"), 
pursuant to which the Company agreed to exclusively license certain technology 
from Ocure related to the development of products and devices for the treatment 
of anal fissures (the "Ocure LOI"). On July 9, 2015, the Company established the
wholly-owned subsidiary Madison-IL Ltd., incorporated under the laws of the 
country of Israel to address the Company's requirement for an Israeli company to
operate and hold the assets associated with Ocure LOI. The Company has no 
revenues and has limited operating history.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">The success of the 
Company is dependent upon the development of products for the treatment of anal 
fissures, the ability of the Company to obtain the necessary financing to 
complete the acquisition, development and commercialize of the Licensed 
Technology, and upon future profitable operations.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><u>Use of Estimates and 
Assumptions</u><u></u></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px; TEXT-INDENT: 0px">The preparation of financial statements in conformity 
with accounting principles generally accepted in the United States of America 
requires management to make certain estimates and assumptions that affect the 
reported amounts of assets and liabilities and disclosure of contingent assets 
and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting periods presented. The Company is 
required to make judgments and estimates about the effect of matters that are 
inherently uncertain. The Company regularly evaluates estimates and assumptions 
related to the useful life and recoverability of long-lived assets, deferred 
income tax asset valuations and loss contingences. The Company bases its 
estimates and assumptions on current facts, historical experience and various 
other factors that it believes to be reasonable under the circumstances, the 
results of which form the basis for making judgments about the carrying value of
assets and liabilities and the accrual of costs and expenses that are not 
readily apparent from other sources. Although, we believe our judgments and 
estimates are appropriate, actual future results may be different; if different 
assumptions or conditions were to prevail, the results could be materially 
different from our reported results.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px" ><table id="pagebreaka851a264-1c40-4d84-ad3e-20b7e9d194e3" 
class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" border="0">    <tr><td 
class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; 
TEXT-ALIGN: center">8</td></tr><tr></tr><tr><td><div style="PAGE-BREAK-AFTER: 
always; LINE-HEIGHT: 0px"></div><div class="assignanchor"><a href="#Toc">Table 
of Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Madison Ventures Inc.</b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><b>Notes to Condensed Consolidated Financial 
Statements (Unaudited)</b></p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>As of June 30, 2016</b></p><p style="MARGIN: 0px">&nbsp;</p><p
style="MARGIN: 0px; TEXT-INDENT: 0px"><b>2.&nbsp;Nature of operations 
(continued)</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><u>License Agreement</u></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">On February 27, 2015, we entered into a
letter of intent (the "Letter of Intent") with Ocure Ltd. ("Ocure"), an Israeli 
corporation, pursuant to which the Company would be obligated to exclusively 
license certain technology from Ocure under terms of a license agreement to be 
negotiated between the Company and Ocure. The Letter of Intent terminated when 
the Company did not make the second required payment, however the Company 
continued to negotiate with Ocure. On August 5, 2015, as amended February 26, 
2016, the company entered into an exclusive license agreement (the "License 
Agreement") with Ocure and Madison-IL Ltd., a wholly-owned subsidiary of the 
Company incorporated in Israel on July 9, 2015 (the "Subsidiary"). Pursuant to 
the License Agreement, Ocure granted to the Subsidiary an exclusive, sub-
licensable, worldwide, license (the "License") to Ocure's semi-occlusive wound 
dressing for ambulatory treatment of acute and chronic anal fissure, pursuant to
Ocure's patents and patent applications (the "Licensed Technology") and to its 
production, use, import, offer for sale, sell, lease, distribute, or otherwise 
commercialize the Licensed Technology for uses classified as medical devices, or
those otherwise approved ultimately as an OTC (over-the-counter) remedy.</p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">Under the
License Agreement, the Company is obligated as consideration for the Licensed 
Technology to provide the Subsidiary $250,000 for the commercialization of the 
Licensed Technology, payable according to the following schedule: $10,000 upon 
execution of the Letter of Intent (paid February 27, 2015 to Ocure), $90,000 at 
the later of May 11, 2015 or the final signing date of the License Agreement 
(the "Effective Date"), and $50,000 on or before March 4, 2016, and $100,000 on 
or before April 8, 2016 (collectively, the "First $250,000 Tranche"). The 
Effective Date will occur upon satisfaction of the Condition Precedent, as 
defined in the License Agreement, and approval of the Agreement by the Chief 
Scientist of the Israeli Ministry of the Economy. The License Agreement 
Effective Date is November 11, 2015; the date approval of the Chief Scientist of
the Israeli Ministry of the Economy was received. Upon the 6-month anniversary 
of the Effective Date, if the Company has paid the First $250,000 Tranche, then 
Ocure will transfer certain assets, as defined, to the Subsidiary, and the 
Company will be obligated to provide the Subsidiary a second $250,000 tranche, 
payable as follows: $100,000 on or before August 12, 2016, $100,000 on or before
September 23, 2016, and $50,000 on or before October 28, 2016. The License 
Agreement
 terminates, on a country-by-country basis, the later of: (a) the date of 
expiration of the last to expire of Ocure's rights in Ocure Patents in such 
country or such other grant of statutory exclusivity, or (b) the end of a period
of fifteen (15) years from the date of making the first commercial sale, as 
defined, in such country; unless sooner terminated pursuant to the terms of the 
License Agreement. As of June 30, 2016 and March 31, 2016, the Company has 
advanced $221,850 and $131,850, respectively, to the Subsidiary and paid Ocure 
$10,000 in furtherance of the commercialization of the Licensed Technology. 
</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px">Immediately after the Effective Date of the License Agreement and for the 
period ending March 31, 2016 (as amended), the shareholders of Ocure and certain
individuals designated by Ocure will have opportunity to purchase up to an 
aggregate of 7,100,000 (1,775,000 presplit) shares of the Company's Common Stock
at the par value of $0.001 per share. In addition, the Company will establish an
incentive stock option plan reserving up to 20% of the Company's issued share 
capital, as of the closing. The right to purchase an aggregate of 7,100,000 
(1,775,000 presplit) shares of the Company's Common Stock expired unexercised, 
but by mutual agreement the purchase right will be extended under similar 
terms.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px">In consideration of the license for the Licensed Technology and with 
respect to any inventions, improvement, development or enhancement based upon, 
consists of, comprises, contains or incorporates the Licensed Technology 
invented following the Effective Date by the Subsidiary, its affiliate or 
sublicensee (the "New Inventions"), the Subsidiary will pay to Ocure royalties 
calculated as 5% of gross sales. In addition, the Subsidiary will pay to Ocure 
20% of any cash or non-cash consideration received, whether for sublicense 
initiation fee, annual fee, sublicense milestone payments, or other such non-
sale based royalty consideration payable by a sublicense as consideration for or
under a sublicense.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"
><table id="pagebreakeac036a9-4cf6-40cf-8754-ae005ecc225d" class="pagebreak" 
style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
border="0">    <tr><td class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-
BOTTOM: black 1px solid; TEXT-ALIGN: center">9</td></tr><tr></tr><tr><td><div 
style="PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div><div 
class="assignanchor"><a href="#Toc">Table of 
Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Madison Ventures Inc.</b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><b>Notes to Condensed Consolidated Financial 
Statements (Unaudited)</b></p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>As of June 30, 2016</b></p><p style="MARGIN: 0px">&nbsp;</p><p
style="MARGIN: 0px; TEXT-INDENT: 0px"><b>2.&nbsp;Nature of operations 
(continued)</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><u>Mineral Properties</u></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Mineral property acquisition costs are 
capitalized in accordance with Codification topic 930 "Extractive Activities - 
Mining". Mineral property pre-exploration and exploration costs are expensed as 
incurred. When it has been determined that a mineral property can be 
economically developed as a result of establishing proven and probable reserves,
the costs incurred to develop such property are capitalized. The Company did not
establish any reserves on its mineral properties prior to terminating its option
under the Revised and Restated Mineral Property Option Agreement (see footnote 
3).</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><u>Rehabilitation Provisions</u></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">The Company was subject to various 
government laws and regulations relating to environmental disturbances which are
caused by exploration and evaluation activities. The Company will record the 
present value for the estimated costs of legal and constructive obligations 
required to restore the exploration sites in the period in which the obligation 
is incurred. The nature of the rehabilitation activities includes restoration, 
reclamation and re-vegetation of the affected exploration sites. The Company has
determined that there were no rehabilitation provisions at February 27, 2015 
when the option to acquire the mineral claim was terminated.<u></u></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><u>Share-
based Compensation</u></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px; TEXT-INDENT: 0px">Codification topic 718 "Stock Compensation" requires that
the cost resulting from all share-based transactions be recorded in the 
financial statements and establishes fair value as the measurement objective for
share-based payment transactions with employees and acquired goods or services 
from non-employees. The codification also provides guidance on valuing and 
expensing these awards, as well as disclosure requirements of these equity 
arrangements. The Company adopted the codification upon creation of the company 
and will expense share based costs in the period incurred. The Company has not 
adopted a stock option plan or completed a share-based transaction; accordingly 
no stock-based compensation has been recorded to date.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><u>Recent Accounting 
Pronouncements</u></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">The Company's management has evaluated all the recently 
issued, but not yet effective, accounting standards that have been issued or 
proposed by the FASB or other standards-setting bodies through the filing date 
of these financial statements and does not believe the future adoption of any 
such pronouncements will have a material effect on the Company's financial 
position and results of operations.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><b>3.&nbsp;Mineral claim</b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">On March 
3, 2012, the Company entered into a Revised and Restated Mineral Property Option
Agreement with 3 individuals (the "Optionors") for an exclusive and irrevocable 
three year option to acquire a 100% undivided interest in three contiguous 
unpatented mining claims comprising 34 units (the "Claim" or the "Property") 
situated in the Thunder Bay Mining Division in the province on Ontario, Canada 
(the "Agreement"). The option payments aggregating $30,000 (U.S. Dollars) (the 
"Option Price") were due: i) $15,000 upon signing but deferred for eight months,
ii) $5,000 on or before March 3, 2013, iii) $5,000 on or before March 3, 2014,
and iv) $5,000 on or before March 3, 2015 (the "Option Payments"). During the 
term of the Agreement the Company is granted free and unrestricted access and 
use of the Property to act as the operator of the Property with the right to 
bring buildings, plant, equipment, machinery, tools, appliances and supplies 
onto the Property. The Optionors hold title to the Property until the full 
payment of the Option Price. Upon full payment of the Option Price the Optionors
would deliver a duly executed transfer of mining claims in respect of the 
Property to transfer a 100% undivided interest in the Property to the Company 
free and clear of all encumbrances except for a retained net smelter return 
royalty (the "NSR"). The NSR is a 2% royalty paid within 30 days of each 
calendar month calculated, as defined, from gross Property revenues less 
permissible deductions. The Company had the right, at any time, to reduce the 
NSR to a 1% royalty by a One Million Dollar payment to the Optionors.</p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" ><table 
id="pagebreake2f737b1-9d72-4cfd-9430-11a1cfdb774f" class="pagebreak" 
style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
border="0">    <tr><td class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-
BOTTOM: black 1px solid; TEXT-ALIGN: center">10</td></tr><tr></tr><tr><td><div 
style="PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div><div 
class="assignanchor"><a href="#Toc">Table of 
Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Madison Ventures Inc.</b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><b>Notes to Condensed Consolidated Financial 
Statements (Unaudited)</b></p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>As of June 30, 2016</b></p><p style="MARGIN: 0px">&nbsp;</p><p
style="MARGIN: 0px; TEXT-INDENT: 0px"><b>3.&nbsp;Mineral 
claim</b><strong>(continued)</strong></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Upon the February 27, 2015 termination of 
the Agreement had the Company brought any buildings, plant, equipment, 
machinery, tools, appliances and supplies onto the Property it would have been 
responsible to remove all such items not later than twelve months after 
termination of the Agreement unless arrangements are made with the Optionors to 
retain some or all of the items brought onto the Property.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">The Company deferred the
first option payment for an eight month term and made the $15,000 payment on 
October 27, 2012. Upon execution of the Agreement, the Company recorded the 
first option payment net of
 imputed interest as $14,984 and accrued the imputed interest ratably over the 
deferral period. Annually the Company had the option to retain the mineral claim
and make the next contractual Option Payment or to terminate the Agreement. The 
Company made the March 3, 2013 Option Payment on March 1, 2013 and the March 3, 
2014 Option Payment on February 25, 2014. On February 27, 2015, the Company 
concluded to terminate the Agreement and not make the final Option Payment. The 
aggregate total of $24,984 previously included in the mineral claim was expensed
as a discontinued operation.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Previously in response to the new GPS 
standards for unpatented claims issued by the Ontario Ministry of Northern 
Development and Mines, the Company expended $1,975 to provide upgraded geo-
referenced location information on its Claim during the quarter ended September 
30, 2013. An aggregate total of zero and $1,975 have been expensed for 
exploration and evaluation of the Company's Claim as of March 31, 2015 and 2014,
respectively.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><b>4.&nbsp;Investment in technology license</b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">On August
5, 2015, as amended February 26, 2016, the company entered into an exclusive 
license agreement (the "License Agreement") with Ocure and Madison-IL Ltd., a 
wholly-owned subsidiary of the Company incorporated in Israel on July 9, 2015 
(the "Subsidiary"). Pursuant to the License Agreement, Ocure granted to the 
Subsidiary an exclusive, sub-licensable, worldwide, license (the "License") to 
Ocure's semi-occlusive wound dressing for ambulatory treatment of acute and 
chronic anal fissure, pursuant to Ocure's patents and patent applications (the 
"Licensed Technology") and to its production, use, import, offer for sale, sell,
lease, distribute, or otherwise commercialize the Licensed Technology for uses
classified as medical devices, or those otherwise approved ultimately as an OTC 
(over-the-counter) remedy.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN:
0px; TEXT-INDENT: 0px">Under the License Agreement, the Company is obligated as 
consideration for the Licensed Technology to provide the Subsidiary $250,000 for
the commercialization of the Licensed Technology, payable according to the 
following schedule: $10,000 upon execution of the Letter of Intent, $90,000 at 
the later of May 11, 2015 or the final signing date of the License Agreement 
(the "Effective Date"), and $50,000 on or before March 4, 2016, and $100,000 on 
or before April 8, 2016 (collectively, the "First $250,000 Tranche"). The 
License Agreement Effective Date is November 11, 2015; the date approval of the 
Chief Scientist of the Israeli Ministry of the Economy was received. Upon the 6-
month anniversary of the Effective Date, if the Company has paid the First 
$250,000 Tranche, then Ocure will transfer certain assets, as defined, to the 
Subsidiary, and the Company will be obligated to provide the Subsidiary a second
$250,000 tranche, payable as follows: $100,000 on or before August 12, 2016, 
$100,000 on or before September 23, 2016, and $50,000 on or before October 28, 
2016. The License Agreement terminates, on a country-by-country basis, the later
of: (a) the date of expiration of the last to expire of Ocure's rights in Ocure 
Patents in such country or such other grant of statutory exclusivity, or (b) the
end of a period of fifteen (15) years from the date of making the first 
commercial sale, as defined, in such country; unless sooner terminated pursuant 
to the terms of the License Agreement. As of June 30, 2016 and March 31, 2016, 
the Company has advanced $221,850 and $131,850, respectively, to the Subsidiary 
and paid Ocure $10,000 in furtherance of the commercialization of the Licensed 
Technology. </p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px">As of June 30, 2016 and March 31, 2016, the Company has expended 
and aggregate of $169,606 and $70,998 recorded as the investment in technology 
license, respectively.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px; TEXT-INDENT: 0px">The Company was in default of its payment schedule by 
June 30, 2016 and no assets had been transferred to the Company's subsidiary. As
of the date of filing of this 10-Q, the Company is also in default of its 
$100,000 payment that was due August 12, 2016. There is no extension agreement 
or amendment negotiated, and there is a risk that the License will be cancelled.
</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" ><table 
id="pagebreak19b134a2-a0a2-474d-a9e1-64c381d84b15" class="pagebreak" 
style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
border="0">    <tr><td class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-
BOTTOM: black 1px solid; TEXT-ALIGN: center">11</td></tr><tr></tr><tr><td><div 
style="PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div><div 
class="assignanchor"><a href="#Toc">Table of 
Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Madison Ventures Inc.</b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><b>Notes to Condensed Consolidated Financial 
Statements (Unaudited)</b></p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>As of June 30, 2016</b></p><p style="MARGIN: 0px">&nbsp;</p><p
style="MARGIN: 0px; TEXT-INDENT: 0px"><b>5.&nbsp;Due to related party</b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">Due to 
related parties at June 30, 2016 and March 31, 2016 consisted of the 
following:</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" ><table 
style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" 
cellpadding="0" width="85%" align="center" border="0" >    <tr><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>June 
30,</b></p></td><td valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" 
valign="bottom" colspan="2" align="center"><p style="MARGIN: 0px; TEXT-INDENT: 
0px" align="center"><b>March 31,</b></p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td></tr><tr><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: 1px solid" 
valign="bottom" colspan="2" align="center"><p style="MARGIN: 0px; TEXT-INDENT: 
0px" align="center"><b>2016</b></p></td><td style="PADDING-BOTTOM: 1px"
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: 1px 
solid" valign="bottom" colspan="2" align="center"><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><b>2016</b></p></td><td style="PADDING-BOTTOM: 1px" 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" colspan="2" align="right"><p
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" colspan="2" align="right"><p
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top" width="76%"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Balance at beginning of period</p></td><td
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">213,442</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%">$</td><td id="ffcell" 
valign="bottom" width="9%" align="right">25,523</td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px; TEXT-INDENT: 0px">Funds 
advanced</p></td><td valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" 
valign="bottom" align="right">-</td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" 
align="right">187,919</td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 15px; TEXT-INDENT: 0px">Funds repaid</p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" 
align="right">-</td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" align="right">-</td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr 
bgcolor="#ffffff"><td valign="top"><p style="MARGIN: 0px 0px 0px 15px; TEXT-
INDENT: 0px">Funds forgiven</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 1px solid" valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: 1px 
solid" valign="bottom" align="right">-</td><td style="PADDING-BOTTOM: 1px" 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td
 valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM:
1px solid" valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
style="BORDER-BOTTOM: 1px solid" valign="bottom" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Balance at end of period</p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 
3px double" valign="bottom">$</td><td id="ffcell" style="BORDER-BOTTOM: 3px 
double" valign="bottom" align="right">213,442</td><td style="PADDING-BOTTOM: 
3px" valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: 
3px double" valign="bottom">$</td><td id="ffcell" style="BORDER-BOTTOM: 3px 
double" valign="bottom" align="right">213,442</td><td style="PADDING-BOTTOM: 
3px" valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">On July 
3, July 8, July 10, August 12, November 12, November 13, 2014, January 23, 
February 27, March 5, May 16, June 17, June 30, July 6, August 13, November 17, 
2015, February 13, February 20, March 7, and March 17,2016 a shareholder of the 
Company advanced the Company $2,000, $775, $1,460, $2,000, $2,000, $1,763, 
$2,000, $10,000, $3,525, $4,093, $2,755, $1,083, $5,000, $3,000, $2,041, $961, 
$5,000, $3,300, and $50,000, respectively, as a series of unsecured obligations.
The funds aggregating $102,756 were used to pay operating costs of the Company. 
The aggregate obligations bears no interest, has no fixed term and is not 
evidenced by any written agreement. The shareholder is under no obligation to 
advance additional funds to the Company.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">On December 3, December 24, 2015, January 
4, January 6, and January 15, 2016 a shareholder of the Company advanced the 
Company $37,473, $7,500, $7,326, $8,412, and $49,975, respectively, as a series 
of unsecured obligations. The funds aggregating $110,686 were used to pay 
operating costs of the Company. On January 8, 2016, the aggregate advances 
received and future advances were structured as a noninterest bearing unsecured 
non-recourse loan due January 31, 2017. The shareholders, if requested by the 
Company, agreed to advance additional funds to the Company up to a maximum of 
$250,000 subject to certain timing limitation as defined.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b>6.</b>&nbsp;<b>Long-
term debt</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px">Long term debt at June 30, 2016 and March 31, 2016 consisted of the
following:</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" ><table 
style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" 
cellpadding="0" width="85%" align="center" border="0" >    <tr><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" valign="bottom" colspan="2" 
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>June 
30,</b></p></td><td valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" 
valign="bottom" colspan="2" align="center"><p style="MARGIN: 0px; TEXT-INDENT: 
0px" align="center"><b>March 31,</b></p></td><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td></tr><tr><td valign="bottom"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="hdcell" style="BORDER-BOTTOM: 1px solid" 
valign="bottom" width="9%" colspan="2" align="center"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>2016</b></p></td><td style="PADDING-BOTTOM: 
1px" valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td><td id="hdcell" 
style="BORDER-BOTTOM: 1px solid" valign="bottom" width="9%" colspan="2" 
align="center"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>2016</b></p></td><td style="PADDING-BOTTOM: 1px" 
valign="bottom"><p style="MARGIN: 0px">&nbsp;</p></td></tr><tr><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
colspan="2" align="right"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell"
valign="bottom" width="9%" colspan="2" align="right"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Balance at beginning of period</p></td><td
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="bottom" width="1%">$</td><td id="ffcell" valign="bottom" width="9%" 
align="right">-</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%">$</td><td id="ffcell" 
valign="bottom" width="9%" align="right">-</td><td valign="bottom" width="1%"><p
style="MARGIN: 0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td 
valign="top"><p style="MARGIN: 0px 0px 0px 15px; TEXT-INDENT: 0px">Funds 
advanced</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" 
align="right">110,000</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td id="ffcell" valign="bottom" width="9%" align="right">-
</td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px 0px 0px 15px; TEXT-INDENT: 0px">Funds repaid</p></td><td
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: black 1px solid" valign="bottom" width="1%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-BOTTOM: black 
1px solid" valign="bottom" width="9%" align="right">-</td><td style="PADDING-
BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black 1px solid" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td id="ffcell" style="BORDER-
BOTTOM: black 1px solid" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 1px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr><tr bgcolor="#ffffff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Balance at end of period</p></td><td 
valign="bottom" width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
style="BORDER-BOTTOM: black 3px double" valign="bottom" width="1%">$</td><td 
id="ffcell" style="BORDER-BOTTOM: black 3px double" valign="bottom" width="9%" 
align="right">110,000</td><td style="PADDING-BOTTOM: 3px" valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="bottom" 
width="1%"><p style="MARGIN: 0px">&nbsp;</p></td><td style="BORDER-BOTTOM: black
3px double" valign="bottom" width="1%">$</td><td id="ffcell" style="BORDER-
BOTTOM: black 3px double" valign="bottom" width="9%" align="right">-</td><td 
style="PADDING-BOTTOM: 3px" valign="bottom" width="1%"><p style="MARGIN: 
0px">&nbsp;</p></td></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">On April 18, 2016, the Company entered 
into a five year non-interest bearing loan agreement for $110,000. Proceeds were
used to fund the Technology acquisition and operations. If the loan is not 
repaid on or before April 15, 2021 the loan amount will be subject to default 
interest on the amount then outstanding of ten percent (10%) per month during 
the first 30 days of delinquency, fifteen percent (15%) per month during the 31 
to 60 days of delinquency, twenty percent (20%) per month during the 61 to 90 
days of delinquency (the "Default Interest"). If the loan amount remains unpaid 
after 90 days the lender, at its option, will be entitled to a default payment 
of one hundred fifty-nine percent (159%) of the then outstanding loan amount 
inclusive of the Default Interest.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px" ><table id="pagebreakc6f6de79-2b62-4edb-9647-0849394df2c6" 
class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" border="0">    <tr><td 
class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; 
TEXT-ALIGN: center">12</td></tr><tr></tr><tr><td><div style="PAGE-BREAK-AFTER: 
always; LINE-HEIGHT: 0px"></div><div class="assignanchor"><a href="#Toc">Table 
of Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Madison Ventures Inc.</b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><b>Notes to Condensed Consolidated Financial 
Statements (Unaudited)</b></p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>As of June 30, 2016</b></p><p style="MARGIN: 0px">&nbsp;</p><p
style="MARGIN: 0px; TEXT-INDENT: 0px"><b>7.&nbsp;Related party 
transactions</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px"><u>Employment Agreements</u></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">On April
 2, 2014, Mr. Gene Gregorio was appointed the Company's President, Chief 
Executive Officer, Chief Financial Officer and sole Director. On April 20, 2014,
the Company agreed to issue Mr. Gregorio 1,000,000 (250,000 presplit) restricted
shares of the Company's Common Stock, valued at $25,000, based on the market 
close, as compensation for his services for an initial term of one year (the 
"April 20<sup>th</sup> Agreement"). On March 31, 2015, the Company issued Mr. 
Gregorio the agreed 250,000 restricted shares of the Company's Common Stock. At 
March 31, 2015, $1,387 was recorded as a prepaid expense for the period April 1 
to April 20, 2015.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">In addition, if during the term of the April 20<sup>th</sup> 
Agreement Mr. Gregorio's direct efforts result in a consummated financing for 
the Company he shall be paid a 5.0% fee on such financing received by the 
Company, at his option, as either cash or shares of Company's Common Stock at 
the offering price. Additionally, the Company will grant Mr. Gregorio a 2 year 
stock option priced at the current market trading price equal to 5% of the
aggregate shares issued to investors within the financing.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">On April 14, 2015, the 
April 20<sup>th</sup> Agreement with Mr. Gene Gregorio was extended for a second
year under the same terms and conditions. Mr. Gregorio will be issued 1,000,000 
(250,000 presplit) restricted shares of the Company's Common Stock, valued at 
$25,000, based on the market close, as compensation for his services for the 
second year the extended April 20<sup>th</sup> Agreement. At June 30, 2016, 
$25,000 was recorded as an accrued liability for the period April 21, 2015 to 
April 20, 2016. </p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">On August 9, 2016, the Company issued Mr. Gregorio the agreed 
1,000,000 (presplit 250,000) restricted shares of the Company's Common 
Stock.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><b>8.&nbsp;Going concern</b></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">These financial statements have been 
prepared on a going concern basis which assumes the Company will be able to 
realize its assets and discharge its liabilities in the normal course of 
business for the foreseeable future. The Company anticipates future losses in 
the development of its business raising substantial doubt about the Company's 
ability to continue as a going concern. The ability to continue as a going 
concern is dependent upon the Company generating profitable operations in the 
future and/or to obtain the necessary financing to meet its obligations and 
repay its liabilities arising from normal business operations when they come 
due. The Company's operating expenditure plan for the next fiscal year ending 
March 31, 2017 will require cash of approximately $500,000. Management intends 
to finance operating costs over the next twelve months with the issuance of 
common shares and/or related party borrowings.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b>9.&nbsp;Capital 
stock</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px">The Company's capitalization is 300,000,000 shares of common stock,
with a par value of $0.001 per share, with 28,400,000 shares issued and 
outstanding at March 31, 2016 and 2015. On April 11, 2016, the Company effected 
a four for one forward stock split of our i) authorized and ii) issued and 
outstanding shares of common stock. All share information has been restated for 
all periods presented giving retroactive effect of the April 11, 2016 four to 
one forward stock split. Prior to the forward stock split the Company had 
75,000,000 authorized shares of common stock, with a par value of $0.001 per 
share and 7,100 shares issued and outstanding at March 31, 2016 and 2015.</p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">As of 
June 30, 2016 and March 31, 2016, the Company has not granted any stock options 
or stock warrants. As a requirement of the Ocure License Agreement, the Company 
will establish an incentive stock option plan reserving up to 20% of the 
Company's issued and outstanding common stock, as of the closing of the License 
Agreement.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" ><table 
id="pagebreaka4b5dbc0-8087-4ef2-808e-1cf3a5bd68ac" class="pagebreak" 
style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
border="0">    <tr><td class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-
BOTTOM: black 1px solid; TEXT-ALIGN: center">13</td></tr><tr></tr><tr><td><div 
style="PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div><div 
class="assignanchor"><a href="#Toc">Table of 
Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>Madison Ventures Inc.</b></p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="center"><b>Notes to Condensed Consolidated Financial 
Statements</b></p><p style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>As 
of June 30, 2016</b></p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><strong></strong>&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><b>10</b><b>.&nbsp;Contingency Liability</b></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">The Licensed Technology 
requires an aggregate first tranche payment to the Subsidiary of $250,000 by 
April 8, 2016; an aggregate of $231,850 has been advanced to the Subsidiary as 
of June 30, 2016. Upon the 6-month anniversary of the Effective Date, if the 
Company has paid the First $250,000 Tranche, then Ocure will transfer certain 
assets, as defined, to the Subsidiary, and the Company will be obligated to 
provide the Subsidiary a second $250,000 tranche, payable as follows: $100,000
on or before August 12, 2016, $100,000 on or before September 23, 2016, and 
$50,000 on or before October 28, 2016.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><b>11.&nbsp;Subsequent events</b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">On August
9, 2016, pursuant to the terms of the April 20<sup>th</sup> Agreement the 
Company issued 1,000,000 (250,000 presplit) shares of the Company's Common Stock
at Mr. Gene Gregorio the Company's President, Chief Executive Officer, Chief 
Financial Officer and sole Director.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">On August 12, 2016, the Company failed to 
pay an amount due under the August 5, 2015 Licensing Agreement. The Company has 
not negotiated the terms of any extension and there is a substantial risk the 
agreement will be cancelled.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px" ><table id="pagebreak9ce04a3c-40f1-4ab1-8fcb-c53a5a53023d" 
class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" border="0">    <tr><td 
class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; 
TEXT-ALIGN: center">14</td></tr><tr></tr><tr><td><div style="PAGE-BREAK-AFTER: 
always; LINE-HEIGHT: 0px"></div><div class="assignanchor"><a href="#Toc">Table 
of Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b><a 
name="ITEM2">ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS.</a></b></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">The following information should be read 
in conjunction with (i) the financial statements of Madison Ventures Inc., a 
Nevada corporation (the "Company"), an development stage company, and the notes 
thereto appearing elsewhere in this Form 10-Q together with (ii) the more 
detailed business information and the March 31, 2016 audited financial 
statements and related notes included in the Company's Form 10-K (File No. 333-
188753; the "Form 10-K"), as filed with the Securities and Exchange Commission 
on July 18, 2016. Statements in this section and elsewhere in this Form 10-Q 
that are not statements of historical or current fact constitute "forward-
looking" statements</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px"><b>OVERVIEW</b></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">The Company was incorporated in the State 
of Nevada on September 14, 2009 and established a fiscal year end of March 31. 
It is a development-stage company.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">During early 2015, we decided to abandon 
our mineral exploration properties and on February 27, 2015, we entered into a 
letter of intent with Ocure, pursuant to which we agreed to exclusively license 
certain technology from Ocure related to the development of products and devices
for the treatment of anal fissures under terms of a license agreement to be 
negotiated between us and Ocure.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">On August 5, 2015, as amended February 25,
2016, our company and Madison-IL Ltd. entered into an exclusive license 
agreement with Ocure to license Ocure's semi-occlusive wound dressing for 
ambulatory treatment of acute and chronic anal fissure, pursuant to Ocure's 
patents and patent applications and to its production, use, import, offer for 
sale, sell, lease, distribute, or otherwise commercialize the Licensed 
Technology for uses classified as medical devices, or those otherwise approved 
ultimately as an OTC (over-the-counter) remedy.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">With this licensing we 
are
 focusing our efforts on the development of products for the treatment of anal 
fissures. We abandoned our efforts in the mineral exploration industry. </p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">Based on 
the licensed technology, we intend to develop and produce propriety devices that
present a novel approach for treating anal fissures that is safe and simple to 
use by patients with minimal discomfort. However, we are in default of our 
obligations under the August 5, 2015 Licensing Agreement and cannot be sure that
it will be brought into good standing. We don't currently have the resources to 
pay the outstanding amounts we owe under the agreement, and there is a 
substantial risk the license we negotiated will be cancelled. </p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b>Going 
Concern</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px">To date the Company has little operations or revenues and 
consequently has incurred recurring losses from operations. No revenues are 
anticipated until we complete the financing we endeavor to obtain, as described 
in the Form 10-K, and implement our initial business plan. The ability of the 
Company to continue as a going concern is dependent on raising capital to fund 
our business plan and ultimately to attain profitable operations. Accordingly, 
these factors raise substantial doubt as to the Company's ability to continue as
a going concern.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">The Company plans to raise additional funds through debt or 
equity offerings. There is no guarantee that the Company will be able to raise 
any capital through this or any other offerings.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px" ><table id="pagebreak90c82bbe-5074-4752-
9be6-b95fd3780180" class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW 
ROMAN" cellspacing="0" cellpadding="0" border="0">    <tr><td 
class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; 
TEXT-ALIGN: center">15</td></tr><tr></tr><tr><td><div style="PAGE-BREAK-AFTER: 
always; LINE-HEIGHT: 0px"></div><div class="assignanchor"><a href="#Toc">Table 
of Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b>PLAN 
OF OPERATION</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">Our intended plan of operation for the twelve months following
the date of this filing is to continue to attempt to meet the conditions of the 
Exclusive License Agreement in order to continue licensing and integrate 
technology from Ocure related to the development of products and devices for the
treatment of anal fissures into our business. </p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b>RESULTS OF 
OPERATIONS</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><b><u>Three-Months Ended June 30, 2016 and 2015</u></b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">We 
recorded no revenues for the three months ended June 30, 2016 and 2015. </p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">For the 
three months ended June 30, 2016, total operating costs were $20,069, consisting
of consulting and professional fees of $14,885, stock-based compensation of 
$1,387 and general and administrative expenses of $3,797. By comparison, for the
three months ended June 30, 2015, total operating costs were $21,827, consisting
of $15,577 of consulting and professional fees and $6,250 of stock-based 
compensation. There were net losses of $23,401 and $21,827, respectively, during
these periods. The decrease in net loss is due primarily to a $4,863 decrease in
stock based compensation offset by a $3,797 increase in other general and 
administrative expenses and Foreign exchange loss $3,332.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b><u>Liquidity and 
Capital Resources</u></b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px; TEXT-INDENT: 0px">At June 30, 2016, we had a cash balance of $92,541, total
current liabilities of approximately $292,233 and working capital deficit of 
$195,076 and a stockholders' deficit of approximately $135,470. We do not have 
sufficient cash on hand to fund our ongoing operational expenses. We will need 
to raise funds to commence fund our ongoing operational expenses. Additional 
funding will likely come from equity financing from the sale of our common. If 
we are successful in completing an equity financing, existing shareholders will 
experience dilution of their interest in our Company. We do not have any 
financing arranged and we cannot provide investors with any assurance that we 
will be able to raise sufficient funding from the sale of our common stock to 
fund ongoing operational expenses. In the absence of such financing, our 
business will likely fail. There are no assurances that we will be able to 
achieve further sales of our common stock or any other form of additional 
financing. If we are unable to achieve the financing necessary to continue our 
plan of operations, then we will not be able to continue our operations and our 
business will fail.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px"><b><u>Subsequent Events</u></b></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">On August 9, 2016, 
pursuant to the terms of the April 20<sup>th</sup> Agreement the Company issued 
1,000,000 (250,000 presplit) shares of the Company's Common Stock at Mr. Gene 
Gregorio the Company's President, Chief Executive Officer, Chief Financial 
Officer and sole Director.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN:
0px; TEXT-INDENT: 0px">On August 12, 2016, we failed to pay an amount due under 
the August 5, 2015 Licensing Agreement. We have not negotiated the terms of any 
extension and there is a substantial risk the agreement will be cancelled.</p><p
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" ><table 
id="pagebreakd1b32cb0-dcad-4ac0-9b79-00cea2f8ea38" class="pagebreak" 
style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
border="0">    <tr><td class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-
BOTTOM: black 1px solid; TEXT-ALIGN: center">16</td></tr><tr></tr><tr><td><div 
style="PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div><div 
class="assignanchor"><a href="#Toc">Table of 
Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b><a 
name="ITEM3">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET 
RISK.</a></b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px">As a smaller reporting company (as defined in Rule 12b-2 of the 
Exchange Act), we are not required to provide the information called for by this
Item 3.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><b><a name="ITEM4">ITEM 4. CONTROLS AND PROCEDURES.</a></b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><b>DISCLOSURE CONTROLS AND PROCEDURES</b></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">Under the supervision 
and with the participation of our management, our principal executive officer 
and principal financial officer are responsible for conducting an evaluation of 
the effectiveness of the design and operation of our disclosure controls and 
procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities 
Exchange Act of 1934, as of the end of the fiscal quarter covered by this 
report. Disclosure controls and procedures means that the material information 
required to be included in our Securities and Exchange Commission reports is 
recorded, processed, summarized and reported within the time periods specified 
in SEC rules and forms relating to our company, including any consolidating 
subsidiaries, and was made known to us by others within those entities, 
particularly during the period when this report was being prepared. Based on 
this evaluation, our principal executive officer and principal financial officer
concluded as of the evaluation date that our disclosure controls and procedures 
were not effective as of June 30, 2016.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">There were no changes in the Company's 
internal controls over financial reporting during the most recently completed 
fiscal quarter that have materially affected or are reasonably likely to 
materially affect the Company's internal control over financial reporting.</p><p
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px" ><table 
id="pagebreak0ff38d55-80c8-4666-8db8-c182947c4196" class="pagebreak" 
style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
border="0">    <tr><td class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-
BOTTOM: black 1px solid; TEXT-ALIGN: center">17</td></tr><tr></tr><tr><td><div 
style="PAGE-BREAK-AFTER: always; LINE-HEIGHT: 0px"></div><div 
class="assignanchor"><a href="#Toc">Table of 
Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b><a name="Part2">PART II. OTHER INFORMATION</a></b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b><a 
name="ITEM1_2">ITEM 1. LEGAL PROCEEDINGS.</a></b></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">The Company is not 
currently subject to any legal proceedings. From time to time, the Company may 
become subject to litigation or proceedings in connection with its business, as 
either a plaintiff or defendant. There are no such pending
 legal proceedings to which the Company is a party that, in the opinion of 
management, is likely to have a material adverse effect on the Company's 
business, financial condition or results of operations.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
name="ITEM1a_2"><b>ITEM 1A. </b><b>RISK FACTORS</b></a></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">As a smaller reporting 
company (as defined in Rule 12b-2 of the Exchange Act), we are not required to 
provide the information called for by this Item 1A.</p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b><a
name="ITEM2_2">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF 
PROCEEDS.</a></b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">None.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px; TEXT-INDENT: 0px"><b><a name="ITEM3_2">ITEM 3. DEFAULTS UPON SENIOR 
SECURITIES.</a></b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">None.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px; TEXT-INDENT: 0px"><b><a name="ITEM4_2">ITEM 4. MINE SAFETY 
DISCLOSURES.</a></b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">None.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px; TEXT-INDENT: 0px"><b><a name="ITEM5_2">ITEM 5. OTHER 
INFORMATION.</a></b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">None.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px" ><table id="pagebreake87798a7-8403-4f48-b49f-dc483e823464" 
class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" border="0">    <tr><td 
class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; 
TEXT-ALIGN: center">18</td></tr><tr></tr><tr><td><div style="PAGE-BREAK-AFTER: 
always; LINE-HEIGHT: 0px"></div><div class="assignanchor"><a href="#Toc">Table 
of Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><b><a 
name="ITEM6_2">ITEM 6. EXHIBITS.</a></b></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">(a) Exhibits required by Item 601 of 
Regulation SK.</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><table
style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" 
cellpadding="0" width="100%" border="0" >    <tr height="15"><td style="BORDER-
BOTTOM: 1px solid" valign="top" width="8%"><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><b>Number</b></p></td><td valign="top" width="2%"></td><td style="BORDER-
BOTTOM: 1px solid" valign="top" width="90%"><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><b>Description</b></p></td></tr><tr height="15"><td valign="top"></td><td 
valign="top"></td><td valign="top"></td></tr><tr height="15" 
bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 
0px">3.1</p></td><td valign="top"></td><td valign="top"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">Articles of Incorporation (1)</p></td></tr><tr height="15" 
bgcolor="#ffffff"><td valign="top"></td><td valign="top"></td><td 
valign="top"></td></tr><tr height="15" bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">3.2</p></td><td valign="top"></td><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Bylaws 
(1)</p></td></tr><tr height="15" bgcolor="#ffffff"><td valign="top"></td><td 
valign="top"></td><td valign="top"></td></tr><tr height="15" 
bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ex31">31.1</a></p></td><td valign="top"></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ex31">Certification of Principal
Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 
2002.</a></p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><a href="#ex31_2">31.2</a></p></td><td valign="top"></td><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ex31_2">Certification of Principal Financial Officer pursuant to Section 
302 of the Sarbanes-Oxley Act of 2002.</a></p></td></tr><tr height="15" 
bgcolor="#ffffff"><td valign="top"></td><td valign="top"></td><td 
valign="top"></td></tr><tr height="15" bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ex32">32.1</a></p></td><td 
valign="top"></td><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ex32">Certification of Principal Executive Officer and Principal 
Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 
2002.</a></p></td></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px"><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW 
ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0" >    <tr 
height="15" bgcolor="#cceeff"><td valign="top" width="8%"><p style="MARGIN: 0px;
TEXT-INDENT: 0px">101.INS *</p></td><td valign="top" width="2%"></td><td 
valign="top" width="90%"><p style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Instance 
Document</p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">101.SCH *</p></td><td valign="top"></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Taxonomy Extension Schema 
Document</p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">101.CAL *</p></td><td valign="top"></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Taxonomy Extension Calculation 
Linkbase Document</p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">101.DEF *</p></td><td valign="top"></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Taxonomy Extension Definition 
Linkbase Document</p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">101.LAB *</p></td><td valign="top"></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Taxonomy Extension Label Linkbase 
Document</p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">101.PRE *</p></td><td valign="top"></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Taxonomy Extension Presentation 
Linkbase Document</p></td></tr></table>_____________________</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><table style="TEXT-ALIGN: justify; FONT: 
10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0" > 
<tr><td valign="top" width="3%">(1)</td><td valign="top">Filed and incorporated 
by reference to the Company's Registration Statement on Form S-1 (File No. 333 
<b>-</b> 188753), as filed with the Securities and Exchange Commission on May 
22, 2013.</td></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">* XBRL (Extensible Business Reporting 
Language) information is furnished and not filed or a part of a registration 
statement or prospectus for purposes of Sections 11 or 12 of the Securities Act 
of 1933, as amended, is deemed not filed for purposes of Section 18 of the 
Securities Exchange Act of 1934, as amended, and otherwise is not subject to 
liability under these sections.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px" ><table id="pagebreak0f9d49e0-4ec7-487a-9cc4-13f534f9ebfe" 
class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" border="0">    <tr><td 
class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; 
TEXT-ALIGN: center">19</td></tr><tr></tr><tr><td><div style="PAGE-BREAK-AFTER: 
always; LINE-HEIGHT: 0px"></div><div class="assignanchor"><a href="#Toc">Table 
of Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b><a name="sig">SIGNATURES</a></b></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">Pursuant to the 
requirements of the Securities Exchange Act of 1934, the Registrant has duly 
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.&nbsp;</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 
0px"><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" width="100%" border="0" >    <tr height="15"><td
valign="top"></td><td valign="top" colspan="3"><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><b>MADISON VENTURES INC.</b></p></td></tr><tr height="15"><td 
valign="top"></td><td valign="top" colspan="3"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">(Name of Registrant)</p></td></tr><tr height="15"><td 
valign="top"></td><td valign="top" colspan="3"></td></tr><tr height="15"><td 
valign="top" width="50%"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Date: August 
16, 2016</p></td><td valign="top" width="5%"><p style="MARGIN: 0px; TEXT-INDENT:
0px">By:</p></td><td style="BORDER-BOTTOM: 1px solid" valign="top" 
width="35%"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><i>/s/ Gene 
Gregorio</i></p></td><td valign="top" width="10%"></td></tr><tr height="15"><td 
valign="top"></td><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 
0px">Name:</p></td><td
 valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Gene Gregorio</p></td><td
valign="top"></td></tr><tr height="15"><td valign="top"></td><td valign="top"><p
style="MARGIN: 0px; TEXT-INDENT: 0px">Title:</p></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="left">President, Secretary, and 
Treasurer</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" align="left">(principal 
executive officer, principal financial officer,</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px" align="left">and principal accounting officer)</p></td><td 
valign="top"></td></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px" ><table id="pagebreaka9c21219-1bac-40f1-9e1c-ef2c3bca957f" 
class="pagebreak" style="WIDTH: 100%; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" border="0">    <tr><td 
class="hpbhr">&nbsp;</td></tr><tr><td style="BORDER-BOTTOM: black 1px solid; 
TEXT-ALIGN: center">20</td></tr><tr></tr><tr><td><div style="PAGE-BREAK-AFTER: 
always; LINE-HEIGHT: 0px"></div><div class="assignanchor"><a href="#Toc">Table 
of Contents</a></div></td></tr><tr><td>&nbsp;</td></tr></table>&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>EXHIBIT INDEX</b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><table style="TEXT-ALIGN: 
justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
width="100%" border="0" >    <tr height="15"><td style="BORDER-BOTTOM: 1px 
solid" valign="top" width="8%"><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><b>Number</b></p></td><td valign="top" width="2%"></td><td style="BORDER-
BOTTOM: 1px solid" valign="top" width="90%"><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><b>Description</b></p></td></tr><tr height="15"><td valign="top"></td><td 
valign="top"></td><td valign="top"></td></tr><tr height="15" 
bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 
0px">3.1</p></td><td valign="top"></td><td valign="top"><p style="MARGIN: 0px; 
TEXT-INDENT: 0px">Articles of Incorporation (1)</p></td></tr><tr height="15" 
bgcolor="#ffffff"><td valign="top"></td><td valign="top"></td><td 
valign="top"></td></tr><tr height="15" bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">3.2</p></td><td valign="top"></td><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Bylaws 
(1)</p></td></tr><tr height="15" bgcolor="#ffffff"><td valign="top"></td><td 
valign="top"></td><td valign="top"></td></tr><tr height="15" 
bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ex31">31.1</a></p></td><td valign="top"></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ex31">Certification of Principal
Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 
2002.</a></p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><a href="#ex31_2">31.2</a></p></td><td valign="top"></td><td 
valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ex31_2">Certification of Principal Financial Officer pursuant to Section 
302 of the Sarbanes-Oxley Act of 2002.</a></p></td></tr><tr height="15" 
bgcolor="#ffffff"><td valign="top"></td><td valign="top"></td><td 
valign="top"></td></tr><tr height="15" bgcolor="#cceeff"><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><a href="#ex32">32.1</a></p></td><td 
valign="top"></td><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><a 
href="#ex32">Certification of Principal Executive Officer and Principal 
Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 
2002.</a></p></td></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px"><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW 
ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0" >    <tr 
height="15" bgcolor="#cceeff"><td valign="top" width="8%"><p style="MARGIN: 0px;
TEXT-INDENT: 0px">101.INS *</p></td><td valign="top" width="2%"></td><td 
valign="top" width="90%"><p style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Instance 
Document</p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">101.SCH *</p></td><td valign="top"></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Taxonomy Extension Schema 
Document</p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">101.CAL *</p></td><td valign="top"></td><td valign="top"><p
style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Taxonomy Extension Calculation 
Linkbase Document</p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">101.DEF *</p></td><td valign="top"></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Taxonomy Extension Definition 
Linkbase Document</p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">101.LAB *</p></td><td valign="top"></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Taxonomy Extension Label Linkbase 
Document</p></td></tr><tr height="15" bgcolor="#ffffff"><td 
valign="top"></td><td valign="top"></td><td valign="top"></td></tr><tr 
height="15" bgcolor="#cceeff"><td valign="top"><p style="MARGIN: 0px; TEXT-
INDENT: 0px">101.PRE *</p></td><td valign="top"></td><td valign="top"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">XBRL Taxonomy Extension Presentation 
Linkbase Document</p></td></tr></table></p><p style="MARGIN: 
0px">&nbsp;_____________________&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 
0px"><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" width="100%" border="0" >    <tr><td 
valign="top" width="3%">(1)</td><td valign="top">Filed and incorporated by 
reference to the Company's Registration Statement on Form S-1 (File No. 333-
188753), as filed with the Securities and Exchange Commission on May 22, 
2013.</td></tr></table></p><p style="MARGIN: 0px">&nbsp;&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">* XBRL (Extensible Business Reporting 
Language) information is furnished and not filed or a part of a registration 
statement or prospectus for purposes of Sections 11 or 12 of the Securities Act 
of 1933, as amended, is deemed not filed for purposes of Section 18 of the 
Securities Exchange Act of 1934, as amended, and otherwise is not subject to 
liability under these sections.</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN:
0px"><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cols="3" cellpadding="0" width="100%" align="center" border="0" 
>    <tr><td width="10%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
width="80%"><p style="MARGIN: 0px" align="center">21</p></td><td width="10%"><p 
style="MARGIN: 0px">&nbsp;</p></td></tr></table></p><p style="FONT-SIZE: 1px; 
WIDTH: 100%; BORDER-BOTTOM: #000000 1px solid; MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px">&nbsp;&nbsp;</p></BODY></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>mdsv_ex311.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>mdsv_ex311.htm</title><!--Document Created by EDGARMaster--
></head><BODY style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN; MARGIN: 
0px 7%" scroll="yes"><p style="MARGIN: 0px" align="right"><strong><a 
name="ex31">EXHIBIT 31.1</a></strong></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px" align="center"><b>SECTION 302 
CERTIFICATION OF<br>PRINCIPAL EXECUTIVE OFFICER OF MADISON VENTURES 
INC.</b></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT:
0px">I, Gene Gregorio, certify that:</p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><table style="TEXT-ALIGN: justify; FONT: 
10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0" > 
<tr><td valign="top" width="3%">1.</td><td valign="top">I have reviewed this 
quarterly report on Form 10-Q of Madison Ventures Inc.;</td></tr><tr><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td><tr><td valign="top" width="3%">2.</td><td 
valign="top">Based on my knowledge, this quarterly report does not contain any 
untrue statement of a material fact or omit to state a material fact necessary 
to make the statements made, in light of the circumstances under which such 
statements were made, not misleading with respect to the period covered by this
quarterly report;</td></tr><tr><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p 
style="MARGIN: 0px">&nbsp;</p></td><tr><td valign="top" width="3%">3.</td><td 
valign="top">Based on my knowledge, the financial statements, and other 
financial information included in this quarterly report, fairly present in all 
material respects the financial condition, results of operations and cash flows 
of the registrant as of, and for, the periods presented in this quarterly 
report;</td></tr><tr><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p 
style="MARGIN: 0px">&nbsp;</p></td><tr><td valign="top" width="3%">4.</td><td 
valign="top">The registrant's other certifying officer(s) and I are responsible 
for establishing and maintaining disclosure controls and procedures (as defined 
in Exchange Act Rules 13a&#8211;15(e) and 15d&#8211;15(e)) and internal control 
over financial reporting (as defined in Exchange Act Rules 13a&#8211;15(f) and 
15d&#8211;15(f)) for the registrant and 
have:</td></tr></tr></tr></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><table style="TEXT-ALIGN: justify; FONT: 
10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0" > 
<tr><td valign="top" width="3%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="top" width="3%">(a)</td><td valign="top">Designed such disclosure 
controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to 
the registrant, including its consolidated subsidiaries, is made known to us by 
others within those entities, particularly during the period in which this 
report is being prepared;</td></tr><tr><td><p style="MARGIN: 
0px">&nbsp;</p></td><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p 
style="MARGIN: 0px">&nbsp;</p></td><tr><td valign="top" width="3%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="top" width="3%">(b)</td><td 
valign="top">Designed such internal control over financial reporting, or caused 
such internal control over financial reporting to be designed under our 
supervision, to provide reasonable assurance regarding the reliability of 
financial reporting and the preparation of financial statements for external 
purposes in accordance with generally accepted accounting 
principles;</td></tr><tr><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td><tr><td valign="top" width="3%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="top" width="3%">(c)</td><td 
valign="top">Evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report our conclusions about the 
effectiveness of the disclosure controls and procedures, as of the end of the 
period covered by this report based on such evaluation; and</td></tr><tr><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td><td><p style="MARGIN: 0px">&nbsp;</p></td><tr><td 
valign="top" width="3%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="top" 
width="3%">(d)</td><td valign="top">Disclosed in this report any change in the 
registrant's internal control over financial reporting that occurred during the 
registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter 
in the case of an annual report) that has materially affected, or is reasonably 
likely to materially affect, the registrant's internal control over financial 
reporting; and</td></tr></tr></tr></tr></table></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><table style="TEXT-
ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
width="100%" border="0" >    <tr><td valign="top" width="3%">5.</td><td 
valign="top">The registrant's other certifying officer(s) and I have disclosed, 
based on our most recent evaluation of internal control over financial 
reporting, to the registrant's auditors and the audit committee of the 
registrant's board of directors (or persons performing the equivalent 
functions):</td></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><table style="TEXT-ALIGN: justify; FONT: 
10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0" > 
<tr><td valign="top" width="3%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="top" width="3%">(a)</td><td valign="top">All significant deficiencies 
and material weaknesses in the design or operation of internal control over 
financial reporting which are reasonably likely to adversely affect the 
registrant's ability to record, process, summarize and report financial 
information; and</td></tr><tr><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td><tr><td valign="top" width="3%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="top" width="3%">(b)</td><td valign="top">Any 
fraud, whether or not material, that involves management or other employees who 
have a significant role in the registrant's internal control over financial 
reporting.</td></tr></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><table style="TEXT-ALIGN: 
justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
width="100%" border="0" >    <tr height="15"><td valign="top" width="50%"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Date: August 16, 2016</p></td><td 
width="3%">By:</td><td style="BORDER-BOTTOM: 1px solid" valign="top" 
width="35%"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><em>/s/ Gene 
Gregorio</em></p></td><td width="12%"></td></tr><tr height="15"><td 
valign="top"></td><td></td><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 
0px">Gene Gregorio</p></td><td></td></tr><tr height="15"><td 
valign="top"></td><td></td><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 
0px">President, Secretary, and Treasurer</p></td><td></td></tr><tr 
height="15"><td valign="top"></td><td></td><td valign="top"><p style="MARGIN: 
0px; TEXT-INDENT: 0px" align="left">(principal executive officer, principal 
financial officer, </p><p style="MARGIN: 0px; TEXT-INDENT: 0px" align="left">and
principal accounting officer)</p></td><td></td></tr></table></p><p 
style="MARGIN: 0px">&nbsp;</p></BODY></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>mdsv_ex312.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>mdsv_ex312.htm</title><!--Document Created by EDGARMaster--
></head><BODY style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN; MARGIN: 
0px 7%" scroll="yes"><p style="MARGIN: 0px">&nbsp; </p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="right"><strong><a name="ex31_2">EXHIBIT 
31.2</a></strong></p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px" align="center"><b>SECTION 302 CERTIFICATION OF<br>PRINCIPAL 
FINANCIAL OFFICER OF MADISON VENTURES INC.</b></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">I, Gene Gregorio, 
certify that:</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-
INDENT: 0px"><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" 
cellspacing="0" cellpadding="0" width="100%" border="0" >    <tr><td 
valign="top" width="3%">1.</td><td valign="top">I have reviewed this quarterly 
report on Form 10-Q of Madison Ventures Inc.;</td></tr><tr><td><p style="MARGIN:
0px">&nbsp;</p></td><td><p style="MARGIN: 0px">&nbsp;</p></td><tr><td 
valign="top" width="3%">2.</td><td valign="top">Based on my knowledge, this 
quarterly report does not contain any untrue statement of a material fact or 
omit to state a material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not misleading with 
respect to the period covered by this quarterly report;</td></tr><tr><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td><tr><td valign="top" width="3%">3.</td><td 
valign="top">Based on my knowledge, the financial statements, and other 
financial information included in this quarterly report, fairly present in all 
material respects the financial condition, results of operations and cash flows 
of the registrant as of, and for, the periods presented in this quarterly 
report;</td></tr><tr><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p 
style="MARGIN: 0px">&nbsp;</p></td><tr><td valign="top" width="3%">4.</td><td 
valign="top">The registrant's other certifying officer(s) and I are responsible 
for establishing and maintaining disclosure controls and procedures (as defined 
in Exchange Act Rules 13a&#8211;15(e) and 15d&#8211;15(e)) and internal control 
over financial reporting (as defined in Exchange Act Rules 13a&#8211;15(f) and 
15d&#8211;15(f)) for the registrant and 
have:</td></tr></tr></tr></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><table style="TEXT-ALIGN: justify; FONT:
10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0" > 
<tr><td valign="top" width="3%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="top" width="3%">(a)</td><td valign="top">Designed such disclosure 
controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to 
the registrant, including its consolidated subsidiaries, is made known to us by 
others within those entities, particularly during the period in which this 
report is being prepared;</td></tr><tr><td><p style="MARGIN: 
0px">&nbsp;</p></td><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p 
style="MARGIN: 0px">&nbsp;</p></td><tr><td valign="top" width="3%"><p 
style="MARGIN: 0px">&nbsp;</p></td><td valign="top" width="3%">(b)</td><td 
valign="top">Designed such internal control over financial reporting, or caused 
such internal control over financial reporting to be designed under our 
supervision, to provide reasonable assurance regarding the reliability of 
financial reporting and the preparation of financial statements for external 
purposes in accordance with generally accepted accounting 
principles;</td></tr><tr><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td><tr><td valign="top" width="3%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="top" width="3%">(c)</td><td 
valign="top">Evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report our conclusions about the 
effectiveness of the disclosure controls and procedures, as of the end of the 
period covered by this report based on such evaluation; and</td></tr><tr><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td><td><p style="MARGIN: 0px">&nbsp;</p></td><tr><td 
valign="top" width="3%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="top" 
width="3%">(d)</td><td valign="top">Disclosed in this report any change in the 
registrant's internal control over financial reporting that occurred during the 
registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter 
in the case of an annual report) that has materially affected, or is reasonably 
likely to materially affect, the registrant's internal control over financial 
reporting; and</td></tr></tr></tr></tr></table></p><p style="MARGIN: 
0px">&nbsp;&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px"><table 
style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" 
cellpadding="0" width="100%" border="0" >    <tr><td valign="top" 
width="3%">5.</td><td valign="top">The registrant's other certifying officer(s) 
and I have disclosed, based on our most recent evaluation of internal control 
over financial reporting, to the registrant's auditors and the audit committee 
of the registrant's board of directors (or persons performing the equivalent 
functions):</td></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px"><table style="TEXT-ALIGN: justify; FONT: 
10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" width="100%" border="0" > 
<tr><td valign="top" width="3%"><p style="MARGIN: 0px">&nbsp;</p></td><td 
valign="top" width="3%">(a)</td><td valign="top">All significant deficiencies 
and material weaknesses in the design or operation of internal control over 
financial reporting which are reasonably likely to adversely affect the 
registrant's ability to record, process, summarize and report financial 
information; and</td></tr><tr><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td><tr><td valign="top" width="3%"><p style="MARGIN: 
0px">&nbsp;</p></td><td valign="top" width="3%">(b)</td><td valign="top">Any 
fraud, whether or not material, that involves management or other employees who 
have a significant role in the registrant's internal control over financial 
reporting.</td></tr><tr><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p 
style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN: 
0px">&nbsp;</p></td></tr></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px"><table style="TEXT-ALIGN: 
justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" cellpadding="0" 
width="100%" border="0" >    <tr height="15"><td valign="top" width="50%"><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">Date: August 16, 2016</p></td><td 
width="3%">By:</td><td style="BORDER-BOTTOM: 1px solid" valign="top" 
width="35%"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><em>/s/ Gene 
Gregorio</em></p></td><td width="12%"></td></tr><tr height="15"><td
valign="top"></td><td></td><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 
0px">Gene Gregorio</p></td><td></td></tr><tr height="15"><td 
valign="top"></td><td></td><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 
0px">President, Secretary, and Treasurer</p></td><td></td></tr><tr 
height="15"><td valign="top"></td><td></td><td valign="top"><p style="MARGIN: 
0px; TEXT-INDENT: 0px">(principal executive officer, principal financial 
officer,</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">and principal accounting 
officer)</p></td><td></td></tr></table></p><p style="MARGIN: 
0px">&nbsp;</p></BODY></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>mdsv_ex321.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>mdsv_ex321.htm</title><!--Document Created by EDGARMaster--
></head><BODY style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN; MARGIN: 
0px 7%" scroll="yes"><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="right"><strong><a name="ex32">EXHIBIT 32.1</a></strong></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" 
align="center"><b>SECTION 906 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER 
AND<br>PRINCIPAL FINANCIAL OFFICER OF MADISON VENTURES INC.</b></p><p 
style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; TEXT-INDENT: 0px">In 
connection with the accompanying Quarterly Report on Form 10-Q of Madison 
Ventures Inc. for the quarter ended June 30, 2016, the undersigned, Gene 
Gregorio, President of Madison Ventures Inc., does hereby certify pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley 
Act of 2002, that:</p><p style="MARGIN: 0px">&nbsp;</p><p style="MARGIN: 0px; 
TEXT-INDENT: 0px"><table style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN"
cellspacing="0" cellpadding="0" width="100%" border="0" >    <tr><td 
valign="top" width="3%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="top" 
width="3%">(1)</td><td valign="top">such Quarterly Report on Form 10-Q for the 
quarter ended June 30, 2016 fully complies with the requirements of Section 
13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; 
and</td></tr><tr><td><p style="MARGIN: 0px">&nbsp;</p></td><td><p style="MARGIN:
0px">&nbsp;</p></td><td><p style="MARGIN: 0px">&nbsp;</p></td><tr><td 
valign="top" width="3%"><p style="MARGIN: 0px">&nbsp;</p></td><td valign="top" 
width="3%">(2)</td><td valign="top">the information contained in such Quarterly 
Report on Form 10-Q for the quarter ended June 30, 2016 fairly presents, in all 
material respects, the financial condition and results of operations of Madison 
Ventures Inc.</td></tr></tr></table></p><p style="MARGIN: 0px">&nbsp;</p><p 
style="MARGIN: 0px; TEXT-INDENT: 0px">&nbsp;</p><p style="MARGIN: 0px"><table 
style="TEXT-ALIGN: justify; FONT: 10pt TIMES NEW ROMAN" cellspacing="0" 
cellpadding="0" width="100%" border="0" >    <tr height="15"><td valign="top" 
width="50%"><p style="MARGIN: 0px; TEXT-INDENT: 0px">Date: August 16, 
2016</p></td><td width="3%">By:</td><td style="BORDER-BOTTOM: 1px solid" 
valign="top" width="35%"><p style="MARGIN: 0px; TEXT-INDENT: 0px"><em>/s/ Gene 
Gregorio</em></p></td><td width="12%"></td></tr><tr height="15"><td 
valign="top"></td><td></td><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 
0px">Gene Gregorio</p></td><td></td></tr><tr height="15"><td 
valign="top"></td><td></td><td valign="top"><p style="MARGIN: 0px; TEXT-INDENT: 
0px">President, Secretary, and Treasurer</p></td><td></td></tr><tr 
height="15"><td valign="top"></td><td></td><td valign="top"><p style="MARGIN: 
0px; TEXT-INDENT: 0px">(principal executive officer, principal financial 
officer,</p><p style="MARGIN: 0px; TEXT-INDENT: 0px" align="left">and principal 
accounting officer)</p></td><td></td></tr></table></p><p style="MARGIN: 
0px">&nbsp;</p><p style="MARGIN: 0px">&nbsp; </p></BODY></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>5
<FILENAME>mdsv-20160630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: mdsv_20160630_10Q.xfr; Date: 
2016%2D08%2D15T18:00:01Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xmlns:xbrldt="http://xbrl.org/2005/xbrldt" 
xmlns:xbrldi="http://xbrl.org/2006/xbrldi" 
xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" 
xmlns:ref="http://www.xbrl.org/2006/ref" 
xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-
gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-
roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" 
xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-
types="http://fasb.org/us-types/2016-01-31" 
xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" 
xmlns:mdsv="http://madisonventures.com/20160630">
    <link:schemaRef xlink:href="mdsv-20160630.xsd" xlink:type="simple" />
    <xbrli:context id="From2016-04-01to2016-06-30">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2015-06-30">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
<xbrli:context id="AsOf2016-08-12">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-08-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2016-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
</xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2016-03-31_us-
gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2016-03-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-03-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_us-
gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
<xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2016-03-31_us-
gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_us-
gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
</xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-06-30_us-
gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-
gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-
gaap:StatementEquityComponentsAxis">us-
gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2016-03-31">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-03-31">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
</xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30">
      <xbrli:entity>
        <xbrli:identifier 
scheme="http://www.sec.gov/CIK">0001575975</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2016-04-01to2016-06-30">Madison 
Ventures Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2016-04-01to2016-06-
30">0001575975</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2016-04-01to2016-06-30">10-
Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2016-04-01to2016-06-30">2016-06-
30</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2016-04-01to2016-06-
30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2016-04-01to2016-06-30">--03-
31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2016-04-01to2016-06-
30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2016-04-01to2016-06-
30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2016-04-01to2016-06-
30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2016-04-01to2016-06-30">Smaller 
Reporting Company</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2016-04-01to2016-06-
30">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2016-04-01to2016-06-
30">2017</dei:DocumentFiscalYearFocus>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2016-03-31" 
unitRef="USD" decimals="0">213442</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2016-06-30" 
unitRef="USD" decimals="0">213442</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2015-03-31" 
unitRef="USD" decimals="0">25523</us-gaap:DueToRelatedPartiesCurrent>
    <mdsv:FundsAdvanced contextRef="From2016-04-01to2016-06-30" unitRef="USD" 
xsi:nil="true" />
    <mdsv:FundsAdvanced contextRef="From2015-04-01to2016-03-31" unitRef="USD" 
decimals="0">187919</mdsv:FundsAdvanced>
<mdsv:Repayments contextRef="From2016-04-01to2016-06-30" unitRef="USD" 
xsi:nil="true" />
    <mdsv:Repayments contextRef="From2015-04-01to2016-03-31" unitRef="USD" 
xsi:nil="true" />
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2016-08-12" 
unitRef="Shares" 
decimals="INF">28400000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-03-31" 
unitRef="USD" decimals="0">144730</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-06-30" 
unitRef="USD" decimals="0">266763</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-03-31" 
unitRef="USD" decimals="0">-194669</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-06-30" 
unitRef="USD" decimals="0">-218070</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-03-31" 
unitRef="USDPShares" decimals="INF">0.001</us-
gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-06-30" 
unitRef="USDPShares" decimals="INF">0.001</us-
gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-03-31" 
unitRef="Shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-06-30" 
unitRef="Shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-03-31" 
unitRef="Shares" decimals="INF">28400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-06-30" 
unitRef="Shares" decimals="INF">28400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-03-31" 
unitRef="Shares" decimals="INF">28400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-06-30" 
unitRef="Shares" decimals="INF">28400000</us-gaap:CommonStockSharesOutstanding>
    <mdsv:StockOptionGranted contextRef="From2016-04-01to2016-06-30" 
unitRef="USD" decimals="0">0</mdsv:StockOptionGranted>
    <mdsv:StockOptionGranted contextRef="From2015-04-01to2016-03-31" 
unitRef="USD" decimals="0">0</mdsv:StockOptionGranted>
    <us-gaap:Cash contextRef="AsOf2016-03-31" unitRef="USD" 
decimals="0">66795</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">92541</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2015-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:Cash contextRef="AsOf2015-06-30" unitRef="USD" xsi:nil="true" />
    <mdsv:FundsForgiven contextRef="From2016-04-01to2016-06-30" unitRef="USD" 
xsi:nil="true" />
    <mdsv:FundsForgiven contextRef="From2015-04-01to2016-03-31" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2016-04-01to2016-06-30" unitRef="USD"
decimals="0">-23401</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-04-01to2015-06-30" unitRef="USD"
decimals="0">-21827</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-03-31" unitRef="USD" 
decimals="0">-112245</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">-135470</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-03-31_us-
gaap_CommonStockMember" unitRef="USD" decimals="0">28400</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-03-31_us-
gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">54100</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-03-31_us-
gaap_CommonStockMember" unitRef="USD" decimals="0">28400</us-
gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="AsOf2016-03-31_us-
gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">54100</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-03-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2016-03-31_us-
gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-
76</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30_us-
gaap_CommonStockMember" unitRef="USD" decimals="0">28400</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30_us-
gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">54100</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-03-31_us-
gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-106811</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-03-31_us-
gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-194669</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30_us-
gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-218070</us-
gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30_us-
gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" 
decimals="0">100</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-03-31" unitRef="USD" 
decimals="0">-24311</us-gaap:StockholdersEquity>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax 
contextRef="AsOf2016-03-31" unitRef="USD" decimals="0">-76</us-
gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax 
contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">100</us-
gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2016-04-01to2016-06-30"
unitRef="USD" decimals="0">-23225</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2015-04-01to2015-06-30"
unitRef="USD" decimals="0">-21827</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2015-04-01to2016-03-
31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2015-04-01to2016-03-
31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2015-04-01to2016-03-
31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" 
decimals="0">-76</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2016-04-01to2016-06-
30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2016-04-01to2016-06-
30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2015-04-01to2016-03-
31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-87858</us-
gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2016-04-01to2016-06-
30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-23401</us-
gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2016-04-01to2016-06-
30_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" 
decimals="0">176</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2015-04-01to2016-03-31"
unitRef="USD" decimals="0">-87934</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:AdvancesForGasExplorationDevelopmentAndProductionAmount 
contextRef="AsOf2016-03-31" unitRef="USD" decimals="0">131850</us-
gaap:AdvancesForGasExplorationDevelopmentAndProductionAmount>
    <us-gaap:AdvancesForGasExplorationDevelopmentAndProductionAmount
contextRef="AsOf2016-06-30" unitRef="USD" decimals="0">221850</us-
gaap:AdvancesForGasExplorationDevelopmentAndProductionAmount>
    <mdsv:FeesPaidForCommercializationLicensedTechnology contextRef="AsOf2016-
03-31" unitRef="USD" 
decimals="0">10000</mdsv:FeesPaidForCommercializationLicensedTechnology>
    <mdsv:FeesPaidForCommercializationLicensedTechnology contextRef="AsOf2016-
06-30" unitRef="USD" 
decimals="0">10000</mdsv:FeesPaidForCommercializationLicensedTechnology>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2016-03-31" 
unitRef="USD" decimals="0">54100</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2016-06-30" 
unitRef="USD" decimals="0">54100</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:CommonStockValue contextRef="AsOf2016-03-31" unitRef="USD" 
decimals="0">28400</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">28400</us-gaap:CommonStockValue>
    <us-gaap:Liabilities contextRef="AsOf2016-03-31" unitRef="USD" 
decimals="0">256975</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">402233</us-gaap:Liabilities>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2016-03-31" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">110000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2016-03-31" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">110000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2015-03-31" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-03-31" unitRef="USD" 
decimals="0">256975</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">292233</us-gaap:LiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2016-03-31" unitRef="USD"
decimals="0">23618</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD"
decimals="0">25000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2016-03-31" unitRef="USD" 
decimals="0">19915</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">53791</us-gaap:AccountsPayableCurrent>
    <us-gaap:Assets contextRef="AsOf2016-03-31" unitRef="USD" 
decimals="0">144730</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">266763</us-gaap:Assets>
    <us-gaap:Investments contextRef="AsOf2016-03-31" unitRef="USD" 
decimals="0">70998</us-gaap:Investments>
    <us-gaap:Investments contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">169606</us-gaap:Investments>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-03-31" unitRef="USD" 
decimals="0">73732</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">97157</us-gaap:AssetsCurrent>
    <us-gaap:AccountsReceivableNet contextRef="AsOf2016-03-31" unitRef="USD" 
decimals="0">4837</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">2077</us-gaap:AccountsReceivableNet>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2016-03-31" unitRef="USD" 
decimals="0">2100</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2016-06-30" unitRef="USD" 
decimals="0">2539</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:DepositAssets contextRef="AsOf2016-03-31" unitRef="USD" 
xsi:nil="true" />
<us-gaap:DepositAssets contextRef="AsOf2016-06-30" unitRef="USD" 
xsi:nil="true" />
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-176</us-
gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
contextRef="From2015-04-01to2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted 
contextRef="From2016-04-01to2016-06-30" unitRef="Shares" 
decimals="INF">28400000</us-
gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted 
contextRef="From2015-04-01to2015-06-30" unitRef="Shares" 
decimals="INF">28400000</us-
gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2016-04-01to2016-
06-30" unitRef="USDPShares" decimals="INF">0.00</us-
gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2015-04-01to2015-
06-30" unitRef="USDPShares" decimals="INF">0.00</us-
gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2016-04-01to2016-06-30" 
unitRef="USD" decimals="0">-3332</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2015-04-01to2015-06-30" 
unitRef="USD" xsi:nil="true" />
    <us-
gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation 
contextRef="From2016-04-01to2016-06-30" unitRef="USD" decimals="0">-3332</us-
gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-
gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation 
contextRef="From2015-04-01to2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OperatingExpenses contextRef="From2016-04-01to2016-06-30" 
unitRef="USD" decimals="0">20069</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2015-04-01to2015-06-30" 
unitRef="USD" decimals="0">21827</us-gaap:OperatingExpenses>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="From2016-04-
01to2016-06-30" unitRef="USD" decimals="0">3797</us-
gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="From2015-04-
01to2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareBasedCompensation contextRef="From2016-04-01to2016-06-30" 
unitRef="USD" decimals="0">1387</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-04-01to2015-06-30" 
unitRef="USD" decimals="0">6250</us-gaap:ShareBasedCompensation>
    <us-gaap:ProfessionalFees contextRef="From2016-04-01to2016-06-30" 
unitRef="USD" decimals="0">14885</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2015-04-01to2015-06-30" 
unitRef="USD" decimals="0">15577</us-gaap:ProfessionalFees>
    <us-gaap:SharesIssued contextRef="AsOf2015-03-31_us-gaap_CommonStockMember" 
unitRef="Shares" decimals="INF">28400000</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2016-03-31_us-gaap_CommonStockMember" 
unitRef="Shares" decimals="INF">28400000</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="AsOf2016-06-30_us-gaap_CommonStockMember" 
unitRef="Shares" decimals="INF">28400000</us-gaap:SharesIssued>
    <us-gaap:IncomeTaxesPaid contextRef="From2016-04-01to2016-06-30" 
unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaid contextRef="From2015-04-01to2015-06-30" 
unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestPaidNet contextRef="From2016-04-01to2016-06-30" 
unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestPaidNet contextRef="From2015-04-01to2015-06-30" 
unitRef="USD" xsi:nil="true" />
    <mdsv:NoncashInvestingAndFinancingActivities contextRef="From2016-04-
01to2016-06-30" unitRef="USD" xsi:nil="true" />
    <mdsv:NoncashInvestingAndFinancingActivities contextRef="From2015-04-
01to2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2016-
04-01to2016-06-30" unitRef="USD" decimals="0">25746</us-
gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2015-
04-01to2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:EffectOfExchangeRateOnCash contextRef="From2016-04-01to2016-06-30" 
unitRef="USD" decimals="0">1012</us-gaap:EffectOfExchangeRateOnCash>
    <us-gaap:EffectOfExchangeRateOnCash contextRef="From2015-04-01to2015-06-30" 
unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2016-04-
01to2016-06-30" unitRef="USD" decimals="0">110000</us-
gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2015-04-
01to2015-06-30" unitRef="USD" decimals="0">7930</us-
gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2016-04-01to2016-
06-30" unitRef="USD" decimals="0">110000</us-
gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2015-04-01to2015-
06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2016-04-01to2016-06-
30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2015-04-01to2015-06-
30" unitRef="USD" decimals="0">7930</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2016-04-
01to2016-06-30" unitRef="USD" decimals="0">-88827</us-
gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2015-04-
01to2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquireSoftware contextRef="From2016-04-01to2016-06-30" 
unitRef="USD" decimals="0">88827</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware contextRef="From2015-04-01to2015-06-30" 
unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2016-04-
01to2016-06-30" unitRef="USD" decimals="0">4561</us-
gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2015-04-
01to2015-06-30" unitRef="USD" decimals="0">-7930</us-
gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2016-04-
01to2016-06-30" unitRef="USD" decimals="0">-5</us-
gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2015-04-
01to2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="From2016-04-
01to2016-06-30" unitRef="USD" decimals="0">24338</us-
gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade contextRef="From2015-04-
01to2015-06-30" unitRef="USD" decimals="0">7647</us-
gaap:IncreaseDecreaseInAccountsPayableTrade>
    <mdsv:IncreaseInDepositOnTechnologyLicense contextRef="From2015-04-01to2015-
06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2016-04-
01to2016-06-30" unitRef="USD" decimals="0">2703</us-
gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2015-04-
01to2015-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2016-04-01to2016-
06-30" unitRef="USD" decimals="0">-461</us-
gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2015-04-01to2015-
06-30" unitRef="USD" xsi:nil="true" />
    <mdsv:StockAccruedAsEmployeeCompensation contextRef="From2016-04-01to2016-
06-30" unitRef="USD" decimals="0">1387</mdsv:StockAccruedAsEmployeeCompensation>
    <mdsv:StockAccruedAsEmployeeCompensation contextRef="From2015-04-01to2015-
06-30" unitRef="USD" decimals="0">6250</mdsv:StockAccruedAsEmployeeCompensation>
    <us-gaap:CondensedFinancialStatementsTextBlock contextRef="From2016-04-
01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;The accompanying unaudited condensed 
consolidated&#13;financial statements are presented in United States dollars and
are prepared using the accrual method of accounting which conforms&#13;to 
generally accepted accounting principles in the United States of America 
(&amp;#34;US GAAP&amp;#34;) for interim financial reporting&#13;and the 
instructions for Form 10-Q pursuant to the rules and regulations of the 
Securities and Exchange Commission. Accordingly,&#13;they do not include all 
information and footnote disclosures necessary for a complete presentation of 
the financial position, results&#13;of operations, cash flows, and stockholders 
equity in conformity with generally accepted accounting principles. In the 
opinion&#13;of management, all adjustments considered necessary for a fair 
presentation of the results of operations and financial position&#13;have been 
included and all such adjustments are of a normal recurring 
nature.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;The unaudited condensed 
consolidated balance&#13;sheet of the Company as of June 30, 2016, and the 
related consolidated balance sheet of the Company as of March 31, 2016, 
which&#13;is derived from the Company's audited financial statements, the 
unaudited condensed consolidated statement of operations and cash&#13;flows for 
the Three Months ended June 30, 2016 and 2015 and the condensed consolidated 
statement of stockholders equity for the&#13;period of March 31, 2015 to June 
30, 2016 and are included in this document. These unaudited condensed 
consolidated financial statements&#13;should be read in conjunction with the 
March 31, 2016 audited financial statements and related notes included in the 
Company's&#13;most recent Form 10-K as filed with the Securities and Exchange 
Commission on July 18, 2016.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times 
New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Operating results for the Three
Months ended&#13;June 30, 2016 are not necessarily indicative of the results 
that can be expected for the year ending March 31, 2017.&lt;/p&gt;</us-
gaap:CondensedFinancialStatementsTextBlock>
    <us-gaap:NatureOfOperations contextRef="From2016-04-01to2016-06-30">&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;Madison Ventures Inc. (&amp;#34;Company&amp;#34;)&#13;was 
incorporated in the State of Nevada as a for-profit company on September 14, 
2009 and established a fiscal year end of March&#13;31. The Company initially 
was engaged in the acquisition, exploration and development of natural resource 
properties. On February&#13;27, 2015, the Company terminated the acquisition of 
the mineral claim and entered into a letter of intent with Ocure Ltd. 
(&amp;#34;Ocure&amp;#34;),&#13;pursuant to which the Company agreed to 
exclusively license certain technology from Ocure related to the development of 
products&#13;and devices for the treatment of anal fissures (the &amp;#34;Ocure 
LOI&amp;#34;). On July 9, 2015, the Company established the wholly-
owned&#13;subsidiary Madison-IL Ltd., incorporated under the laws of the country
of Israel to address the Company's requirement for an Israeli&#13;company to 
operate and hold the assets associated with Ocure LOI. The Company has no 
revenues and has limited operating history.&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;
text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The success of
the Company is dependent upon&#13;the development of products for the treatment 
of anal fissures, the ability of the Company to obtain the necessary financing 
to&#13;complete the acquisition, development and commercialize of the Licensed 
Technology, and upon future profitable operations.&lt;/p&gt;&#13;&#13;&lt;p
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;
text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Use 
of Estimates and Assumptions&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent:
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;The preparation of financial 
statements in&#13;conformity with accounting principles generally accepted in 
the United States of America requires management to make certain 
estimates&#13;and assumptions that affect the reported amounts of assets and 
liabilities and disclosure of contingent assets and liabilities&#13;at the date 
of the financial statements and the reported amounts of revenues and expenses 
during the reporting periods presented.&#13;The Company is required to make 
judgments and estimates about the effect of matters that are inherently 
uncertain. The Company&#13;regularly evaluates estimates and assumptions related
to the useful life and recoverability of long-lived assets, deferred 
income&#13;tax asset valuations and loss contingences. The Company bases its 
estimates and assumptions on current facts, historical experience&#13;and 
various other factors that it believes to be reasonable under the circumstances,
the results of which form the basis for making&#13;judgments about the carrying 
value of assets and liabilities and the accrual of costs and expenses that are 
not readily apparent&#13;from other sources. Although, we believe our judgments 
and estimates are appropriate, actual future results may be different;&#13;if 
different assumptions or conditions were to prevail, the results could be 
materially different from our reported results.&lt;/p&gt;&#13;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;License 
Agreement&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;On February 27, 2015, we 
entered into a letter&#13;of intent (the &amp;#34;Letter of Intent&amp;#34;) 
with Ocure Ltd. (&amp;#34;Ocure&amp;#34;), an Israeli corporation, pursuant to 
which the&#13;Company would be obligated to exclusively license certain 
technology from Ocure under terms of a license agreement to be 
negotiated&#13;between the Company and Ocure. The Letter of Intent terminated 
when the Company did not make the second required payment, however&#13;the 
Company continued to negotiate with Ocure. On August 5, 2015, as amended 
February 26, 2016, the company entered into an exclusive&#13;license agreement 
(the &amp;#34;License Agreement&amp;#34;) with Ocure and Madison-IL Ltd., a 
wholly-owned subsidiary of the Company&#13;incorporated in Israel on July 9, 
2015 (the &amp;#34;Subsidiary&amp;#34;). Pursuant to the License Agreement, 
Ocure granted to the Subsidiary&#13;an exclusive, sub-licensable, worldwide, 
license (the &amp;#34;License&amp;#34;) to Ocure's semi-occlusive wound dressing
for ambulatory&#13;treatment of acute and chronic anal fissure, pursuant to 
Ocure's patents and patent applications (the &amp;#34;Licensed 
Technology&amp;#34;)&#13;and to its production, use, import, offer for sale, 
sell, lease, distribute, or otherwise commercialize the Licensed 
Technology&#13;for uses classified as medical devices, or those otherwise 
approved ultimately as an OTC (over-the-counter) 
remedy.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Under the License Agreement, 
the Company is&#13;obligated as consideration for the Licensed Technology to 
provide the Subsidiary $250,000 for the commercialization of the 
Licensed&#13;Technology, payable according to the following schedule: $10,000 
upon execution of the Letter of Intent (paid February 27, 2015&#13;to Ocure), 
$90,000 at the later of May 11, 2015 or the final signing date of the License 
Agreement (the &amp;#34;Effective Date&amp;#34;),&#13;and $50,000 on or before 
March 4, 2016, and $100,000 on or before April 8, 2016 (collectively, the 
&amp;#34;First $250,000 Tranche&amp;#34;).&#13;The Effective Date will occur 
upon satisfaction of the Condition Precedent, as defined in the License
Agreement, and approval of&#13;the Agreement by the Chief Scientist of the 
Israeli Ministry of the Economy. The License Agreement Effective Date is 
November 11,&#13;2015; the date approval of the Chief Scientist of the Israeli 
Ministry of the Economy was received. Upon the 6-month anniversary&#13;of the 
Effective Date, if the Company has paid the First $250,000 Tranche, then Ocure 
will transfer certain assets, as defined,&#13;to the Subsidiary, and the Company
will be obligated to provide the Subsidiary a second $250,000 tranche, payable 
as follows: $100,000&#13;on or before August 12, 2016, $100,000 on or before 
September 23, 2016, and $50,000 on or before October 28, 2016. The 
License&#13;Agreement terminates, on a country-by-country basis, the later of: 
(a) the date of expiration of the last to expire of Ocure's&#13;rights in Ocure 
Patents in such country or such other grant of statutory exclusivity, or (b) the
end of a period of fifteen (15)&#13;years from the date of making the first 
commercial sale, as defined, in such country; unless sooner terminated pursuant 
to the&#13;terms of the License Agreement. As of June 30, 2016 and March 31, 
2016, the Company has advanced $221,850 and $131,850, respectively,&#13;to the 
Subsidiary and paid Ocure $10,000 in furtherance of the commercialization of the
Licensed Technology.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Immediately after the Effective
Date of the&#13;License Agreement and for the period ending March 31, 2016 (as 
amended), the shareholders of Ocure and certain individuals designated&#13;by 
Ocure will have opportunity to purchase up to an aggregate of 7,100,000 
(1,775,000 presplit) shares of the Company's Common&#13;Stock at the par value 
of $0.001 per share. In addition, the Company will establish an incentive stock 
option plan reserving up&#13;to 20% of the Company's issued share capital, as of
the closing. The right to purchase an aggregate of 7,100,000 (1,775,000 
presplit)&#13;shares of the Company's Common Stock expired unexercised, but by 
mutual agreement the purchase right will be extended under 
similar&#13;terms.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;In consideration of the license
for the Licensed&#13;Technology and with respect to any inventions, improvement,
development or enhancement based upon, consists of, comprises, contains&#13;or 
incorporates the Licensed Technology invented following the Effective Date by 
the Subsidiary, its affiliate or sublicensee&#13;(the &amp;#34;New 
Inventions&amp;#34;), the Subsidiary will pay to Ocure royalties calculated as 
5% of gross sales. In addition, the&#13;Subsidiary will pay to Ocure 20% of any 
cash or non-cash consideration received, whether for sublicense initiation fee, 
annual&#13;fee, sublicense milestone payments, or other such non-sale based 
royalty consideration payable by a sublicense as consideration&#13;for or under 
a sublicense.&lt;/p&gt;&#13;&#13;&lt;p style="font:
 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-
indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times 
New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Mineral 
Properties&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Mineral property acquisition 
costs are capitalized&#13;in accordance with Codification topic 930 
&amp;#34;Extractive Activities - Mining&amp;#34;. Mineral property pre-
exploration and exploration&#13;costs are expensed as incurred. When it has been
determined that a mineral property can be economically developed as a result 
of&#13;establishing proven and probable reserves, the costs incurred to develop 
such property are capitalized. The Company did not establish&#13;any reserves on
its mineral properties prior to terminating its option under the Revised and 
Restated Mineral Property Option Agreement&#13;(see footnote 
3).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Rehabilitation 
Provisions&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;The Company was subject to 
various government&#13;laws and regulations relating to environmental 
disturbances which are caused by exploration and evaluation activities. The 
Company&#13;will record the present value for the estimated costs of legal and 
constructive obligations required to restore the exploration&#13;sites in the 
period in which the obligation is incurred. The nature of the rehabilitation 
activities includes restoration, reclamation&#13;and re-vegetation of the 
affected exploration sites. The Company has determined that there were no 
rehabilitation provisions at&#13;February 27, 2015 when the option to acquire 
the mineral claim was terminated.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Share-based 
Compensation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Codification topic 718 
&amp;#34;Stock Compensation&amp;#34;&#13;requires that the cost resulting from 
all share-based transactions be recorded in the financial statements and 
establishes fair&#13;value as the measurement objective for share-based payment 
transactions with employees and acquired goods or services from non-
employees.&#13;The codification also provides guidance on valuing and expensing 
these awards, as well as disclosure requirements of these 
equity&#13;arrangements. The Company adopted the codification upon creation of 
the company and will expense share based costs in the period&#13;incurred. The 
Company has not adopted a stock option plan or completed a share-based 
transaction; accordingly no stock-based compensation&#13;has been recorded to 
date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Recent Accounting 
Pronouncements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New 
Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;The Company's management has 
evaluated all&#13;the recently issued, but not yet effective, accounting 
standards that have been issued or proposed by the FASB or other standards-
setting&#13;bodies through the filing date of these financial statements and 
does not believe the future adoption of any such pronouncements&#13;will have a 
material effect on the Company's financial position and results of 
operations.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:MineralIndustriesDisclosuresTextBlock contextRef="From2016-04-
01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;On March 3, 2012, the Company entered into&#13;a 
Revised and Restated Mineral Property Option Agreement with 3 individuals (the 
&amp;#34;Optionors&amp;#34;) for an exclusive and irrevocable&#13;three year 
option to acquire a 100% undivided interest in three contiguous unpatented 
mining claims comprising 34 units (the &amp;#34;Claim&amp;#34;&#13;or the 
&amp;#34;Property&amp;#34;) situated in the Thunder Bay Mining Division in the 
province on Ontario, Canada (the &amp;#34;Agreement&amp;#34;).&#13;The option 
payments aggregating $30,000 (U.S. Dollars) (the &amp;#34;Option Price&amp;#34;)
were due: i) $15,000 upon signing but deferred&#13;for eight months, ii) $5,000 
on or before March 3, 2013, iii) $5,000 on or before March 3, 2014, and iv) 
$5,000 on or before March&#13;3, 2015 (the &amp;#34;Option Payments&amp;#34;). 
During the term of the Agreement the Company is granted free and unrestricted 
access&#13;and use of the Property to act as the operator of the Property with 
the right to bring buildings, plant, equipment, machinery,&#13;tools, appliances
and supplies onto the Property. The Optionors hold title to the Property until 
the full payment of the Option&#13;Price. Upon full payment of the Option Price 
the Optionors would deliver a duly executed transfer of mining claims in respect
of&#13;the Property to transfer a 100% undivided interest in the Property to the
Company free and clear of all encumbrances except for&#13;a retained net smelter
return royalty (the &amp;#34;NSR&amp;#34;). The NSR is a 2% royalty paid within 
30 days of each calendar month&#13;calculated, as defined, from gross Property 
revenues less permissible deductions. The Company had the right, at any time, to
reduce&#13;the NSR to a 1% royalty by a One Million Dollar payment to the 
Optionors.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Upon the February 27, 2015 
termination of the&#13;Agreement had the Company brought any buildings, plant, 
equipment, machinery, tools, appliances and supplies onto the Property&#13;it 
would have been responsible to remove all such items not later than twelve 
months after termination of the Agreement unless&#13;arrangements are made with 
the Optionors to retain some or all of the items brought onto the 
Property.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;The Company deferred the first 
option payment&#13;for an eight month term and made the $15,000 payment on 
October 27, 2012. Upon execution of the Agreement, the Company recorded&#13;the 
first option payment net of imputed interest as $14,984 and accrued the imputed 
interest ratably over the deferral period.&#13;Annually the Company had the 
option to retain the mineral claim and make the next contractual Option Payment 
or to terminate the&#13;Agreement. The Company made the March 3, 2013 Option 
Payment on March 1, 2013 and the March 3, 2014 Option Payment on 
February&#13;25, 2014. On February 27, 2015, the Company concluded to terminate 
the Agreement and not make the final Option Payment. The aggregate&#13;total of 
$24,984 previously included in the mineral claim was expensed as a discontinued 
operation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Previously in response to the 
new GPS standards&#13;for unpatented claims issued by the Ontario Ministry of 
Northern Development and Mines, the Company expended $1,975 to 
provide&#13;upgraded geo-referenced location information on its Claim during the
quarter ended September 30, 2013. An aggregate total of zero&#13;and $1,975 have
been expensed for exploration and evaluation of the Company's Claim as of March 
31, 2015 and 2014, respectively.&lt;/p&gt;</us-
gaap:MineralIndustriesDisclosuresTextBlock>
    <invest:InvestmentTextBlock contextRef="From2016-04-01to2016-06-30">&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;On August 5, 2015, as amended February 26,&#13;2016, the company 
entered into an exclusive license agreement (the &amp;#34;License 
Agreement&amp;#34;) with Ocure and Madison-IL Ltd.,&#13;a wholly-owned 
subsidiary of the Company incorporated in Israel on July 9, 2015 (the 
&amp;#34;Subsidiary&amp;#34;). Pursuant to the License&#13;Agreement, Ocure 
granted to the Subsidiary an exclusive, sub-licensable, worldwide, license (the 
&amp;#34;License&amp;#34;) to Ocure's&#13;semi-occlusive wound dressing for 
ambulatory treatment of acute and chronic anal fissure, pursuant to Ocure's 
patents and patent&#13;applications (the &amp;#34;Licensed Technology&amp;#34;) 
and to its production, use, import, offer for sale, sell, lease, 
distribute,&#13;or otherwise commercialize the Licensed Technology for uses 
classified as medical devices, or those otherwise approved ultimately&#13;as an 
OTC (over-the-counter) remedy.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times 
New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Under the License Agreement, 
the Company is&#13;obligated as consideration for the Licensed Technology to 
provide the Subsidiary $250,000 for the commercialization of the 
Licensed&#13;Technology, payable according to the following schedule: $10,000 
upon execution of the Letter of Intent, $90,000 at the later of&#13;May 11, 2015
or the final signing date of the License Agreement (the &amp;#34;Effective 
Date&amp;#34;), and $50,000 on or before March&#13;4, 2016, and $100,000 on or 
before April 8, 2016 (collectively, the &amp;#34;First $250,000 
Tranche&amp;#34;). The License Agreement&#13;Effective Date is November 11,
2015; the date approval of the Chief Scientist of the Israeli Ministry of the 
Economy was received.&#13;Upon the 6-month anniversary of the Effective Date, if
the Company has paid the First $250,000 Tranche, then Ocure will 
transfer&#13;certain assets, as defined, to the Subsidiary, and the Company will
be obligated to provide the Subsidiary a second $250,000 tranche,&#13;payable as
follows: $100,000 on or before August 12, 2016, $100,000 on or before September 
23, 2016, and $50,000 on or before October&#13;28, 2016. The License Agreement 
terminates, on a country-by-country basis, the later of: (a) the date of 
expiration of the last&#13;to expire of Ocure's rights in Ocure Patents in such 
country or such other grant of statutory exclusivity, or (b) the end of 
a&#13;period of fifteen (15) years from the date of making the first commercial 
sale, as defined, in such country; unless sooner terminated&#13;pursuant to the 
terms of the License Agreement. As of June 30, 2016 and March 31, 2016, the 
Company has advanced $221,850 and $131,850,&#13;respectively, to the Subsidiary 
and paid Ocure $10,000 in furtherance of the commercialization of the Licensed 
Technology.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;As of June 30, 2016 and March 
31, 2016, the&#13;Company has expended and aggregate of $169,606 and $70,998 
recorded as the investment in technology license, 
respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times,
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;The Company was in default of 
its payment schedule&#13;by June 30, 2016 and no assets had been transferred to 
the Company's subsidiary. As of the date of filing of this 10-Q, the 
Company&#13;is also in default of its $100,000 payment that was due August 12, 
2016. There is no extension agreement or amendment negotiated,&#13;and there is 
a risk that the License will be 
cancelled.&lt;/p&gt;</invest:InvestmentTextBlock>
    <mdsv:DueToRelatedPartyTextBlock contextRef="From2016-04-01to2016-06-
30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;Due to related parties at June 30, 2016 and&#13;March 31, 
2016 consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; 
font-size-adjust: none; font-stretch: normal"&gt;&#13;&lt;tr style="vertical-
align: bottom"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="hdcell" 
style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;June 
30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: 
center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;March 
31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-
bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font 
style="font-size: 10pt"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13; 
&lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: 
center"&gt;&lt;font style="font-size: 
10pt"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="ffcell"
style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13; 
&lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13; 
&lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color:
#CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; width: 78%; text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance at beginning of 
period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 8%; text-align: right"&gt;&lt;font 
style="font-size: 10pt"&gt;213,442&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 8%; text-align: right"&gt;&lt;font 
style="font-size: 10pt"&gt;25,523&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color:
white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; 
text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Funds 
advanced&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom;
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;187,919&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top;
padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 
10pt"&gt;Funds repaid&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; 
padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 
10pt"&gt;Funds forgiven&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 
1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 
1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td
style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 
1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 
1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top;
text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance at end of 
period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-
align: justify"&gt;&lt;font style="font-size: 10pt"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-
bottom-style: double; border-bottom-width: 2.25pt; text-align: 
right"&gt;&lt;font style="font-size: 
10pt"&gt;213,442&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
border-bottom-style: double; border-bottom-width: 2.25pt; text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="vertical-align: bottom; border-bottom-style: double; border-
bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;213,442&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;
text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 3, 
July 8, July 10, August 12, November&#13;12, November 13, 2014, January 23, 
February 27, March 5, May 16, June 17, June 30, July 6, August 13, November 17, 
2015, February&#13;13, February 20, March 7, and March 17,2016 a shareholder of 
the Company advanced the Company $2,000, $775, $1,460, $2,000, 
$2,000,&#13;$1,763, $2,000, $10,000, $3,525, $4,093, $2,755, $1,083, $5,000, 
$3,000, $2,041, $961, $5,000, $3,300, and $50,000, respectively,&#13;as a series
of unsecured obligations. The funds aggregating $102,756 were used to pay 
operating costs of the Company. The aggregate&#13;obligations bears no interest,
has no fixed term and is not evidenced by any written agreement. The shareholder
is under no obligation&#13;to advance additional funds to the 
Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;On
 December 3, December 24, 2015, January 4,&#13;January 6, and January 15, 2016 a
shareholder of the Company advanced the Company $37,473, $7,500, $7,326, $8,412,
and $49,975,&#13;respectively, as a series of unsecured obligations. The funds 
aggregating $110,686 were used to pay operating costs of the Company.&#13;On 
January 8, 2016, the aggregate advances received and future advances were 
structured as a noninterest bearing unsecured non-recourse&#13;loan due January 
31, 2017. The shareholders, if requested by the Company, agreed to advance 
additional funds to the Company up&#13;to a maximum of $250,000 subject to 
certain timing limitation as 
defined.&lt;/p&gt;</mdsv:DueToRelatedPartyTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2016-04-01to2016-06-
30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;Long term debt at June 30, 2016 and March 31,&#13;2016 
consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New
Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; 
font-size-adjust: none; font-stretch: normal"&gt;&#13;&lt;tr style="vertical-
align: bottom"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="hdcell"
style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;June 
30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: 
center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;March 
31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-
bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font 
style="font-size: 10pt"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13; 
&lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: 
center"&gt;&lt;font style="font-size: 
10pt"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="ffcell" 
style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13; 
&lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13; 
&lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color:
#CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance at beginning of 
period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font 
style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font 
style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color:
white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; 
text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Funds 
advanced&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;110,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top;
padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 
10pt"&gt;Funds repaid&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td
style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt
solid; vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom;
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt
solid; vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom;
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; 
text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance at end of 
period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; border-bottom: black 2.25pt double; text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-
align: right"&gt;&lt;font style="font-size: 
10pt"&gt;110,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
border-bottom: black 2.25pt double; text-align: justify"&gt;&lt;font 
style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: 
right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify;
text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt 
Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 18, 
2016, the Company entered into&#13;a five year non-interest bearing loan 
agreement for $110,000. Proceeds were used to fund the Technology acquisition 
and operations.&#13;If the loan is not repaid on or before April 15, 2021 the 
loan amount will be subject to default interest on the amount then 
outstanding&#13;of ten percent (10%) per month during the first 30 days of 
delinquency, fifteen percent (15%) per month during the 31 to 60 days&#13;of 
delinquency, twenty percent (20%) per month during the 61 to 90 days of 
delinquency (the &amp;#34;Default Interest&amp;#34;). If the&#13;loan amount 
remains unpaid after 90 days the lender, at its option, will be entitled to a 
default payment of one hundred fifty-nine&#13;percent (159%) of the then 
outstanding loan amount inclusive of the Default Interest.&lt;/p&gt;</us-
gaap:DebtDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2016-
04-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"&gt;&lt;u&gt;Employment 
Agreements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;On April 2, 2014, Mr. Gene 
Gregorio was appointed&#13;the Company's President, Chief Executive Officer, 
Chief Financial Officer and sole Director. On April 20, 2014, the Company 
agreed&#13;to issue Mr. Gregorio 1,000,000 (250,000 presplit) restricted shares 
of the Company's Common Stock, valued at $25,000, based on&#13;the market close,
as compensation for his services for an initial term of one year (the 
&amp;#34;April 20&lt;sup&gt;th&lt;/sup&gt; Agreement&amp;#34;).&#13;On March 31,
2015, the Company issued Mr. Gregorio the agreed 250,000 restricted shares of 
the Company's Common Stock. At March&#13;31, 2015, $1,387 was recorded as a 
prepaid expense for the period April 1 to April 20, 
2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;In addition, if during the term
of the April&#13;20&lt;sup&gt;th&lt;/sup&gt; Agreement Mr. Gregorio's direct 
efforts result in a consummated financing for the Company he shall be paid a 
5.0%&#13;fee on such financing received by the Company, at his option, as either
cash or shares of Company's Common Stock at the offering&#13;price. 
Additionally, the Company will grant Mr. Gregorio a 2 year stock option priced 
at the current market trading price equal&#13;to 5% of the aggregate shares 
issued to investors within the financing.&lt;/p&gt;&#13;&#13;&lt;p style="font: 
10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent:
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;On April 14, 2015, the April 
20&lt;sup&gt;th&lt;/sup&gt;&#13;Agreement with Mr. Gene Gregorio was extended 
for a second year under the same terms and conditions. Mr. Gregorio will be 
issued&#13;1,000,000 (250,000 presplit) restricted shares of the Company's 
Common Stock, valued at $25,000, based on the market close, as&#13;compensation 
for his services for the second year the extended April 
20&lt;sup&gt;th&lt;/sup&gt; Agreement. At June 30, 2016, $25,000 was 
recorded&#13;as an accrued liability for the period April 21, 2015 to April 20, 
2016.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;On August 9, 2016, the Company 
issued Mr. Gregorio&#13;the agreed 1,000,000 (presplit 250,000) restricted 
shares of the Company's Common Stock.&lt;/p&gt;</us-
gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <mdsv:GoingConcernTextBlock contextRef="From2016-04-01to2016-06-30">&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;These financial statements have been prepared&#13;on a going concern
basis which assumes the Company will be able to realize its assets and discharge
its liabilities in the normal&#13;course of business for the foreseeable future.
The Company anticipates future losses in the development of its business 
raising&#13;substantial doubt about the Company's ability to continue as a going
concern. The ability to continue as a going concern is dependent&#13;upon the 
Company generating profitable operations in the future and/or to obtain the 
necessary financing to meet its obligations&#13;and repay its liabilities 
arising from normal business operations when they come due. The Company's 
operating expenditure plan&#13;for the next fiscal year ending March 31, 2017 
will require cash of approximately $500,000. Management intends to finance 
operating&#13;costs over the next twelve months with the issuance of common 
shares and/or related party borrowings.&lt;/p&gt;</mdsv:GoingConcernTextBlock>
    <mdsv:CapitalStockTextBlock contextRef="From2016-04-01to2016-06-30">&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;The Company's capitalization is 300,000,000&#13;shares of common 
stock, with a par value of $0.001 per share, with 28,400,000 shares issued and 
outstanding at March 31, 2016 and&#13;2015. On April 11, 2016, the Company 
effected a four for one forward stock split of our i) authorized and ii) issued 
and outstanding&#13;shares of common stock. All share information has been 
restated for all periods presented giving retroactive effect of the 
April&#13;11, 2016 four to one forward stock split. Prior to the forward stock 
split the Company had 75,000,000 authorized shares of common&#13;stock, with a 
par value of $0.001 per share and 7,100 shares issued and outstanding at March 
31, 2016 and 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;As of June 30, 2016 and March 
31, 2016, the&#13;Company has not granted any stock options or stock warrants. 
As a requirement of the Ocure License Agreement, the Company will&#13;establish 
an incentive stock option plan reserving up to 20% of the Company's issued and 
outstanding common stock, as of the closing&#13;of the License 
Agreement.&lt;/p&gt;</mdsv:CapitalStockTextBlock>
    <us-gaap:MalpracticeLossContingencyDisclosureTextBlock contextRef="From2016-
04-01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; 
margin: 0; text-align: justify"&gt;The Licensed Technology requires an 
aggregate&#13;first tranche payment to the Subsidiary of $250,000 by April 8, 
2016; an aggregate of $231,850 has been advanced to the Subsidiary&#13;as of
June 30, 2016. Upon the 6-month anniversary of the Effective Date, if the 
Company has paid the First $250,000 Tranche, then&#13;Ocure will transfer 
certain assets, as defined, to the Subsidiary, and the Company will be obligated
to provide the Subsidiary&#13;a second $250,000 tranche, payable as follows: 
$100,000 on or before August 12, 2016, $100,000 on or before September 23, 
2016,&#13;and $50,000 on or before October 28, 2016.&lt;/p&gt;</us-
gaap:MalpracticeLossContingencyDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2016-04-01to2016-06-
30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;On August 9, 2016, pursuant to the terms of&#13;the April 
20&lt;sup&gt;th&lt;/sup&gt; Agreement the Company issued 1,000,000 (250,000 
presplit) shares of the Company's Common Stock at Mr.&#13;Gene Gregorio the 
Company's President, Chief Executive Officer, Chief Financial Officer and sole 
Director.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;On August 12, 2016, the Company
failed to pay&#13;an amount due under the August 5, 2015 Licensing Agreement. 
The Company has not negotiated the terms of any extension and there&#13;is a 
substantial risk the agreement will be cancelled.&lt;/p&gt;</us-
gaap:SubsequentEventsTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2016-04-01to2016-06-30">&lt;p 
style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"&gt;The preparation of financial statements in&#13;conformity with 
accounting principles generally accepted in the United States of America 
requires management to make certain estimates&#13;and assumptions that affect 
the reported amounts of assets and liabilities and disclosure of contingent 
assets and liabilities&#13;at the date of the financial statements and the 
reported amounts of revenues and expenses during the reporting periods 
presented.&#13;The Company is required to make judgments and estimates about the
effect of matters that are inherently uncertain. The Company&#13;regularly 
evaluates estimates and assumptions related to the useful life and 
recoverability of long-lived assets, deferred income&#13;tax asset valuations 
and loss contingences. The Company bases its estimates and assumptions on 
current facts, historical experience&#13;and various other factors that it 
believes to be reasonable under the circumstances, the results of which form the
basis for making&#13;judgments about the carrying value of assets and 
liabilities and the accrual of costs and expenses that are not readily 
apparent&#13;from other sources. Although, we believe our judgments and 
estimates are appropriate, actual future results may be different; 
if&#13;different assumptions or conditions were to prevail, the results could be
materially different from our reported results.&lt;/p&gt;</us-
gaap:UseOfEstimates>
    <mdsv:ProspectiveLicenseAgreementPolicyTextBlock contextRef="From2016-04-
01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;On February 27, 2015, we entered into a letter&#13;of
intent (the &amp;#34;Letter of Intent&amp;#34;) with Ocure Ltd. 
(&amp;#34;Ocure&amp;#34;), an Israeli corporation, pursuant to which 
the&#13;Company would be obligated to exclusively license certain technology 
from Ocure under terms of a license agreement to be negotiated&#13;between the 
Company and Ocure. The Letter of Intent terminated when the Company did not make
the second required payment, however&#13;the Company continued to negotiate with
Ocure. On August 5, 2015, as amended February 26, 2016, the company entered into
an exclusive&#13;license agreement (the &amp;#34;License Agreement&amp;#34;) 
with Ocure and Madison-IL Ltd., a wholly-owned subsidiary of the 
Company&#13;incorporated in Israel on July 9, 2015 (the 
&amp;#34;Subsidiary&amp;#34;). Pursuant to the License Agreement, Ocure granted 
to the Subsidiary&#13;an exclusive, sub-licensable, worldwide, license (the 
&amp;#34;License&amp;#34;) to Ocure's semi-occlusive wound dressing for 
ambulatory&#13;treatment of acute and chronic anal fissure, pursuant to Ocure's 
patents and patent applications (the &amp;#34;Licensed 
Technology&amp;#34;)&#13;and to its production, use, import, offer for sale, 
sell, lease, distribute, or otherwise commercialize the Licensed 
Technology&#13;for uses classified as medical devices, or those otherwise
approved ultimately as an OTC (over-the-counter) 
remedy.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Under the License Agreement, 
the Company is&#13;obligated as consideration for the Licensed Technology to 
provide the Subsidiary $250,000 for the commercialization of the 
Licensed&#13;Technology, payable according to the following schedule: $10,000 
upon execution of the Letter of Intent (paid February 27, 2015&#13;to Ocure), 
$90,000 at the later of May 11, 2015 or the final signing date of the License 
Agreement (the &amp;#34;Effective Date&amp;#34;),&#13;and $50,000 on or before 
March 4, 2016, and $100,000 on or before April 8, 2016 (collectively, the 
&amp;#34;First $250,000 Tranche&amp;#34;).&#13;The Effective Date will occur 
upon satisfaction of the Condition Precedent, as defined in the License 
Agreement, and approval of&#13;the Agreement by the Chief Scientist of the 
Israeli Ministry of the Economy. The License Agreement Effective Date is 
November 11,&#13;2015; the date approval of the Chief Scientist of the Israeli 
Ministry of the Economy was received. Upon the 6-month anniversary&#13;of the 
Effective Date, if the Company has paid the First $250,000 Tranche, then Ocure 
will transfer certain assets, as defined,&#13;to the Subsidiary, and the Company
will be obligated to provide the Subsidiary a second $250,000 tranche, payable 
as follows: $100,000&#13;on or before August 12, 2016, $100,000 on or before 
September 23, 2016, and $50,000 on or before October 28, 2016. The 
License&#13;Agreement terminates, on a country-by-country basis, the later of: 
(a) the date of expiration of the last to expire of Ocure's&#13;rights in Ocure 
Patents in such country or such other grant of statutory exclusivity, or (b) the
end of a period of fifteen (15)&#13;years from the date of making the first 
commercial sale, as defined, in such country; unless sooner terminated pursuant 
to the&#13;terms of the License Agreement. As of June 30, 2016 and March 31, 
2016, the Company has advanced $221,850 and $131,850, respectively,&#13;to the 
Subsidiary and paid Ocure $10,000 in furtherance of the commercialization of the
Licensed Technology.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Immediately after the Effective
Date of the&#13;License Agreement and for the period ending March 31, 2016 (as 
amended), the shareholders of Ocure and certain individuals designated&#13;by 
Ocure will have opportunity to purchase up to an aggregate of 7,100,000 
(1,775,000 presplit) shares of the Company's Common&#13;Stock at the par value 
of $0.001 per share. In addition, the Company will establish an incentive stock 
option plan reserving up&#13;to 20% of the Company's issued share capital, as of
the closing. The right to purchase an aggregate of 7,100,000 (1,775,000 
presplit)&#13;shares of the Company's Common Stock expired unexercised, but by 
mutual agreement the purchase right will be extended under 
similar&#13;terms.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, 
Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;In consideration of the license
for the Licensed&#13;Technology and with respect to any inventions, improvement,
development or enhancement based upon, consists of, comprises, contains&#13;or 
incorporates the Licensed Technology invented following the Effective Date by 
the Subsidiary, its affiliate or sublicensee (the&#13;&amp;#34;New 
Inventions&amp;#34;), the Subsidiary will pay to Ocure royalties calculated as 
5% of gross sales. In addition, the Subsidiary&#13;will pay to Ocure 20% of any 
cash or non-cash consideration received, whether for sublicense initiation fee, 
annual fee, sublicense&#13;milestone payments, or other such non-sale based 
royalty consideration payable by a sublicense as consideration for or under 
a&#13;sublicense.&lt;/p&gt;</mdsv:ProspectiveLicenseAgreementPolicyTextBlock>
    <us-gaap:OilAndGasPropertiesPolicyPolicyTextBlock contextRef="From2016-04-
01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;Mineral property acquisition costs are 
capitalized&#13;in accordance with Codification topic 930 &amp;#34;Extractive 
Activities - Mining&amp;#34;. Mineral property pre-exploration and 
exploration&#13;costs are expensed as incurred. When it has been determined that
a mineral property can be economically developed as a result of&#13;establishing
proven and probable reserves, the costs incurred to develop such property are 
capitalized. The Company did not establish&#13;any reserves on its mineral 
properties prior to terminating its option under the Revised and Restated 
Mineral Property Option Agreement&#13;(see footnote 3).&lt;/p&gt;</us-
gaap:OilAndGasPropertiesPolicyPolicyTextBlock>
    <mdsv:RehabilitationProvisionsPolicyTextBlock contextRef="From2016-04-
01to2016-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 
0; text-align: justify"&gt;The Company was subject to various 
government&#13;laws and regulations relating to environmental disturbances which
are caused by exploration and evaluation activities. The Company&#13;will record
the present value for the estimated costs of legal and constructive obligations 
required to restore the exploration&#13;sites in the period in which the 
obligation is incurred. The nature of the rehabilitation activities includes 
restoration, reclamation&#13;and re-vegetation of the affected exploration 
sites. The Company has determined that there were no rehabilitation provisions 
at&#13;February 27, 2015 when the option to acquire the mineral claim was 
terminated.&lt;/p&gt;</mdsv:RehabilitationProvisionsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy 
contextRef="From2016-04-01to2016-06-30">&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Codification topic 718 
&amp;#34;Stock Compensation&amp;#34;&#13;requires that the cost resulting from 
all share-based transactions be recorded in the financial statements and 
establishes fair&#13;value as the measurement objective for share-based payment 
transactions with employees and acquired goods or services from non-
employees.&#13;The codification also provides guidance on valuing and expensing 
these awards, as well as disclosure requirements of these 
equity&#13;arrangements. The Company adopted the codification upon creation of 
the company and will expense share based costs in the period&#13;incurred. The 
Company has not adopted a stock option plan or completed a share-based 
transaction; accordingly no stock-based compensation&#13;has been recorded to 
date.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock 
contextRef="From2016-04-01to2016-06-30">&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;The Company's management has 
evaluated all&#13;the recently issued, but not yet effective, accounting 
standards that have been issued or proposed by the FASB or other standards-
setting&#13;bodies through the filing date of these financial statements and 
does not believe the future adoption of any such pronouncements&#13;will have a 
material effect on the Company's financial position and results of 
operations.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock 
contextRef="From2016-04-01to2016-06-30">&lt;p style="font: 10pt Times New Roman,
Times, Serif; margin: 0; text-align: justify"&gt;Due to related parties at June 
30, 2016 and&#13;March 31, 2016 consisted of the 
following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, 
Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; 
font-size-adjust: none; font-stretch: normal"&gt;&#13;&lt;tr style="vertical-
align: bottom"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="hdcell" 
style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;June 
30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: 
center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;March 
31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-
bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font
style="font-size: 10pt"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13; 
&lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom-style: solid; border-bottom-width: 1pt; text-align: 
center"&gt;&lt;font style="font-size: 
10pt"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="ffcell" 
style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13; 
&lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13; 
&lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color:
#CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; width: 78%; text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance at beginning of 
period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 8%; text-align: right"&gt;&lt;font 
style="font-size: 10pt"&gt;213,442&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 8%; text-align: right"&gt;&lt;font 
style="font-size: 10pt"&gt;25,523&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color:
white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; 
text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Funds 
advanced&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom;
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;187,919&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top;
padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 
10pt"&gt;Funds repaid&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr
style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; 
padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 
10pt"&gt;Funds forgiven&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 
1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 
1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 
1pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; border-bottom-style: solid; border-bottom-width: 
1pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top;
text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance at end of 
period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; border-bottom-style: double; border-bottom-width: 2.25pt; text-
align: justify"&gt;&lt;font style="font-size: 10pt"&gt;
$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; border-
bottom-style: double; border-bottom-width: 2.25pt; text-align: 
right"&gt;&lt;font style="font-size: 
10pt"&gt;213,442&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
border-bottom-style: double; border-bottom-width: 2.25pt; text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="vertical-align: bottom; border-bottom-style: double; border-
bottom-width: 2.25pt; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;213,442&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-
gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2016-04-01to2016-06-
30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-
align: justify"&gt;Long term debt at June 30, 2016 and March 31,&#13;2016 
consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New
Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 
0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" 
cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; 
font-size-adjust: none; font-stretch: normal"&gt;&#13;&lt;tr style="vertical-
align: bottom"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="hdcell" 
style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;June 
30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: 
center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;March 
31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: 
bottom"&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-
bottom-style: solid; border-bottom-width: 1pt; text-align: center"&gt;&lt;font 
style="font-size: 10pt"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13; 
&lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="border-bottom-style: solid; border-bottom-width: 1pt; text-align:
center"&gt;&lt;font style="font-size: 
10pt"&gt;&lt;b&gt;2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td 
style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" id="ffcell" 
style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13; 
&lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" 
style="vertical-align: bottom; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13; 
&lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color:
#CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top; text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance at beginning of 
period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font 
style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
width: 1%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: justify"&gt;&lt;font 
style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 9%; text-align: right"&gt;&lt;font 
style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; width: 1%; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color:
white"&gt;&#13;    &lt;td style="vertical-align: top; padding-left: 11.25pt; 
text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Funds 
advanced&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;110,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-
&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; text-
align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: #CCEEFF"&gt;&#13;    &lt;td style="vertical-align: top;
padding-left: 11.25pt; text-align: justify"&gt;&lt;font style="font-size: 
10pt"&gt;Funds repaid&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt
solid; vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom;
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; border-bottom: black 1pt solid; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt
solid; vertical-align: bottom; text-align: right"&gt;&lt;font style="font-size: 
10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom;
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr 
style="background-color: white"&gt;&#13;    &lt;td style="vertical-align: top; 
text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Balance at end of 
period&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-
align: bottom; border-bottom: black 2.25pt double; text-align: 
justify"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;  
&lt;td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-
align: right"&gt;&lt;font style="font-size: 
10pt"&gt;110,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="vertical-align: 
bottom; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td 
style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="vertical-align: bottom; 
border-bottom: black 2.25pt double; text-align: justify"&gt;&lt;font 
style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td 
style="border-bottom: black 2.25pt double; vertical-align: bottom; text-align: 
right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    
&lt;td style="vertical-align: bottom; text-align: 
justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-
gaap:ScheduleOfDebtTableTextBlock>
    <mdsv:FundsAdvancedLongTermDebtNoncurrent contextRef="From2016-04-01to2016-
06-30" unitRef="USD" 
decimals="0">110000</mdsv:FundsAdvancedLongTermDebtNoncurrent>
    <mdsv:FundsAdvancedLongTermDebtNoncurrent contextRef="From2015-04-01to2016-
03-31" unitRef="USD" xsi:nil="true" />
    <mdsv:FundsRepaidLongTermDebtNoncurrent contextRef="From2016-04-01to2016-06-
30" unitRef="USD" xsi:nil="true" />
    <mdsv:FundsRepaidLongTermDebtNoncurrent contextRef="From2015-04-01to2016-03-
31" unitRef="USD" xsi:nil="true" />
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>mdsv-20160630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: mdsv_20160630_10Q.xfr; Date: 
2016%2D08%2D15T18:00:01Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 
9alZs7xRiXgen8uJZ3RcWaeBuaPtwJ1wKZkhvWZ4HYkqvysg9JQ7oStSufM2QU0D -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xmlns:xbrldt="http://xbrl.org/2005/xbrldt" 
xmlns:xbrldi="http://xbrl.org/2006/xbrldi" 
xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-
gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-
roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" 
xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-
types="http://fasb.org/us-types/2016-01-31" 
xmlns:mdsv="http://madisonventures.com/20160630" elementFormDefault="qualified" 
targetNamespace="http://madisonventures.com/20160630">
    <annotation>
      <appinfo>
<link:roleType
roleURI="http://madisonventures.com/role/DocumentAndEntityInformation" 
id="DocumentAndEntityInformation">
<link:definition>00000001 - Document - Document and Entity
Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://madisonventures.com/role/BalanceSheets"
id="BalanceSheets">
<link:definition>00000002 - Statement - Condensed Consolidated Balance
Sheets</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/BalanceSheetsParenthetical" 
id="BalanceSheetsParenthetical">
<link:definition>00000003 - Statement - Condensed Consolidated Balance
Sheets (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/StatementsOfOperations" 
id="StatementsOfOperations">
<link:definition>00000004 - Statement - Condensed Consolidated
Statements of Operations (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/StatementsOfChangesInStockholdersEquity
Deficit" id="StatementsOfChangesInStockholdersEquityDeficit">
<link:definition>00000005 - Statement - Consolidated Statements of
Changes in Stockholders' Equity (Deficit)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/StatementsOfCashFlows" 
id="StatementsOfCashFlows">
<link:definition>00000006 - Statement - Consolidated Statements of Cash
Flows (Unaudited)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/FinancialStatements" 
id="FinancialStatements">
<link:definition>00000007 - Disclosure - Condensed financial
statements</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/NatureOfOperations" 
id="NatureOfOperations">
<link:definition>00000008 - Disclosure - Nature of
operations</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://madisonventures.com/role/MineralClaim"
id="MineralClaim">
<link:definition>00000009 - Disclosure - Mineral claim</link:definition>
  <link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/InvestmentInTechnologyLicense" 
id="InvestmentInTechnologyLicense">
<link:definition>00000010 - Disclosure - Investment in technology
license</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://madisonventures.com/role/DueToRelatedParty"
id="DueToRelatedParty">
<link:definition>00000011 - Disclosure - Due to related
party</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://madisonventures.com/role/Long-termDebt"
id="Long-termDebt">
<link:definition>00000012 - Disclosure - Long-term
debt</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/RelatedPartyTransactions" 
id="RelatedPartyTransactions">
<link:definition>00000013 - Disclosure - Related party
transactions</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://madisonventures.com/role/GoingConcern"
id="GoingConcern">
<link:definition>00000014 - Disclosure - Going concern</link:definition>
  <link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://madisonventures.com/role/CapitalStock"
id="CapitalStock">
<link:definition>00000015 - Disclosure - Capital stock</link:definition>
  <link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/ContingencyLiability" 
id="ContingencyLiability">
<link:definition>00000016 - Disclosure - Contingency
Liability</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://madisonventures.com/role/SubsequentEvents"
id="SubsequentEvents">
<link:definition>00000017 - Disclosure - Subsequent
events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/NatureOfOperationsPolicies" 
id="NatureOfOperationsPolicies">
<link:definition>00000018 - Disclosure - Nature of operations
(Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/DueToRelatedPartyTables" 
id="DueToRelatedPartyTables">
<link:definition>00000019 - Disclosure - Due to related Party
(Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://madisonventures.com/role/Long-
termDebtTables" id="Long-termDebtTables">
<link:definition>00000020 - Disclosure - Long-term debt
(Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/NatureOfOperationsDetailsNarrative" 
id="NatureOfOperationsDetailsNarrative">
<link:definition>00000021 - Disclosure - Nature of operations (Details
Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/InvestmentInTechnologyLicenseDetailsNar
rative" id="InvestmentInTechnologyLicenseDetailsNarrative">
<link:definition>00000022 - Disclosure - Investment in technology
license (Details Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/DueToRelatedPartyDetails" 
id="DueToRelatedPartyDetails">
<link:definition>00000023 - Disclosure - Due to related Party
(Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://madisonventures.com/role/Long-
termDebtDetails" id="Long-termDebtDetails">
<link:definition>00000024 - Disclosure - Long-term debt
(Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/RelatedPartyTransactionsDetailsNarrativ
e" id="RelatedPartyTransactionsDetailsNarrative">
<link:definition>00000025 - Disclosure - Related party transactions
(Details Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType
roleURI="http://madisonventures.com/role/CapitalStockDetailsNarrative" 
id="CapitalStockDetailsNarrative">
<link:definition>00000026 - Disclosure - Capital stock (Details
Narrative)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
  <link:usedOn>link:calculationLink</link:usedOn>
  <link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="mdsv-20160630_pre.xml"
xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" 
xlink:title="Presentation Links" />
<link:linkbaseRef xlink:type="simple" xlink:href="mdsv-20160630_lab.xml"
xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" 
xlink:title="Label Links" />
<link:linkbaseRef xlink:type="simple" xlink:href="mdsv-20160630_cal.xml"
xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" 
xlink:title="Calculation Links" />
<link:linkbaseRef xlink:type="simple" xlink:href="mdsv-20160630_def.xml"
xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" 
xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" 
xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" 
schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" 
schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" 
schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2016-01-31" 
schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-
31.xsd" />
    <import namespace="http://fasb.org/us-types/2016-01-31" 
schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-
31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" 
schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" 
schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/invest/2013-01-31" 
schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
    <element id="mdsv_FundsAdvanced" name="FundsAdvanced" nillable="true" 
xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_Repayments" name="Repayments" nillable="true"
xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_StockOptionGranted" name="StockOptionGranted" 
nillable="true" xbrli:periodType="duration" xbrli:balance="debit" 
type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="mdsv_FundsForgiven" name="FundsForgiven" nillable="true" 
xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_FeesPaidForCommercializationLicensedTechnology" 
name="FeesPaidForCommercializationLicensedTechnology" nillable="true" 
xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_NoncashInvestingAndFinancingActivities" 
name="NoncashInvestingAndFinancingActivities" nillable="true" 
xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_IncreaseInDepositOnTechnologyLicense" 
name="IncreaseInDepositOnTechnologyLicense" nillable="true" 
xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_StockAccruedAsEmployeeCompensation" 
name="StockAccruedAsEmployeeCompensation" nillable="true" 
xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_DueToRelatedPartyTextBlock" 
name="DueToRelatedPartyTextBlock" nillable="true" xbrli:periodType="duration" 
type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="mdsv_GoingConcernTextBlock" name="GoingConcernTextBlock" 
nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_CapitalStockTextBlock" name="CapitalStockTextBlock" 
nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_ProspectiveLicenseAgreementPolicyTextBlock" 
name="ProspectiveLicenseAgreementPolicyTextBlock" nillable="true" 
xbrli:periodType="duration" type="nonnum:textBlockItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_RehabilitationProvisionsPolicyTextBlock" 
name="RehabilitationProvisionsPolicyTextBlock" nillable="true" 
xbrli:periodType="duration" type="nonnum:textBlockItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_FundsAdvancedLongTermDebtNoncurrent" 
name="FundsAdvancedLongTermDebtNoncurrent" nillable="true" 
xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType"
substitutionGroup="xbrli:item" />
    <element id="mdsv_FundsRepaidLongTermDebtNoncurrent" 
name="FundsRepaidLongTermDebtNoncurrent" nillable="true" 
xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType"
substitutionGroup="xbrli:item" />
    <element id="mdsv_AccumulatedDeficitDuringExplorationStageMember" 
name="AccumulatedDeficitDuringExplorationStageMember" nillable="true" 
xbrli:periodType="duration" type="nonnum:domainItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_DocumentAndEntityInformationAbstract" 
name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_BalanceSheetsAbstract" name="BalanceSheetsAbstract" 
abstract="true" nillable="true" xbrli:periodType="duration" 
type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="mdsv_BalanceSheetsParentheticalAbstract" 
name="BalanceSheetsParentheticalAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
<element id="mdsv_StatementsOfOperationsAbstract" 
name="StatementsOfOperationsAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_StatementsOfCashFlowsAbstract" 
name="StatementsOfCashFlowsAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_NotesToFinancialStatementsAbstract" 
name="NotesToFinancialStatementsAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" 
name="SummaryOfSignificantAccountingPoliciesPoliciesAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_DueToRelatedPartyTablesAbstract" 
name="DueToRelatedPartyTablesAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_LongtermDebtTablesAbstract" 
name="LongtermDebtTablesAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_NatureOfOperationsDetailsNarrativeAbstract" 
name="NatureOfOperationsDetailsNarrativeAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_InvestmentInTechnologyLicenseDetailsNarrativeAbstract" 
name="InvestmentInTechnologyLicenseDetailsNarrativeAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_DueToRelatedPartyDetailsAbstract" 
name="DueToRelatedPartyDetailsAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_LongtermDebtDetailsAbstract" 
name="LongtermDebtDetailsAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_RelatedPartyTransactionsDetailsNarrativeAbstract" 
name="RelatedPartyTransactionsDetailsNarrativeAbstract" abstract="true" 
nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
    <element id="mdsv_CapitalStockDetailsNarrativeAbstract" 
name="CapitalStockDetailsNarrativeAbstract" abstract="true" nillable="true" 
xbrli:periodType="duration" type="xbrli:stringItemType" 
substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>mdsv-20160630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: mdsv_20160630_10Q.xfr; Date: 
2016%2D08%2D15T18:00:01Z -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase 
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef 
roleURI="http://madisonventures.com/role/DocumentAndEntityInformation" 
xlink:href="mdsv-20160630.xsd#DocumentAndEntityInformation" 
xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/BalanceSheets" 
xlink:href="mdsv-20160630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/BalanceSheetsParenthetical" 
xlink:href="mdsv-20160630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/StatementsOfOperations" 
xlink:href="mdsv-20160630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/StatementsOfChangesInStockholdersEquity
Deficit" xlink:href="mdsv-
20160630.xsd#StatementsOfChangesInStockholdersEquityDeficit" xlink:type="simple"
/>
    <link:roleRef 
roleURI="http://madisonventures.com/role/StatementsOfCashFlows" 
xlink:href="mdsv-20160630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/FinancialStatements" 
xlink:href="mdsv-20160630.xsd#FinancialStatements" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/NatureOfOperations" 
xlink:href="mdsv-20160630.xsd#NatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/MineralClaim" 
xlink:href="mdsv-20160630.xsd#MineralClaim" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/InvestmentInTechnologyLicense" 
xlink:href="mdsv-20160630.xsd#InvestmentInTechnologyLicense" xlink:type="simple"
/>
    <link:roleRef roleURI="http://madisonventures.com/role/DueToRelatedParty" 
xlink:href="mdsv-20160630.xsd#DueToRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/Long-termDebt" 
xlink:href="mdsv-20160630.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/RelatedPartyTransactions" 
xlink:href="mdsv-20160630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/GoingConcern" 
xlink:href="mdsv-20160630.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/CapitalStock" 
xlink:href="mdsv-20160630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/ContingencyLiability"
xlink:href="mdsv-20160630.xsd#ContingencyLiability" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/SubsequentEvents" 
xlink:href="mdsv-20160630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/NatureOfOperationsPolicies" 
xlink:href="mdsv-20160630.xsd#NatureOfOperationsPolicies" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/DueToRelatedPartyTables" 
xlink:href="mdsv-20160630.xsd#DueToRelatedPartyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/Long-termDebtTables" 
xlink:href="mdsv-20160630.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/NatureOfOperationsDetailsNarrative" 
xlink:href="mdsv-20160630.xsd#NatureOfOperationsDetailsNarrative" 
xlink:type="simple" />
<link:roleRef 
roleURI="http://madisonventures.com/role/InvestmentInTechnologyLicenseDetailsNar
rative" xlink:href="mdsv-
20160630.xsd#InvestmentInTechnologyLicenseDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/DueToRelatedPartyDetails" 
xlink:href="mdsv-20160630.xsd#DueToRelatedPartyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/Long-termDebtDetails"
xlink:href="mdsv-20160630.xsd#Long-termDebtDetails" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/RelatedPartyTransactionsDetailsNarrativ
e" xlink:href="mdsv-20160630.xsd#RelatedPartyTransactionsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/CapitalStockDetailsNarrative" 
xlink:href="mdsv-20160630.xsd#CapitalStockDetailsNarrative" 
xlink:type="simple" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DocumentAndEntityInformation" 
xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/BalanceSheets" xlink:title="00000002
- Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" 
xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-
gaapCash" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" 
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositAssets" 
xlink:label="loc_us-gaapDepositAssets" />
      <link:calculationArc order="2" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapDepositAssets" 
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" 
xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="3" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-
gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNet" 
xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:calculationArc order="4" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-
gaapAccountsReceivableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-
gaapAssets" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" 
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-
gaapInvestments" />
      <link:calculationArc order="2" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapInvestments" 
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" 
xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" 
xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-
gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" 
xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-
gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" 
xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:calculationArc order="3" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-
gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" 
xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" 
xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-
gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-
gaapLiabilities" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" 
xlink:type="arc" weight="1" />
      <link:calculationArc order="2" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" 
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" 
xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-
gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-
gaapAdditionalPaidInCapitalCommonStock" />
<link:calculationArc order="2" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-
gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-
gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="3" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-
gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-
gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-
gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1"
/>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" 
xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-
gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-
gaapLiabilities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/BalanceSheetsParenthetical" 
xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets 
(Parenthetical)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/StatementsOfOperations" 
xlink:title="00000004 - Statement - Condensed Consolidated Statements of 
Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" 
xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-
gaapOtherGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-
gaapOtherGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfessionalFees" 
xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="2" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees"
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" 
xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item"
xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-
gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" 
xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" 
xlink:label="loc_us-
gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-
gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" 
xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" 
xlink:type="arc" weight="-1" />
      <link:calculationArc order="2" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-
gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" 
xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-
gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" 
xlink:label="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:calculationArc order="2" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" 
xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/StatementsOfChangesInStockholdersEqu
ityDeficit" xlink:title="00000005 - Statement - Consolidated Statements of 
Changes in Stockholders' Equity (Deficit)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/StatementsOfCashFlows" 
xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows 
(Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-
gaapIncreaseDecreaseInAccountsPayableTrade" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc"
weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="2" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-
gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="3" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" 
weight="1" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_StockAccruedAsEmployeeCompensation" 
xlink:label="loc_mdsvStockAccruedAsEmployeeCompensation" />
      <link:calculationArc order="4" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_mdsvStockAccruedAsEmployeeCompensation" xlink:type="arc" 
weight="1" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_IncreaseInDepositOnTechnologyLicense" 
xlink:label="loc_mdsvIncreaseInDepositOnTechnologyLicense" />
      <link:calculationArc order="5" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_mdsvIncreaseInDepositOnTechnologyLicense" xlink:type="arc" 
weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" 
xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="6" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" 
weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-
gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="7" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" 
weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireSoftware" 
xlink:label="loc_us-gaapPaymentsToAcquireSoftware" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" 
xlink:to="loc_us-gaapPaymentsToAcquireSoftware" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"
xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" 
xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" 
weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" 
xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="2" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" 
xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" 
weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/FinancialStatements" 
xlink:title="00000007 - Disclosure - Condensed financial statements" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/NatureOfOperations" 
xlink:title="00000008 - Disclosure - Nature of operations" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/MineralClaim" xlink:title="00000009 
- Disclosure - Mineral claim" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/InvestmentInTechnologyLicense" 
xlink:title="00000010 - Disclosure - Investment in technology license" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DueToRelatedParty" 
xlink:title="00000011 - Disclosure - Due to related party" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/Long-termDebt" xlink:title="00000012
- Disclosure - Long-term debt" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/RelatedPartyTransactions" 
xlink:title="00000013 - Disclosure - Related party transactions" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/GoingConcern" xlink:title="00000014 
- Disclosure - Going concern" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/CapitalStock" xlink:title="00000015 
- Disclosure - Capital stock" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/ContingencyLiability" 
xlink:title="00000016 - Disclosure - Contingency Liability" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/SubsequentEvents" 
xlink:title="00000017 - Disclosure - Subsequent events" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/NatureOfOperationsPolicies" 
xlink:title="00000018 - Disclosure - Nature of operations (Policies)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DueToRelatedPartyTables" 
xlink:title="00000019 - Disclosure - Due to related Party (Tables)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/Long-termDebtTables" 
xlink:title="00000020 - Disclosure - Long-term debt (Tables)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/NatureOfOperationsDetailsNarrative" 
xlink:title="00000021 - Disclosure - Nature of operations (Details 
Narrative)" />
<link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/InvestmentInTechnologyLicenseDetails
Narrative" xlink:title="00000022 - Disclosure - Investment in technology license
(Details Narrative)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DueToRelatedPartyDetails" 
xlink:title="00000023 - Disclosure - Due to related Party (Details)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/Long-termDebtDetails" 
xlink:title="00000024 - Disclosure - Long-term debt (Details)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/RelatedPartyTransactionsDetailsNarra
tive" xlink:title="00000025 - Disclosure - Related party transactions (Details 
Narrative)" />
    <link:calculationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/CapitalStockDetailsNarrative" 
xlink:title="00000026 - Disclosure - Capital stock (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>mdsv-20160630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: mdsv_20160630_10Q.xfr; Date: 
2016%2D08%2D15T18:00:01Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrldt="http://xbrl.org/2005/xbrldt" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase 
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef 
roleURI="http://madisonventures.com/role/DocumentAndEntityInformation" 
xlink:href="mdsv-20160630.xsd#DocumentAndEntityInformation" 
xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/BalanceSheets" 
xlink:href="mdsv-20160630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/BalanceSheetsParenthetical" 
xlink:href="mdsv-20160630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/StatementsOfOperations" 
xlink:href="mdsv-20160630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/StatementsOfChangesInStockholdersEquity
Deficit" xlink:href="mdsv-
20160630.xsd#StatementsOfChangesInStockholdersEquityDeficit" xlink:type="simple"
/>
    <link:roleRef 
roleURI="http://madisonventures.com/role/StatementsOfCashFlows" 
xlink:href="mdsv-20160630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/FinancialStatements" 
xlink:href="mdsv-20160630.xsd#FinancialStatements" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/NatureOfOperations"
xlink:href="mdsv-20160630.xsd#NatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/MineralClaim" 
xlink:href="mdsv-20160630.xsd#MineralClaim" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/InvestmentInTechnologyLicense" 
xlink:href="mdsv-20160630.xsd#InvestmentInTechnologyLicense" xlink:type="simple"
/>
    <link:roleRef roleURI="http://madisonventures.com/role/DueToRelatedParty" 
xlink:href="mdsv-20160630.xsd#DueToRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/Long-termDebt" 
xlink:href="mdsv-20160630.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/RelatedPartyTransactions" 
xlink:href="mdsv-20160630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/GoingConcern" 
xlink:href="mdsv-20160630.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/CapitalStock" 
xlink:href="mdsv-20160630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/ContingencyLiability"
xlink:href="mdsv-20160630.xsd#ContingencyLiability" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/SubsequentEvents" 
xlink:href="mdsv-20160630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/NatureOfOperationsPolicies" 
xlink:href="mdsv-20160630.xsd#NatureOfOperationsPolicies" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/DueToRelatedPartyTables" 
xlink:href="mdsv-20160630.xsd#DueToRelatedPartyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/Long-termDebtTables" 
xlink:href="mdsv-20160630.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/NatureOfOperationsDetailsNarrative" 
xlink:href="mdsv-20160630.xsd#NatureOfOperationsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/InvestmentInTechnologyLicenseDetailsNar
rative" xlink:href="mdsv-
20160630.xsd#InvestmentInTechnologyLicenseDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/DueToRelatedPartyDetails" 
xlink:href="mdsv-20160630.xsd#DueToRelatedPartyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/Long-termDebtDetails"
xlink:href="mdsv-20160630.xsd#Long-termDebtDetails" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/RelatedPartyTransactionsDetailsNarrativ
e" xlink:href="mdsv-20160630.xsd#RelatedPartyTransactionsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/CapitalStockDetailsNarrative" 
xlink:href="mdsv-20160630.xsd#CapitalStockDetailsNarrative" 
xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" 
arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" 
arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" 
arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" 
arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
<link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" 
arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" 
arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DocumentAndEntityInformation" 
xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/BalanceSheets" xlink:title="00000002
- Statement - Condensed Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/BalanceSheetsParenthetical" 
xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets 
(Parenthetical)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/StatementsOfOperations" 
xlink:title="00000004 - Statement - Condensed Consolidated Statements of 
Operations (Unaudited)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/StatementsOfChangesInStockholdersEqu
ityDeficit" xlink:title="00000005 - Statement - Consolidated Statements of 
Changes in Stockholders' Equity (Deficit)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" 
xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" 
xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" 
xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" 
xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" 
xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" 
xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc 
xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" 
xbrldt:contextElement="segment" xlink:from="loc_us-
gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" 
xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-
gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"
xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-
gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" 
xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-
gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-
gaapAccumulatedOtherComprehensiveIncomeMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-
gaapAccumulatedOtherComprehensiveIncomeMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-
gaapSharesIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapSharesIssued_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapStockholdersEquity_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" 
xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-
member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapComprehensiveIncomeNetOfTax_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/StatementsOfCashFlows" 
xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows 
(Unaudited)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/FinancialStatements" 
xlink:title="00000007 - Disclosure - Condensed financial statements" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/NatureOfOperations" 
xlink:title="00000008 - Disclosure - Nature of operations" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/MineralClaim" xlink:title="00000009 
- Disclosure - Mineral claim" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/InvestmentInTechnologyLicense" 
xlink:title="00000010 - Disclosure - Investment in technology license" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DueToRelatedParty" 
xlink:title="00000011 - Disclosure - Due to related party" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/Long-termDebt" xlink:title="00000012
- Disclosure - Long-term debt" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/RelatedPartyTransactions" 
xlink:title="00000013 - Disclosure - Related party transactions" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/GoingConcern" xlink:title="00000014 
- Disclosure - Going concern" />
<link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/CapitalStock" xlink:title="00000015 
- Disclosure - Capital stock" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/ContingencyLiability" 
xlink:title="00000016 - Disclosure - Contingency Liability" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/SubsequentEvents" 
xlink:title="00000017 - Disclosure - Subsequent events" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/NatureOfOperationsPolicies" 
xlink:title="00000018 - Disclosure - Nature of operations (Policies)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DueToRelatedPartyTables" 
xlink:title="00000019 - Disclosure - Due to related Party (Tables)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/Long-termDebtTables" 
xlink:title="00000020 - Disclosure - Long-term debt (Tables)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/NatureOfOperationsDetailsNarrative" 
xlink:title="00000021 - Disclosure - Nature of operations (Details 
Narrative)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/InvestmentInTechnologyLicenseDetails
Narrative" xlink:title="00000022 - Disclosure - Investment in technology license
(Details Narrative)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DueToRelatedPartyDetails" 
xlink:title="00000023 - Disclosure - Due to related Party (Details)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/Long-termDebtDetails" 
xlink:title="00000024 - Disclosure - Long-term debt (Details)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/RelatedPartyTransactionsDetailsNarra
tive" xlink:title="00000025 - Disclosure - Related party transactions (Details 
Narrative)" />
    <link:definitionLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/CapitalStockDetailsNarrative" 
xlink:title="00000026 - Disclosure - Capital stock (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>mdsv-20160630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: mdsv_20160630_10Q.xfr; Date: 
2016%2D08%2D15T18:00:01Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase 
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"
roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedPeriodEndLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedPeriodStartLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedTotalLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"
roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-
16.xsd#negatedTerseLabel" 
roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" 
xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" 
roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" 
xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" 
xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-
gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" 
xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-
gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components 
[Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" 
xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-
gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In 
Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-
gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" 
xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated
other comprehensive Income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" 
xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-
gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated 
Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_DocumentAndEntityInformationAbstract" 
xlink:label="mdsv_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_DocumentAndEntityInformationAbstract" 
xlink:to="mdsv_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-
US">Document And Entity Information</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityRegistrantName" 
xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant 
Name</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityCentralIndexKey" 
xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central 
Index Key</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" 
xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_DocumentPeriodEndDate" 
xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End
Date</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" 
xlink:label="dei_AmendmentFlag" />
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_CurrentFiscalYearEndDate" 
xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_CurrentFiscalYearEndDate" 
xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal 
Year End Date</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityWellKnownSeasonedIssuer" 
xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityWellKnownSeasonedIssuer" 
xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Is Entity a
Well-known Seasoned Issuer?</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityVoluntaryFilers" 
xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Is Entity a 
Voluntary Filer?</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCurrentReportingStatus" 
xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityCurrentReportingStatus" 
xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Is Entity's 
Reporting Status Current?</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityFilerCategory" 
xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer 
Category</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCommonStockSharesOutstanding" 
xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_EntityCommonStockSharesOutstanding" 
xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity
Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentFiscalPeriodFocus" 
xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_DocumentFiscalPeriodFocus" 
xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal
Period Focus</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="dei_DocumentFiscalYearFocus" 
xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal 
Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_BalanceSheetsAbstract" 
xlink:label="mdsv_BalanceSheetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_BalanceSheetsAbstract" 
xlink:to="mdsv_BalanceSheetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_BalanceSheetsAbstract_lbl" xml:lang="en-US">Condensed 
Consolidated Balance Sheets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-
gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" 
xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-
gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="us-
gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" 
xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositAssets" xlink:label="us-
gaap_DepositAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DepositAssets" xlink:to="us-gaap_DepositAssets_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DepositAssets_lbl" xml:lang="en-US">Deposit on Technology 
License</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" 
xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-
gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNet" 
xlink:label="us-gaap_AccountsReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-
gaap_AccountsReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Miscellaneous 
receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-
gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Investments" xlink:label="us-
gaap_Investments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_Investments_lbl" xml:lang="en-US">Investment in technology 
license</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-
gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-
gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" 
xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc"
/>
<link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES 
AND SHAREHOLDERS' EQUITY (DEFICIT)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" 
xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-
gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current 
liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" 
xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-
gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" 
xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-
gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued 
liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" 
xlink:label="us-gaap_DueToRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-
gaap_DueToRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DueToRelatedPartiesCurrent_lbl" xml:lang="en-US">Due to related 
party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" 
xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-
gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current 
liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" 
xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-
gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-term 
liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" 
xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-
gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" 
xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-
gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term 
liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-
gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" 
xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-
gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and 
Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" 
xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-
gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders' equity 
(deficit):</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-
gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-
gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock: 300,000,000 shares 
authorized of $0.001 par value; 28,400,000 and 28,400,000 shares issued and 
outstanding as of June 30, 2016 and March 31, 2016</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-
gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-
gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in
capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-
gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-
gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated 
deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" 
xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-
US">Accumulated other comprehensive income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-
gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders' equity 
(deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" 
xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-
gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities 
and shareholders' equity (deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_BalanceSheetsParentheticalAbstract" 
xlink:label="mdsv_BalanceSheetsParentheticalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_BalanceSheetsParentheticalAbstract" 
xlink:to="mdsv_BalanceSheetsParentheticalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_BalanceSheetsParentheticalAbstract_lbl" xml:lang="en-
US">Condensed Consolidated Balance Sheets Parenthetical</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-
gaap_StockholdersEquityAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_StockholdersEquityAbstract_2_lbl" xml:lang="en-US">Stockholders'
equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-
gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-
gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par
value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" 
xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-
gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares 
authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" 
xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-
gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares 
issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" 
xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-
gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares 
outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_StatementsOfOperationsAbstract" 
xlink:label="mdsv_StatementsOfOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_StatementsOfOperationsAbstract" 
xlink:to="mdsv_StatementsOfOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_StatementsOfOperationsAbstract_lbl" xml:lang="en-US">Condensed
Consolidated Statements Of Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" 
xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-
gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating 
costs:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="us-
gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-
gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ProfessionalFees_lbl" xml:lang="en-US">Consulting and professional 
fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" 
xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-
gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock based 
compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_OtherGeneralAndAdministrativeExpense" xlink:label="us-
gaap_OtherGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="us-
gaap_OtherGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OtherGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Other general 
&amp; administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" 
xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-
gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"
xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-
gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income 
(expenses):</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" 
xlink:label="us-
gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" 
xlink:to="us-
gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_lbl" 
xml:lang="en-US">Foreign exchange gain</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" 
xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-
gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income 
(expenses)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-
gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-
gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" 
xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Loss per 
common share:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" 
xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-
gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and 
diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="us-
gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="us-
gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xml:lang="en-
US">Weighted average common shares outstanding:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-
US">Basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-
gaap_ComprehensiveIncomeNetOfTaxAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-
gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xml:lang="en-US">Comprehensive 
income (loss):</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" 
xlink:label="us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" 
xlink:to="us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" 
xml:lang="en-US">Other comprehensive income:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" 
xlink:label="us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" 
xlink:to="us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_lbl" 
xml:lang="en-US">Foreign currency translation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" 
xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-
gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive 
(loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-
gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-
gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line 
Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssued" xlink:label="us-
gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-
gaap_SharesIssued_lbl" xml:lang="en-US">Beginning Balance, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-
gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-
gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning Balance, 
Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-
gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive 
loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-
gaap_SharesIssued_2_lbl" xml:lang="en-US">Ending Balance, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-
gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-
gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending Balance, 
Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_StatementsOfCashFlowsAbstract" 
xlink:label="mdsv_StatementsOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_StatementsOfCashFlowsAbstract" 
xlink:to="mdsv_StatementsOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_StatementsOfCashFlowsAbstract_lbl" xml:lang="en-
US">Consolidated Statements Of Cash Flows</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" 
xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-
US">Cash flows from operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract" xlink:label="us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract" xlink:to="us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash 
(used in) provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_StockAccruedAsEmployeeCompensation" 
xlink:label="mdsv_StockAccruedAsEmployeeCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_StockAccruedAsEmployeeCompensation" 
xlink:to="mdsv_StockAccruedAsEmployeeCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_StockAccruedAsEmployeeCompensation_lbl" xml:lang="en-US">Stock
accrued as employee compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" 
xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in
operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" 
xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-
gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">(Increase) in 
prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-
gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-
gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
<link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Decrease 
(increase) in miscellaneous receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_IncreaseInDepositOnTechnologyLicense" 
xlink:label="mdsv_IncreaseInDepositOnTechnologyLicense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_IncreaseInDepositOnTechnologyLicense" 
xlink:to="mdsv_IncreaseInDepositOnTechnologyLicense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_IncreaseInDepositOnTechnologyLicense_lbl" xml:lang="en-
US">Decrease (increase) in deposit on technology license</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-
gaap_IncreaseDecreaseInAccountsPayableTrade" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="us-
gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncreaseDecreaseInAccountsPayableTrade_lbl" xml:lang="en-US">Increase in 
accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-
gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-
gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">(Decrease) in 
accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-
gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash 
(used in) provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" 
xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-
US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireSoftware" 
xlink:label="us-gaap_PaymentsToAcquireSoftware" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PaymentsToAcquireSoftware" xlink:to="us-
gaap_PaymentsToAcquireSoftware_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-
gaap_PaymentsToAcquireSoftware_lbl" xml:lang="en-US">Acquisition of technology 
license</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-
gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash 
(used in) investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" 
xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-
US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" 
xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-
gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from related 
parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"
xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-
gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from non-
interest bearing term-debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-
gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-
gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash 
provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCash"
xlink:label="us-gaap_EffectOfExchangeRateOnCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_EffectOfExchangeRateOnCash" xlink:to="us-
gaap_EffectOfExchangeRateOnCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_EffectOfExchangeRateOnCash_lbl" xml:lang="en-US">Effect of exchange rate 
changes on cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" 
xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net 
increase (decrease) in cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-
gaap_Cash_2_lbl" xml:lang="en-US">Cash, beginning of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_3_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-
gaap_Cash_3_lbl" xml:lang="en-US">Cash, end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NoncashInvestingAndFinancingActivities" 
xlink:label="mdsv_NoncashInvestingAndFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_NoncashInvestingAndFinancingActivities" 
xlink:to="mdsv_NoncashInvestingAndFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_NoncashInvestingAndFinancingActivities_lbl" xml:lang="en-
US">Non-cash investing and financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-
gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" 
xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplement 
cash flow disclosure:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-
gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-
gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-
gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-
gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income tax paid</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="mdsv_NotesToFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_NotesToFinancialStatementsAbstract" 
xlink:to="mdsv_NotesToFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_NotesToFinancialStatementsAbstract_lbl" xml:lang="en-US">Notes
to Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_CondensedFinancialStatementsTextBlock" xlink:label="us-
gaap_CondensedFinancialStatementsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_CondensedFinancialStatementsTextBlock" xlink:to="us-
gaap_CondensedFinancialStatementsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_CondensedFinancialStatementsTextBlock_lbl" xml:lang="en-US">Note 1. 
Condensed financial statements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" 
xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-
gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NatureOfOperations_lbl" xml:lang="en-US">Note 2. Nature of 
operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_MineralIndustriesDisclosuresTextBlock" xlink:label="us-
gaap_MineralIndustriesDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_MineralIndustriesDisclosuresTextBlock" xlink:to="us-
gaap_MineralIndustriesDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_MineralIndustriesDisclosuresTextBlock_lbl" xml:lang="en-US">Note 3. Mineral
claim</link:label>
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-
31.xsd#invest_InvestmentTextBlock" xlink:label="invest_InvestmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="invest_InvestmentTextBlock" 
xlink:to="invest_InvestmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="invest_InvestmentTextBlock_lbl" xml:lang="en-US">Note 4. Investment
in technology license</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_DueToRelatedPartyTextBlock" 
xlink:label="mdsv_DueToRelatedPartyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_DueToRelatedPartyTextBlock" 
xlink:to="mdsv_DueToRelatedPartyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_DueToRelatedPartyTextBlock_lbl" xml:lang="en-US">Note 5. Due 
to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" 
xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-
gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Note 6. Long-term 
debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-
gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" 
xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Note 7. 
Related party transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_GoingConcernTextBlock" 
xlink:label="mdsv_GoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_GoingConcernTextBlock" 
xlink:to="mdsv_GoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_GoingConcernTextBlock_lbl" xml:lang="en-US">Note 8. Going 
concern</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_CapitalStockTextBlock" 
xlink:label="mdsv_CapitalStockTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_CapitalStockTextBlock" 
xlink:to="mdsv_CapitalStockTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_CapitalStockTextBlock_lbl" xml:lang="en-US">Note 9. Capital 
stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_MalpracticeLossContingencyDisclosureTextBlock" xlink:label="us-
gaap_MalpracticeLossContingencyDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_MalpracticeLossContingencyDisclosureTextBlock" 
xlink:to="us-gaap_MalpracticeLossContingencyDisclosureTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_MalpracticeLossContingencyDisclosureTextBlock_lbl" xml:lang="en-US">Note 
10. Contingency Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" 
xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-
gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Note 11. Subsequent 
events</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" 
xlink:label="mdsv_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="mdsv_SummaryOfSignificantAccountingPoliciesPoliciesAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_SummaryOfSignificantAccountingPoliciesPoliciesAbstract_lbl" 
xml:lang="en-US">Nature Of Operations Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-
gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates and 
Assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_ProspectiveLicenseAgreementPolicyTextBlock" 
xlink:label="mdsv_ProspectiveLicenseAgreementPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_ProspectiveLicenseAgreementPolicyTextBlock" 
xlink:to="mdsv_ProspectiveLicenseAgreementPolicyTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_ProspectiveLicenseAgreementPolicyTextBlock_lbl" xml:lang="en-
US">License Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_OilAndGasPropertiesPolicyPolicyTextBlock" xlink:label="us-
gaap_OilAndGasPropertiesPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OilAndGasPropertiesPolicyPolicyTextBlock" 
xlink:to="us-gaap_OilAndGasPropertiesPolicyPolicyTextBlock_lbl" xlink:type="arc"
/>
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OilAndGasPropertiesPolicyPolicyTextBlock_lbl" xml:lang="en-US">Mineral 
Properties</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_RehabilitationProvisionsPolicyTextBlock" 
xlink:label="mdsv_RehabilitationProvisionsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_RehabilitationProvisionsPolicyTextBlock" 
xlink:to="mdsv_RehabilitationProvisionsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_RehabilitationProvisionsPolicyTextBlock_lbl" xml:lang="en-
US">Rehabilitation Provisions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-
gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" 
xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-
US">Share-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" 
xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-
US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_DueToRelatedPartyTablesAbstract" 
xlink:label="mdsv_DueToRelatedPartyTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_DueToRelatedPartyTablesAbstract" 
xlink:to="mdsv_DueToRelatedPartyTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_DueToRelatedPartyTablesAbstract_lbl" xml:lang="en-US">Due To 
Related Party Tables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-
gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" 
xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">Due 
to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_LongtermDebtTablesAbstract" 
xlink:label="mdsv_LongtermDebtTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_LongtermDebtTablesAbstract" 
xlink:to="mdsv_LongtermDebtTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_LongtermDebtTablesAbstract_lbl" xml:lang="en-US">Long-term 
Debt Tables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" 
xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-
gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Long term 
debt</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NatureOfOperationsDetailsNarrativeAbstract"
xlink:label="mdsv_NatureOfOperationsDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_NatureOfOperationsDetailsNarrativeAbstract" 
xlink:to="mdsv_NatureOfOperationsDetailsNarrativeAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_NatureOfOperationsDetailsNarrativeAbstract_lbl" xml:lang="en-
US">Nature Of Operations Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount" xlink:label="us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount" xlink:to="us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount_lbl" xml:lang="en-
US">Advance for commercialization of the Licensed Technology</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_FeesPaidForCommercializationLicensedTechnology" 
xlink:label="mdsv_FeesPaidForCommercializationLicensedTechnology" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_FeesPaidForCommercializationLicensedTechnology" 
xlink:to="mdsv_FeesPaidForCommercializationLicensedTechnology_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_FeesPaidForCommercializationLicensedTechnology_lbl" 
xml:lang="en-US">Fees paid for commercialization Licensed 
Technology</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_InvestmentInTechnologyLicenseDetailsNarrativeAbstract" 
xlink:label="mdsv_InvestmentInTechnologyLicenseDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_InvestmentInTechnologyLicenseDetailsNarrativeAbstract" 
xlink:to="mdsv_InvestmentInTechnologyLicenseDetailsNarrativeAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_InvestmentInTechnologyLicenseDetailsNarrativeAbstract_lbl" 
xml:lang="en-US">Investment In Technology License Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_DueToRelatedPartyDetailsAbstract" 
xlink:label="mdsv_DueToRelatedPartyDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_DueToRelatedPartyDetailsAbstract" 
xlink:to="mdsv_DueToRelatedPartyDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_DueToRelatedPartyDetailsAbstract_lbl" xml:lang="en-US">Due To 
Related Party Details</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-
gaap_DueToRelatedPartiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-
gaap_DueToRelatedPartiesCurrent_2_lbl" xml:lang="en-US">Balance at beginning of 
period</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_FundsAdvanced" xlink:label="mdsv_FundsAdvanced" />
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_FundsAdvanced" xlink:to="mdsv_FundsAdvanced_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_FundsAdvanced_lbl" xml:lang="en-US">Funds 
advanced</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_Repayments" xlink:label="mdsv_Repayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_Repayments" xlink:to="mdsv_Repayments_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_Repayments_lbl" xml:lang="en-US">Funds repaid</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_FundsForgiven" xlink:label="mdsv_FundsForgiven" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_FundsForgiven" xlink:to="mdsv_FundsForgiven_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_FundsForgiven_lbl" xml:lang="en-US">Funds 
forgiven</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="us-
gaap_DueToRelatedPartiesCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-
gaap_DueToRelatedPartiesCurrent_3_lbl" xml:lang="en-US">Balance at end of 
period</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_LongtermDebtDetailsAbstract" 
xlink:label="mdsv_LongtermDebtDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_LongtermDebtDetailsAbstract" 
xlink:to="mdsv_LongtermDebtDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_LongtermDebtDetailsAbstract_lbl" xml:lang="en-US">Long-term 
Debt Details</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-
gaap_LongTermDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-
gaap_LongTermDebtNoncurrent_2_lbl" xml:lang="en-US">Balance at beginning of 
period</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_FundsAdvancedLongTermDebtNoncurrent" 
xlink:label="mdsv_FundsAdvancedLongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_FundsAdvancedLongTermDebtNoncurrent" 
xlink:to="mdsv_FundsAdvancedLongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" 
xlink:label="mdsv_FundsAdvancedLongTermDebtNoncurrent_lbl" xml:lang="en-
US">Funds advanced</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_FundsRepaidLongTermDebtNoncurrent" 
xlink:label="mdsv_FundsRepaidLongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_FundsRepaidLongTermDebtNoncurrent" 
xlink:to="mdsv_FundsRepaidLongTermDebtNoncurrent_lbl" xlink:type="arc" />
<link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" 
xlink:label="mdsv_FundsRepaidLongTermDebtNoncurrent_lbl" xml:lang="en-US">Funds 
repaid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-
gaap_LongTermDebtNoncurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-
gaap_LongTermDebtNoncurrent_3_lbl" xml:lang="en-US">Balance at end of 
period</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_RelatedPartyTransactionsDetailsNarrativeAbstract" 
xlink:label="mdsv_RelatedPartyTransactionsDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_RelatedPartyTransactionsDetailsNarrativeAbstract" 
xlink:to="mdsv_RelatedPartyTransactionsDetailsNarrativeAbstract_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_RelatedPartyTransactionsDetailsNarrativeAbstract_lbl" 
xml:lang="en-US">Related Party Transactions Details Narrative</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-
gaap_AccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-
gaap_AccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Accrued 
liability</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_CapitalStockDetailsNarrativeAbstract" 
xlink:label="mdsv_CapitalStockDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_CapitalStockDetailsNarrativeAbstract" 
xlink:to="mdsv_CapitalStockDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_CapitalStockDetailsNarrativeAbstract_lbl" xml:lang="en-
US">Capital Stock Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_StockOptionGranted" xlink:label="mdsv_StockOptionGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_StockOptionGranted" 
xlink:to="mdsv_StockOptionGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_StockOptionGranted_lbl" xml:lang="en-US">Stock options or 
warrants granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_CapitalStockTextBlock" 
xlink:to="mdsv_CapitalStockTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="mdsv_CapitalStockTextBlock_doc" xml:lang="en-US">custom: Capital 
stock text block</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_FundsAdvanced" xlink:to="mdsv_FundsAdvanced_doc" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="mdsv_FundsAdvanced_doc" xml:lang="en-US">Funds 
advanced.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_NoncashInvestingAndFinancingActivities"
xlink:to="mdsv_NoncashInvestingAndFinancingActivities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="mdsv_NoncashInvestingAndFinancingActivities_doc" xml:lang="en-
US">custom:Non cash investing and financing activities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_Repayments" xlink:to="mdsv_Repayments_doc" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/documentation" 
xlink:label="mdsv_Repayments_doc" xml:lang="en-US">Repayments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl"
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-
gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, 
Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-
gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, 
Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-
gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity 
Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-
gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and 
Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-
gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-
gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income 
(Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_lbl" xml:lang="en-
US">Weighted Average Number of Shares Outstanding, Basic and 
Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" 
xlink:to="us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_2_lbl" 
xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation
Adjustment, Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_3_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_SharesIssued_3_lbl" xml:lang="en-US">Shares, Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash
Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_PaymentsToAcquireSoftware" xlink:to="us-
gaap_PaymentsToAcquireSoftware_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_PaymentsToAcquireSoftware_2_lbl" xml:lang="en-US">Payments to Acquire 
Software</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash
Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" 
xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" 
xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-
gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash
Provided by (Used in) Financing Activities</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_FundsAdvancedLongTermDebtNoncurrent" 
xlink:to="mdsv_FundsAdvancedLongTermDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_FundsAdvancedLongTermDebtNoncurrent_2_lbl" xml:lang="en-
US">FundsAdvancedLongTermDebtNoncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-
label" xlink:from="mdsv_FundsRepaidLongTermDebtNoncurrent" 
xlink:to="mdsv_FundsRepaidLongTermDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" 
xlink:role="http://www.xbrl.org/2003/role/label" 
xlink:label="mdsv_FundsRepaidLongTermDebtNoncurrent_2_lbl" xml:lang="en-
US">FundsRepaidLongTermDebtNoncurrent</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>mdsv-20160630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: mdsv_20160630_10Q.xfr; Date: 
2016%2D08%2D15T18:00:01Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xmlns:xlink="http://www.w3.org/1999/xlink" 
xmlns:link="http://www.xbrl.org/2003/linkbase" 
xmlns:xbrli="http://www.xbrl.org/2003/instance" 
xsi:schemaLocation="http://www.xbrl.org/2003/linkbase 
http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef 
roleURI="http://madisonventures.com/role/DocumentAndEntityInformation" 
xlink:href="mdsv-20160630.xsd#DocumentAndEntityInformation" 
xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/BalanceSheets" 
xlink:href="mdsv-20160630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/BalanceSheetsParenthetical" 
xlink:href="mdsv-20160630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/StatementsOfOperations" 
xlink:href="mdsv-20160630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/StatementsOfChangesInStockholdersEquity
Deficit" xlink:href="mdsv-
20160630.xsd#StatementsOfChangesInStockholdersEquityDeficit" xlink:type="simple"
/>
    <link:roleRef 
roleURI="http://madisonventures.com/role/StatementsOfCashFlows" 
xlink:href="mdsv-20160630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/FinancialStatements" 
xlink:href="mdsv-20160630.xsd#FinancialStatements" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/NatureOfOperations" 
xlink:href="mdsv-20160630.xsd#NatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/MineralClaim" 
xlink:href="mdsv-20160630.xsd#MineralClaim" xlink:type="simple" />
<link:roleRef 
roleURI="http://madisonventures.com/role/InvestmentInTechnologyLicense" 
xlink:href="mdsv-20160630.xsd#InvestmentInTechnologyLicense" xlink:type="simple"
/>
    <link:roleRef roleURI="http://madisonventures.com/role/DueToRelatedParty" 
xlink:href="mdsv-20160630.xsd#DueToRelatedParty" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/Long-termDebt" 
xlink:href="mdsv-20160630.xsd#Long-termDebt" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/RelatedPartyTransactions" 
xlink:href="mdsv-20160630.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/GoingConcern" 
xlink:href="mdsv-20160630.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/CapitalStock" 
xlink:href="mdsv-20160630.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/ContingencyLiability"
xlink:href="mdsv-20160630.xsd#ContingencyLiability" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/SubsequentEvents" 
xlink:href="mdsv-20160630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/NatureOfOperationsPolicies" 
xlink:href="mdsv-20160630.xsd#NatureOfOperationsPolicies" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/DueToRelatedPartyTables" 
xlink:href="mdsv-20160630.xsd#DueToRelatedPartyTables" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/Long-termDebtTables" 
xlink:href="mdsv-20160630.xsd#Long-termDebtTables" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/NatureOfOperationsDetailsNarrative" 
xlink:href="mdsv-20160630.xsd#NatureOfOperationsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/InvestmentInTechnologyLicenseDetailsNar
rative" xlink:href="mdsv-
20160630.xsd#InvestmentInTechnologyLicenseDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/DueToRelatedPartyDetails" 
xlink:href="mdsv-20160630.xsd#DueToRelatedPartyDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://madisonventures.com/role/Long-termDebtDetails"
xlink:href="mdsv-20160630.xsd#Long-termDebtDetails" xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/RelatedPartyTransactionsDetailsNarrativ
e" xlink:href="mdsv-20160630.xsd#RelatedPartyTransactionsDetailsNarrative" 
xlink:type="simple" />
    <link:roleRef 
roleURI="http://madisonventures.com/role/CapitalStockDetailsNarrative" 
xlink:href="mdsv-20160630.xsd#CapitalStockDetailsNarrative" 
xlink:type="simple" />
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DocumentAndEntityInformation" 
xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_DocumentAndEntityInformationAbstract" 
xlink:label="loc_mdsvDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" 
xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" 
xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_CurrentFiscalYearEndDate" 
xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityWellKnownSeasonedIssuer" 
xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCurrentReportingStatus" 
xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
<link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_EntityCommonStockSharesOutstanding" 
xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentFiscalPeriodFocus" 
xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-
31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus"
/>
      <link:presentationArc order="120" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDocumentAndEntityInformationAbstract" 
xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/BalanceSheets" xlink:title="00000002
- Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_BalanceSheetsAbstract" 
xlink:label="loc_mdsvBalanceSheetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" 
xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvBalanceSheetsAbstract" xlink:to="loc_us-gaapAssetsAbstract" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" 
xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-
gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-
gaapCash" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepositAssets" 
xlink:label="loc_us-gaapDepositAssets" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-
gaapDepositAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseCurrent" 
xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-
gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableNet" 
xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-
gaapAccountsReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" 
xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-
gaapInvestments" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapInvestments" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-
gaapAssets" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvBalanceSheetsAbstract" xlink:to="loc_us-gaapAssets" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-
gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvBalanceSheetsAbstract" xlink:to="loc_us-
gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" 
xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" 
xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" 
xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="110" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-
gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" 
xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="120" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-
gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" 
xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="130" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-
gaapDueToRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" 
xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="140" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" 
xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" 
xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="150" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" 
xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" 
xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="160" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-
gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" 
xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="170" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" 
xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-
gaapLiabilities" />
      <link:presentationArc order="180" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" 
xlink:to="loc_us-gaapLiabilities" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" 
xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="190" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" 
xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" 
xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" 
xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" 
xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="210" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-
gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="220" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-
gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="230" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-
gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="240" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="250" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" 
xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" 
xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="260" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvBalanceSheetsAbstract" xlink:to="loc_us-
gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/BalanceSheetsParenthetical" 
xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets 
(Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_BalanceSheetsParentheticalAbstract" 
xlink:label="loc_mdsvBalanceSheetsParentheticalAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" 
xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvBalanceSheetsParentheticalAbstract" xlink:to="loc_us-
gaapStockholdersEquityAbstract" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-
gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" 
xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
<link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" 
xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" 
xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-
gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/StatementsOfOperations" 
xlink:title="00000004 - Statement - Condensed Consolidated Statements of 
Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_StatementsOfOperationsAbstract" 
xlink:label="loc_mdsvStatementsOfOperationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpensesAbstract" 
xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfOperationsAbstract" xlink:to="loc_us-
gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfessionalFees" 
xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-
gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" 
xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-
gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_OtherGeneralAndAdministrativeExpense" xlink:label="loc_us-
gaapOtherGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-
gaapOtherGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingExpenses" 
xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfOperationsAbstract" xlink:to="loc_us-
gaapOperatingExpenses" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"
xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfOperationsAbstract" xlink:to="loc_us-
gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" 
xlink:label="loc_us-
gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-
gaapDefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" 
xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-
gaapNonoperatingIncomeExpense" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-
gaapNetIncomeLoss" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-
gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfOperationsAbstract" xlink:to="loc_us-
gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" 
xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" 
xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" 
xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"
/>
      <link:presentationArc order="110" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfOperationsAbstract" xlink:to="loc_us-
gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" 
xlink:label="loc_us-
gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="120" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"
xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="loc_us-
gaapComprehensiveIncomeNetOfTaxAbstract" />
      <link:presentationArc order="130" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" 
xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss_2" />
      <link:presentationArc order="140" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" xlink:to="loc_us-
gaapNetIncomeLoss_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" 
xlink:label="loc_us-
gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="150" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" xlink:to="loc_us-
gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" 
xlink:label="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" />
      <link:presentationArc order="160" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" 
xlink:to="loc_us-
gaapOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" 
xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="170" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" 
xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/StatementsOfChangesInStockholdersEqu
ityDeficit" xlink:title="00000005 - Statement - Consolidated Statements of 
Changes in Stockholders' Equity (Deficit)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-
gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" 
xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-
gaapStatementTable" order="100" />
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" 
xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" 
order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" 
xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-
gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" 
xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" 
xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" 
xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsMember" 
xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-
gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-
gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-
gaapSharesIssued" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"
/>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapStockholdersEquity" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" 
xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapComprehensiveIncomeNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-
gaapSharesIssued_2" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued_2" 
xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" 
xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-
gaapStockholdersEquity_2" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/StatementsOfCashFlows" 
xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows 
(Unaudited)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_StatementsOfCashFlowsAbstract" 
xlink:label="loc_mdsvStatementsOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-
gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" 
xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" 
xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract" xlink:label="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" 
xlink:to="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_StockAccruedAsEmployeeCompensation" 
xlink:label="loc_mdsvStockAccruedAsEmployeeCompensation" />
      <link:presentationArc order="30"
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" xlink:to="loc_mdsvStockAccruedAsEmployeeCompensation" xlink:type="arc"
/>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-
gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-
gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
Abstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" 
xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" 
xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-
gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="60" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" 
xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_IncreaseInDepositOnTechnologyLicense" 
xlink:label="loc_mdsvIncreaseInDepositOnTechnologyLicense" />
      <link:presentationArc order="70" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" 
xlink:to="loc_mdsvIncreaseInDepositOnTechnologyLicense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-
gaapIncreaseDecreaseInAccountsPayableTrade" />
      <link:presentationArc order="80" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" 
xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-
gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="90" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" 
xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="100" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" 
xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-
gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="110" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireSoftware" 
xlink:label="loc_us-gaapPaymentsToAcquireSoftware" />
      <link:presentationArc order="120" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" 
xlink:to="loc_us-gaapPaymentsToAcquireSoftware" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="130" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" 
xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-
gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="140" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" 
xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="150" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" 
xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"
xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="160" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" 
xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-
gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="170" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" 
xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCash" 
xlink:label="loc_us-gaapEffectOfExchangeRateOnCash" />
      <link:presentationArc order="180" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" 
xlink:to="loc_us-gaapEffectOfExchangeRateOnCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-
gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="190" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-
gaapCash" />
      <link:presentationArc order="200" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfCashFlowsAbstract" xlink:to="loc_us-gaapCash" 
xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"
/>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-
gaapCash_2" />
      <link:presentationArc order="210" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfCashFlowsAbstract" xlink:to="loc_us-gaapCash_2" 
xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NoncashInvestingAndFinancingActivities" 
xlink:label="loc_mdsvNoncashInvestingAndFinancingActivities" />
      <link:presentationArc order="220" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfCashFlowsAbstract" 
xlink:to="loc_mdsvNoncashInvestingAndFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-
gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="230" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvStatementsOfCashFlowsAbstract" xlink:to="loc_us-
gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaidNet" 
xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="240" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" 
xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" 
xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="250" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" 
xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/FinancialStatements" 
xlink:title="00000007 - Disclosure - Condensed financial statements">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="loc_mdsvNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_CondensedFinancialStatementsTextBlock" xlink:label="loc_us-
gaapCondensedFinancialStatementsTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapCondensedFinancialStatementsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/NatureOfOperations" 
xlink:title="00000008 - Disclosure - Nature of operations">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="loc_mdsvNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NatureOfOperations" 
xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/MineralClaim" xlink:title="00000009 
- Disclosure - Mineral claim">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="loc_mdsvNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_MineralIndustriesDisclosuresTextBlock" xlink:label="loc_us-
gaapMineralIndustriesDisclosuresTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapMineralIndustriesDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/InvestmentInTechnologyLicense" 
xlink:title="00000010 - Disclosure - Investment in technology license">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="loc_mdsvNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" 
xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-
31.xsd#invest_InvestmentTextBlock" 
xlink:label="loc_investInvestmentTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNotesToFinancialStatementsAbstract" 
xlink:to="loc_investInvestmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DueToRelatedParty" 
xlink:title="00000011 - Disclosure - Due to related party">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="loc_mdsvNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_DueToRelatedPartyTextBlock" 
xlink:label="loc_mdsvDueToRelatedPartyTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNotesToFinancialStatementsAbstract" 
xlink:to="loc_mdsvDueToRelatedPartyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/Long-termDebt" xlink:title="00000012
- Disclosure - Long-term debt">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="loc_mdsvNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtDisclosureTextBlock" 
xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/RelatedPartyTransactions" 
xlink:title="00000013 - Disclosure - Related party transactions">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="loc_mdsvNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-
gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/GoingConcern" xlink:title="00000014 
- Disclosure - Going concern">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="loc_mdsvNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_GoingConcernTextBlock" 
xlink:label="loc_mdsvGoingConcernTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNotesToFinancialStatementsAbstract" 
xlink:to="loc_mdsvGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/CapitalStock" xlink:title="00000015 
- Disclosure - Capital stock">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="loc_mdsvNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_CapitalStockTextBlock" 
xlink:label="loc_mdsvCapitalStockTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNotesToFinancialStatementsAbstract" 
xlink:to="loc_mdsvCapitalStockTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/ContingencyLiability" 
xlink:title="00000016 - Disclosure - Contingency Liability">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="loc_mdsvNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_MalpracticeLossContingencyDisclosureTextBlock" xlink:label="loc_us-
gaapMalpracticeLossContingencyDisclosureTextBlock" />
      <link:presentationArc order="0"
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapMalpracticeLossContingencyDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/SubsequentEvents" 
xlink:title="00000017 - Disclosure - Subsequent events">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NotesToFinancialStatementsAbstract" 
xlink:label="loc_mdsvNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" 
xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNotesToFinancialStatementsAbstract" xlink:to="loc_us-
gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/NatureOfOperationsPolicies" 
xlink:title="00000018 - Disclosure - Nature of operations (Policies)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" 
xlink:label="loc_mdsvSummaryOfSignificantAccountingPoliciesPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_UseOfEstimates" 
xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvSummaryOfSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_ProspectiveLicenseAgreementPolicyTextBlock" 
xlink:label="loc_mdsvProspectiveLicenseAgreementPolicyTextBlock" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvSummaryOfSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_mdsvProspectiveLicenseAgreementPolicyTextBlock" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_OilAndGasPropertiesPolicyPolicyTextBlock" xlink:label="loc_us-
gaapOilAndGasPropertiesPolicyPolicyTextBlock" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvSummaryOfSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapOilAndGasPropertiesPolicyPolicyTextBlock" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_RehabilitationProvisionsPolicyTextBlock" 
xlink:label="loc_mdsvRehabilitationProvisionsPolicyTextBlock" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvSummaryOfSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_mdsvRehabilitationProvisionsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-
gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvSummaryOfSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" 
xlink:type="arc" />
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-
gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="50" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvSummaryOfSignificantAccountingPoliciesPoliciesAbstract" 
xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" 
xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DueToRelatedPartyTables" 
xlink:title="00000019 - Disclosure - Due to related Party (Tables)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_DueToRelatedPartyTablesAbstract" 
xlink:label="loc_mdsvDueToRelatedPartyTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-
gaapScheduleOfRelatedPartyTransactionsTableTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDueToRelatedPartyTablesAbstract" xlink:to="loc_us-
gaapScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/Long-termDebtTables" 
xlink:title="00000020 - Disclosure - Long-term debt (Tables)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_LongtermDebtTablesAbstract" 
xlink:label="loc_mdsvLongtermDebtTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" 
xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvLongtermDebtTablesAbstract" xlink:to="loc_us-
gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/NatureOfOperationsDetailsNarrative" 
xlink:title="00000021 - Disclosure - Nature of operations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_NatureOfOperationsDetailsNarrativeAbstract" 
xlink:label="loc_mdsvNatureOfOperationsDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount" 
xlink:label="loc_us-gaapAdvancesForGasExplorationDevelopmentAndProductionAmount"
/>
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNatureOfOperationsDetailsNarrativeAbstract" 
xlink:to="loc_us-gaapAdvancesForGasExplorationDevelopmentAndProductionAmount" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_FeesPaidForCommercializationLicensedTechnology" 
xlink:label="loc_mdsvFeesPaidForCommercializationLicensedTechnology" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvNatureOfOperationsDetailsNarrativeAbstract" 
xlink:to="loc_mdsvFeesPaidForCommercializationLicensedTechnology" 
xlink:type="arc" />
    </link:presentationLink>
<link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/InvestmentInTechnologyLicenseDetails
Narrative" xlink:title="00000022 - Disclosure - Investment in technology license
(Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_InvestmentInTechnologyLicenseDetailsNarrativeAbstract" 
xlink:label="loc_mdsvInvestmentInTechnologyLicenseDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount" 
xlink:label="loc_us-gaapAdvancesForGasExplorationDevelopmentAndProductionAmount"
/>
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvInvestmentInTechnologyLicenseDetailsNarrativeAbstract" 
xlink:to="loc_us-gaapAdvancesForGasExplorationDevelopmentAndProductionAmount" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_FeesPaidForCommercializationLicensedTechnology" 
xlink:label="loc_mdsvFeesPaidForCommercializationLicensedTechnology" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvInvestmentInTechnologyLicenseDetailsNarrativeAbstract" 
xlink:to="loc_mdsvFeesPaidForCommercializationLicensedTechnology" 
xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Investments" xlink:label="loc_us-
gaapInvestments" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvInvestmentInTechnologyLicenseDetailsNarrativeAbstract" 
xlink:to="loc_us-gaapInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/DueToRelatedPartyDetails" 
xlink:title="00000023 - Disclosure - Due to related Party (Details)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_DueToRelatedPartyDetailsAbstract" 
xlink:label="loc_mdsvDueToRelatedPartyDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" 
xlink:label="loc_us-gaapDueToRelatedPartiesCurrent" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDueToRelatedPartyDetailsAbstract" xlink:to="loc_us-
gaapDueToRelatedPartiesCurrent" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_FundsAdvanced" xlink:label="loc_mdsvFundsAdvanced" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDueToRelatedPartyDetailsAbstract" 
xlink:to="loc_mdsvFundsAdvanced" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_Repayments" xlink:label="loc_mdsvRepayments" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDueToRelatedPartyDetailsAbstract" 
xlink:to="loc_mdsvRepayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_FundsForgiven" xlink:label="loc_mdsvFundsForgiven" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDueToRelatedPartyDetailsAbstract"
xlink:to="loc_mdsvFundsForgiven" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" 
xlink:label="loc_us-gaapDueToRelatedPartiesCurrent_2" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvDueToRelatedPartyDetailsAbstract" xlink:to="loc_us-
gaapDueToRelatedPartiesCurrent_2" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/Long-termDebtDetails" 
xlink:title="00000024 - Disclosure - Long-term debt (Details)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_LongtermDebtDetailsAbstract" 
xlink:label="loc_mdsvLongtermDebtDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" 
xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvLongtermDebtDetailsAbstract" xlink:to="loc_us-
gaapLongTermDebtNoncurrent" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_FundsAdvancedLongTermDebtNoncurrent" 
xlink:label="loc_mdsvFundsAdvancedLongTermDebtNoncurrent" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvLongtermDebtDetailsAbstract" 
xlink:to="loc_mdsvFundsAdvancedLongTermDebtNoncurrent" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_FundsRepaidLongTermDebtNoncurrent" 
xlink:label="loc_mdsvFundsRepaidLongTermDebtNoncurrent" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvLongtermDebtDetailsAbstract" 
xlink:to="loc_mdsvFundsRepaidLongTermDebtNoncurrent" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" 
xlink:label="loc_us-gaapLongTermDebtNoncurrent_2" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvLongtermDebtDetailsAbstract" xlink:to="loc_us-
gaapLongTermDebtNoncurrent_2" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/RelatedPartyTransactionsDetailsNarra
tive" xlink:title="00000025 - Disclosure - Related party transactions (Details 
Narrative)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_RelatedPartyTransactionsDetailsNarrativeAbstract" 
xlink:label="loc_mdsvRelatedPartyTransactionsDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" 
xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvRelatedPartyTransactionsDetailsNarrativeAbstract" 
xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" 
preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</link:presentationLink>
    <link:presentationLink xlink:type="extended" 
xlink:role="http://madisonventures.com/role/CapitalStockDetailsNarrative" 
xlink:title="00000026 - Disclosure - Capital stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_CapitalStockDetailsNarrativeAbstract" 
xlink:label="loc_mdsvCapitalStockDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-
gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-
gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvCapitalStockDetailsNarrativeAbstract" xlink:to="loc_us-
gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" 
xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvCapitalStockDetailsNarrativeAbstract" xlink:to="loc_us-
gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" 
xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvCapitalStockDetailsNarrativeAbstract" xlink:to="loc_us-
gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-
gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" 
xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvCapitalStockDetailsNarrativeAbstract" xlink:to="loc_us-
gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="mdsv-
20160630.xsd#mdsv_StockOptionGranted" 
xlink:label="loc_mdsvStockOptionGranted" />
      <link:presentationArc order="40" 
xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" 
xlink:from="loc_mdsvCapitalStockDetailsNarrativeAbstract" 
xlink:to="loc_mdsvStockOptionGranted" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
{ e.nextSibling.style.display='none'; }
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6729683216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Aug. 12, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_DocumentAndEntityInformationAbstract', window );"><strong>Document 
And Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Madison Ventures Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001575975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End 
Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityWellKnownSeasonedIssuer', window );">Is Entity a Well-known 
Seasoned Issuer?</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityVoluntaryFilers', window );">Is Entity a Voluntary Filer?
</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityCurrentReportingStatus', window );">Is Entity's Reporting 
Status Current?</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock,
Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period 
Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year 
Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>If the value is true, then the document is an amendment to
previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>End date of current fiscal year in the format --MM-
DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>This is focus fiscal period of the document report. For a 
first quarter 2006 quarterly report, which may also provide financial 
information from prior periods, the first fiscal quarter should be given as the 
fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, 
CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>This is focus fiscal year of the document report in CCYY 
format. For a 2006 annual report, which may also provide financial information 
from prior periods, fiscal 2006 should be given as the fiscal year focus. 
Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The end date of the period reflected on the cover page if 
a periodic report. For all other reports and registration statements containing 
historical data, it is the date up through which that historical data is 
presented.  If there is no historical data in the report, use the filing date. 
The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 
485BPOS, etc). The document type is limited to the same value as the supporting 
SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities 
that have filed disclosures with the SEC. It is commonly abbreviated as 
CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Indicate number of shares or other units outstanding of 
each of registrant's classes of capital or common stock or other ownership 
interests, if and as stated on cover of related periodic report. Where multiple 
classes or units exist define each class/interest by adding class of stock items
such as Common Class A [Member], Common Class B [Member] or Partnership Interest
[Member] onto the Instrument [Domain] of the Entity Listings, 
Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed 
all reports required to be filed by Section 13 or 15(d) of the Securities 
Exchange Act of 1934 during the preceding 12 months (or for such shorter period 
that registrants were required to file such reports), and (2) have been subject 
to such filing requirements for the past 90 days. This information should be 
based on the registrant's current or most recent filing containing the related 
disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Indicate whether the registrant is one of the following: 
(1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, 
(4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting 
Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of 
the Exchange Act. This information should be based on the registrant's current 
or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The exact name of the entity filing the report as 
specified in its charter, which is required by forms filed with the 
SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required 
to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known 
seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form 
Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-
1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0"
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6729971536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 
200px;"><strong>Condensed Consolidated Balance Sheets - USD 
($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AssetsCurrentAbstract', window );"><strong>Current 
assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 92,541<span></span>
</td>
<td class="nump">$ 66,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DepositAssets', window );">Deposit on Technology License</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">2,539<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccountsReceivableNet', window );">Miscellaneous receivable</a></td>
<td class="nump">2,077<span></span>
</td>
<td class="nump">4,837<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">97,157<span></span>
</td>
<td class="nump">73,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Investments', window );">Investment in technology license</a></td>
<td class="nump">169,606<span></span>
</td>
<td class="nump">70,998<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Assets', window );">Total assets</a></td>
<td class="nump">266,763<span></span>
</td>
<td class="nump">144,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LiabilitiesCurrentAbstract', window );"><strong>Current 
liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">53,791<span></span>
</td>
<td class="nump">19,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">23,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="nump">213,442<span></span>
</td>
<td class="nump">213,442<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">292,233<span></span>
</td>
<td class="nump">256,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term 
liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">402,233<span></span>
</td>
<td class="nump">256,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity 
(deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockValue', window );">Common stock: 300,000,000 shares authorized 
of $0.001 par value; 28,400,000 and 28,400,000 shares issued and outstanding as 
of June 30, 2016 and March 31, 2016</a></td>
<td class="nump">28,400<span></span>
</td>
<td class="nump">28,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in 
capital</a></td>
<td class="nump">54,100<span></span>
</td>
<td class="nump">54,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated 
deficit</a></td>
<td class="num">(218,070)<span></span>
</td>
<td class="num">(194,669)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated 
other comprehensive income (loss)</a></td>
<td class="nump">100<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquity', window );">Total shareholders' equity 
(deficit)</a></td>
<td class="num">(135,470)<span></span>
</td>
<td class="num">(112,245)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and 
shareholders' equity (deficit)</a></td>
<td class="nump">$ 266,763<span></span>
</td>
<td class="nump">$ 144,730<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Carrying value as of the balance sheet date of liabilities
incurred (and for which invoices have typically been received) and payable to 
vendors for goods and services received that are used in an entity's business. 
Used to reflect the current portion of the liabilities (due within one year or 
within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>For an unclassified balance sheet, the amount due from 
customers or clients for goods or services that have been delivered or sold in 
the normal course of business, reduced to their estimated net realizable fair 
value by an allowance established by the entity of the amount it deems uncertain
of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> 
-SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-
03(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-
122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> 
-SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-
03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-
122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Carrying value as of the balance sheet date of obligations
incurred and payable, pertaining to costs that are statutory in nature, are 
incurred on contractual obligations, or accumulate over time and for which 
invoices have not yet been received or will not be rendered. Examples include 
taxes, interest, rent and utilities. Used to reflect the current portion of the 
liabilities (due within one year or within the normal operating cycle if 
longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Accumulated change in equity from transactions and other 
events and circumstances from non-owner sources, net of tax effect, at period 
end. Excludes Net Income (Loss), and accumulated changes in equity from 
transactions resulting from investments by owners and distributions to owners. 
Includes foreign currency translation items, certain pension adjustments, 
unrealized gains and losses on certain investments in debt and equity 
securities, other than temporary impairment (OTTI) losses related to factors 
other than credit losses on available-for-sale and held-to-maturity debt 
securities that an entity does not intend to sell and it is not more likely than
not that the entity will be required to sell before recovery of the amortized 
cost basis, as well as changes in the fair value of derivatives related to the 
effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 11<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-
108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-
108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-
108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Value received from shareholders in common stock-related 
transactions that are in excess of par value or stated value and amounts 
received from other stock-related transactions. Includes only common stock 
transactions (excludes preferred stock transactions). May be called contributed 
capital, capital in excess of par, capital surplus, or paid-in 
capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date 
of all assets that are recognized. Assets are probable future economic benefits 
obtained or controlled by an entity as a result of past transactions or 
events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-
122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> 
-SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-
03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-
122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date 
of all assets that are expected to be realized in cash, sold, or consumed within
one year (or the normal operating cycle, if longer). Assets are probable future 
economic benefits obtained or controlled by an entity as a result of past 
transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-
107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-
107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of currency on hand as well as demand deposits with
banks or financial institutions. Includes other kinds of accounts that have the 
general characteristics of demand deposits. Excludes cash and cash equivalents 
within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Cash<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">-
Definition</a><div><p>Aggregate par or stated value of issued nonredeemable 
common stock (or common stock redeemable solely at the option of the issuer). 
This item includes treasury stock repurchased by the entity. Note: elements for 
number of nonredeemable common shares, par value and other disclosure concepts 
are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The carrying amount of the asset transferred to a third 
party to serve as a deposit, which typically serves as security against failure 
by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Carrying amount as of the balance sheet date of 
obligations due all related parties. For classified balance sheets, represents 
the current portion of such liabilities (due within one year or within the 
normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-
122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-
107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date 
of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-
122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date 
of all liabilities that are recognized. Liabilities are probable future 
sacrifices of economic benefits arising from present obligations of an entity to
transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of liabilities and equity items, including the 
portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-
122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> 
-SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-
03(a)(25))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-
122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Total obligations incurred as part of normal operations 
that are expected to be paid during the following twelve months or within one 
business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">-
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of obligation due after one year or beyond the 
normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-
02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-
02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-
02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount after unamortized (discount) premium and debt 
issuance costs of long-term debt classified as noncurrent and excluding amounts
to be repaid within one year or the normal operating cycle, if longer. Includes,
but not limited to, notes payable, bonds payable, debentures, mortgage loans and
commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of asset related to consideration paid in advance 
for costs that provide economic benefits within a future period of one year or 
the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-
107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> 
-SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-
108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary 
Current Assets<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 4: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-
107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The cumulative amount of the reporting entity's 
undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-
122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-
04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-
122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02(30)(a)(3))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of 
receivables from officers, directors, owners, and affiliates of the entity which
are attributable to the parent. The amount of the economic entity's 
stockholders' equity attributable to the parent excludes the amount of 
stockholders' equity which is allocable to that ownership interest in subsidiary
equity which is not attributable to the parent (noncontrolling interest, 
minority interest). This excludes temporary equity and is sometimes called 
permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 
4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-
122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6723863552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 
200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / 
shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' 
equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par 
value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesAuthorized', window );">Common stock, shares 
authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">28,400,000<span></span>
</td>
<td class="nump">28,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesOutstanding', window );">Common stock, shares 
outstanding</a></td>
<td class="nump">28,400,000<span></span>
</td>
<td class="nump">28,400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Face amount or stated value per share of common 
stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The maximum number of common shares permitted to be issued
by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Total number of common shares of an entity that have been 
sold or granted to shareholders (includes common shares that were issued, 
repurchased and remain in the treasury). These shares represent capital invested
by the firm's shareholders and owners, and may be all or only a portion of the 
number of shares authorized. Shares issued include shares outstanding and shares
held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of shares of common stock outstanding. Common stock
represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6729896192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - 
USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OperatingExpensesAbstract', window );"><strong>Operating 
costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProfessionalFees', window );">Consulting and professional fees</a></td>
<td class="nump">$ 14,885<span></span>
</td>
<td class="nump">$ 15,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">1,387<span></span>
</td>
<td class="nump">6,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OtherGeneralAndAdministrativeExpense', window );">Other general &amp; 
administrative expenses</a></td>
<td class="nump">3,797<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OperatingExpenses', window );">Total operating costs</a></td>
<td class="nump">20,069<span></span>
</td>
<td class="nump">21,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income 
(expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', 
window );">Foreign exchange gain</a></td>
<td class="num">(3,332)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NonoperatingIncomeExpense', window );">Total other income 
(expenses)</a></td>
<td class="num">(3,332)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetIncomeLoss', window );">Net (loss)</a></td>
<td class="num">$ (23,401)<span></span>
</td>
<td class="num">$ (21,827)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Loss per 
common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', 
window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic 
and diluted</a></td>
<td class="nump">28,400,000<span></span>
</td>
<td class="nump">28,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Comprehensive 
income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetIncomeLoss', window );">Net (loss)</a></td>
<td class="num">$ (23,401)<span></span>
</td>
<td class="num">$ (21,827)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window
);"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', 
window );">Foreign currency translation</a></td>
<td class="nump">176<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss)</a></td>
<td class="num">$ (23,225)<span></span>
</td>
<td class="num">$ (21,827)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount after tax of increase (decrease) in equity from 
transactions and other events and circumstances from net income and other 
comprehensive income, attributable to parent entity. Excludes changes in equity 
resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> 
-URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Comprehensive Income<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51831223<br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e557-
108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net 
Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of gain (loss) from foreign currency exchange rate 
changes for benefit obligation for plans of a foreign operation whose functional
currency is not the reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 
50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-
114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The amount of net income or loss for the period per each 
share in instances when basic and diluted earnings per share are the same amount
and reported as a single line item on the face of the financial statements.  
Basic earnings per share is the amount of net income or loss for the period per 
each share of common stock or unit outstanding during the reporting period.  
Diluted earnings per share includes the amount of net income or loss for the 
period available to each share of common stock or common unit outstanding during
the reporting period and to each share or unit that would have been outstanding 
assuming the issuance of common shares or units for all dilutive potential 
common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The portion of profit or loss for the period, net of 
income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Net Income<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-
108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> 
-SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-
04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-
122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> 
-SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-
04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br>
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other 
Comprehensive Income<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-
122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The aggregate amount of income or expense from ancillary 
business-related activities (that is to say, excluding major activities 
considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-
122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Generally recurring costs associated with normal 
operations except for the portion of these expenses which can be clearly related
to production and included in cost of sales or services. Includes selling, 
general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">-
Definition</a><div><p>Amount of tax expense (benefit), after reclassification 
adjustments of gain (loss) on foreign currency translation adjustments, foreign 
currency transactions designated and effective as economic hedges of a net 
investment in a foreign entity and intra-entity foreign currency transactions 
that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 12<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e640-
108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-
108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of general and administrative expense classified as
other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-
122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>A fee charged for services from professionals such as 
doctors, lawyers and accountants. The term is often expanded to include other 
professions, for example, pharmacists charging to maintain a medicinal profile 
of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 946<br> -SubTopic 225<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6488393&amp;loc=d3e606610-
122999<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> 
-SubTopic 225<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6488370&amp;loc=d3e13550-
115849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The aggregate amount of noncash, equity-based employee 
remuneration. This may include the value of stock or unit options, amortization 
of restricted stock or units, and adjustment for officers' compensation. As 
noncash, this element is an add back when calculating net cash generated by 
operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Average number of shares or units issued and outstanding 
that are used in calculating basic and diluted earnings per share 
(EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6729758096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 
200px;"><strong>Consolidated Statements of Changes in Stockholders' Equity 
(Deficit) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated other comprehensive Income (loss)</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharesIssued', window );">Beginning Balance, Shares at Mar. 31, 
2015</a></td>
<td class="nump">28,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquity', window );">Beginning Balance, Amount at Mar. 31, 
2015</a></td>
<td class="nump">$ 28,400<span></span>
</td>
<td class="nump">$ 54,100<span></span>
</td>
<td class="num">$ (106,811)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (24,311)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(87,858)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="num">(87,934)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharesIssued', window );">Ending Balance, Shares at Mar. 31, 2016</a></td>
<td class="nump">28,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquity', window );">Ending Balance, Amount at Mar. 31, 
2016</a></td>
<td class="nump">$ 28,400<span></span>
</td>
<td class="nump">54,100<span></span>
</td>
<td class="num">(194,669)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="num">(112,245)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(23,401)<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="num">(23,225)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SharesIssued', window );">Ending Balance, Shares at Jun. 30, 2016</a></td>
<td class="nump">28,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_StockholdersEquity', window );">Ending Balance, Amount at Jun. 30, 
2016</a></td>
<td class="nump">$ 28,400<span></span>
</td>
<td class="nump">$ 54,100<span></span>
</td>
<td class="num">$ (218,070)<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="num">$ (135,470)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount after tax of increase (decrease) in equity from 
transactions and other events and circumstances from net income and other 
comprehensive income, attributable to parent entity. Excludes changes in equity 
resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> 
-URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Comprehensive Income<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51831223<br><br>Reference 3: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e557-
108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net 
Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of shares of stock issued as of the balance sheet 
date, including shares that had been issued and were previously outstanding but 
which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of 
receivables from officers, directors, owners, and affiliates of the entity which
are attributable to the parent. The amount of the economic entity's 
stockholders' equity attributable to the parent excludes the amount of 
stockholders' equity which is allocable to that ownership interest in subsidiary
equity which is not attributable to the parent (noncontrolling interest, 
minority interest). This excludes temporary equity and is sometimes called 
permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 
4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-
122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData"
style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-
gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-
gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-
gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-
gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-
gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-
gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-
gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6730068848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Consolidated Statements of Cash Flows (Unaudited) - USD 
($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', 
window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetIncomeLoss', window );">Net (loss)</a></td>
<td class="num">$ (23,401)<span></span>
</td>
<td class="num">$ (21,827)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract', window );"><strong>Adjustments to reconcile net loss to net cash 
(used in) provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_StockAccruedAsEmployeeCompensation', window );">Stock accrued as 
employee compensation</a></td>
<td class="nump">1,387<span></span>
</td>
<td class="nump">6,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in 
operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInPrepaidExpense', window );">(Increase) in prepaid 
expenses</a></td>
<td class="num">(461)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInAccountsReceivable', window );">Decrease (increase) in 
miscellaneous receivable</a></td>
<td class="nump">2,703<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_IncreaseInDepositOnTechnologyLicense', window );">Decrease 
(increase) in deposit on technology license</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Increase in accounts 
payable</a></td>
<td class="nump">24,338<span></span>
</td>
<td class="nump">7,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncreaseDecreaseInAccruedLiabilities', window );">(Decrease) in accrued 
liabilities</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) 
provided by operating activities</a></td>
<td class="nump">4,561<span></span>
</td>
<td class="num">(7,930)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', 
window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_PaymentsToAcquireSoftware', window );">Acquisition of technology 
license</a></td>
<td class="num">(88,827)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) 
investing activities</a></td>
<td class="num">(88,827)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', 
window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from related 
parties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from non-interest 
bearing term-debt</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided 
by financing activities</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="nump">7,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_EffectOfExchangeRateOnCash', window );">Effect of exchange rate changes on 
cash</a></td>
<td class="nump">1,012<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase 
(decrease) in cash</a></td>
<td class="nump">25,746<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Cash', window );">Cash, beginning of the period</a></td>
<td class="nump">66,795<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Cash', window );">Cash, end of the period</a></td>
<td class="nump">92,541<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_NoncashInvestingAndFinancingActivities', window );">Non-cash 
investing and financing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplement 
cash flow disclosure:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_IncomeTaxesPaid', window );">Income tax paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_IncreaseInDepositOnTechnologyLicense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_IncreaseInDepositOnTechnologyLicense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NoncashInvestingAndFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>custom:Non cash investing and financing 
activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NoncashInvestingAndFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_StockAccruedAsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_StockAccruedAsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitie
sAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">-
Definition</a><div><p>Amount of currency on hand as well as demand deposits with
banks or financial institutions. Includes other kinds of accounts that have the 
general characteristics of demand deposits. Excludes cash and cash equivalents 
within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Cash<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of increase (decrease) in cash and cash 
equivalents. Cash and cash equivalents are the amount of currency on hand as 
well as demand deposits with banks or financial institutions. Includes other 
kinds of accounts that have the general characteristics of demand deposits. Also
includes short-term, highly liquid investments that are both readily convertible
to known amounts of cash and so near their maturity that they present 
insignificant risk of changes in value because of changes in interest rates. 
Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 24<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br>
-SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-
110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of effect of exchange rate changes on cash balances
held in foreign currencies. Excludes cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 
45<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-
110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The amount of cash paid during the current period to 
foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-
108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Change in recurring obligations of a business that arise 
from the acquisition of merchandise, materials, supplies and services used in
the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The increase (decrease) during the reporting period in 
amount due within one year (or one business cycle) from customers for the credit
sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The increase (decrease) during the reporting period in the
aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The increase (decrease) during the reporting period in the
amount of outstanding money paid in advance for goods or services that bring 
economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The amount of cash paid for interest during the period net
of cash paid for interest that is capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of cash inflow (outflow) from financing activities,
including discontinued operations. Financing activity cash flows include 
obtaining resources from owners and providing them with a return on, and a 
return of, their investment; borrowing money and repaying amounts borrowed, or 
settling the obligation; and obtaining and paying for other resources obtained 
from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 24<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of cash inflow (outflow) from investing activities,
including discontinued operations. Investing activity cash flows include making 
and collecting loans and acquiring and disposing of debt or equity instruments 
and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 24<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount of cash inflow (outflow) from operating activities,
including discontinued operations. Operating activity cash flows include 
transactions, adjustments, and changes in value not defined as investing or 
financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 24<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-
108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> 
-SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The portion of profit or loss for the period, net of 
income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Net Income<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 28<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-
108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-
109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> 
-SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-
04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-
122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> 
-SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-
04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-
122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other 
Comprehensive Income<br> -URI 
http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-
122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The cash outflow associated with the acquisition from 
vendors of software programs or applications for internal use (that is, not to 
be sold, leased or otherwise marketed to others) that qualify for 
capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The cash inflow from the additional capital contribution 
to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-
108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The cash inflow from a long-term borrowing made from 
related parties where one party can exercise control or significant influence 
over another party; including affiliates, owners or officers and their immediate
families, pension trusts, and so forth. Alternate caption: Proceeds from 
Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 
45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-
108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary 
Financing Activities<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6720645952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Condensed financial statements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CondensedFinancialStatementsTextBlock', window );">Note 1. Condensed 
financial statements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">The accompanying unaudited condensed consolidated
financial statements are presented in United States dollars and are prepared 
using the accrual method of accounting which conforms
to generally accepted accounting principles in the United States of America 
(&#34;US GAAP&#34;) for interim financial reporting
and the instructions for Form 10-Q pursuant to the rules and regulations of the 
Securities and Exchange Commission. Accordingly,
they do not include all information and footnote disclosures necessary for a 
complete presentation of the financial position, results
of operations, cash flows, and stockholders equity in conformity with generally 
accepted accounting principles. In the opinion
of management, all adjustments considered necessary for a fair presentation of 
the results of operations and financial position
have been included and all such adjustments are of a normal recurring 
nature.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">The unaudited condensed consolidated balance
sheet of the Company as of June 30, 2016, and the related consolidated balance 
sheet of the Company as of March 31, 2016, which
is derived from the Company's audited financial statements, the unaudited 
condensed consolidated statement of operations and cash
flows for the Three Months ended June 30, 2016 and 2015 and the condensed 
consolidated statement of stockholders equity for the
period of March 31, 2015 to June 30, 2016 and are included in this document. 
These unaudited condensed consolidated financial statements
should be read in conjunction with the March 31, 2016 audited financial 
statements and related notes included in the Company's
most recent Form 10-K as filed with the Securities and Exchange Commission on 
July 18, 2016.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">Operating results for the Three Months ended
June 30, 2016 are not necessarily indicative of the results that can be expected
for the year ending March 31, 2017.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_CondensedFinancialStatementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for condensed financial 
statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-
122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-
111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br>
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.10-
01(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=27015980&amp;loc=d3e46468-
122699<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_CondensedFinancialStatementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6598354368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature
of operations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NatureOfOperations', window );">Note 2. Nature of operations</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">Madison Ventures Inc. (&#34;Company&#34;)
was incorporated in the State of Nevada as a for-profit company on September 14,
2009 and established a fiscal year end of March
31. The Company initially was engaged in the acquisition, exploration and 
development of natural resource properties. On February
27, 2015, the Company terminated the acquisition of the mineral claim and 
entered into a letter of intent with Ocure Ltd. (&#34;Ocure&#34;),
pursuant to which the Company agreed to exclusively license certain technology 
from Ocure related to the development of products
and devices for the treatment of anal fissures (the &#34;Ocure LOI&#34;). On 
July 9, 2015, the Company established the wholly-owned
subsidiary Madison-IL Ltd., incorporated under the laws of the country of Israel
to address the Company's requirement for an Israeli
company to operate and hold the assets associated with Ocure LOI. The Company 
has no revenues and has limited operating history.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">The success of the Company is dependent upon
the development of products for the treatment of anal fissures, the ability of 
the Company to obtain the necessary financing to
complete the acquisition, development and commercialize of the Licensed 
Technology, and upon future profitable operations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><u>Use of Estimates and Assumptions</u></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of
America requires management to make certain estimates
and assumptions that affect the reported amounts of assets and liabilities and 
disclosure of contingent assets and liabilities
at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting periods presented.
The Company is required to make judgments and estimates about the effect of 
matters that are inherently uncertain. The Company
regularly evaluates estimates and assumptions related to the useful life and 
recoverability of long-lived assets, deferred income
tax asset valuations and loss contingences. The Company bases its estimates and 
assumptions on current facts, historical experience
and various other factors that it believes to be reasonable under the
circumstances, the results of which form the basis for making
judgments about the carrying value of assets and liabilities and the accrual of 
costs and expenses that are not readily apparent
from other sources. Although, we believe our judgments and estimates are 
appropriate, actual future results may be different;
if different assumptions or conditions were to prevail, the results could be 
materially different from our reported results.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><u>License Agreement</u></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">On February 27, 2015, we entered into a letter
of intent (the &#34;Letter of Intent&#34;) with Ocure Ltd. (&#34;Ocure&#34;), an
Israeli corporation, pursuant to which the
Company would be obligated to exclusively license certain technology from Ocure 
under terms of a license agreement to be negotiated
between the Company and Ocure. The Letter of Intent terminated when the Company 
did not make the second required payment, however
the Company continued to negotiate with Ocure. On August 5, 2015, as amended 
February 26, 2016, the company entered into an exclusive
license agreement (the &#34;License Agreement&#34;) with Ocure and Madison-IL 
Ltd., a wholly-owned subsidiary of the Company
incorporated in Israel on July 9, 2015 (the &#34;Subsidiary&#34;). Pursuant to 
the License Agreement, Ocure granted to the Subsidiary
an exclusive, sub-licensable, worldwide, license (the &#34;License&#34;) to 
Ocure's semi-occlusive wound dressing for ambulatory
treatment of acute and chronic anal fissure, pursuant to Ocure's patents and 
patent applications (the &#34;Licensed Technology&#34;)
and to its production, use, import, offer for sale, sell, lease, distribute, or 
otherwise commercialize the Licensed Technology
for uses classified as medical devices, or those otherwise approved ultimately 
as an OTC (over-the-counter) remedy.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">Under the License Agreement, the Company is
obligated as consideration for the Licensed Technology to provide the Subsidiary
$250,000 for the commercialization of the Licensed
Technology, payable according to the following schedule: $10,000 upon execution 
of the Letter of Intent (paid February 27, 2015
to Ocure), $90,000 at the later of May 11, 2015 or the final signing date of the
License Agreement (the &#34;Effective Date&#34;),
and $50,000 on or before March 4, 2016, and $100,000 on or before April 8, 2016 
(collectively, the &#34;First $250,000 Tranche&#34;).
The Effective Date will occur upon satisfaction of the Condition Precedent, as 
defined in the License Agreement, and approval of
the Agreement by the Chief Scientist of the Israeli Ministry of the Economy. The
License Agreement Effective Date is November 11,
2015; the date approval of the Chief Scientist of the Israeli Ministry of the 
Economy was received. Upon the 6-month anniversary
of the Effective Date, if the Company has paid the First $250,000 Tranche, then 
Ocure will transfer certain assets, as defined,
to the Subsidiary, and the Company will be obligated to provide the Subsidiary a
second $250,000 tranche, payable as follows: $100,000
on or before August 12, 2016, $100,000 on or before September 23, 2016, and
$50,000 on or before October 28, 2016. The License
Agreement terminates, on a country-by-country basis, the later of: (a) the date 
of expiration of the last to expire of Ocure's
rights in Ocure Patents in such country or such other grant of statutory 
exclusivity, or (b) the end of a period of fifteen (15)
years from the date of making the first commercial sale, as defined, in such 
country; unless sooner terminated pursuant to the
terms of the License Agreement. As of June 30, 2016 and March 31, 2016, the 
Company has advanced $221,850 and $131,850, respectively,
to the Subsidiary and paid Ocure $10,000 in furtherance of the commercialization
of the Licensed Technology.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">Immediately after the Effective Date of the
License Agreement and for the period ending March 31, 2016 (as amended), the 
shareholders of Ocure and certain individuals designated
by Ocure will have opportunity to purchase up to an aggregate of 7,100,000 
(1,775,000 presplit) shares of the Company's Common
Stock at the par value of $0.001 per share. In addition, the Company will 
establish an incentive stock option plan reserving up
to 20% of the Company's issued share capital, as of the closing. The right to 
purchase an aggregate of 7,100,000 (1,775,000 presplit)
shares of the Company's Common Stock expired unexercised, but by mutual 
agreement the purchase right will be extended under similar
terms.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">In consideration of the license for the Licensed
Technology and with respect to any inventions, improvement, development or 
enhancement based upon, consists of, comprises, contains
or incorporates the Licensed Technology invented following the Effective Date by
the Subsidiary, its affiliate or sublicensee
(the &#34;New Inventions&#34;), the Subsidiary will pay to Ocure royalties 
calculated as 5% of gross sales. In addition, the
Subsidiary will pay to Ocure 20% of any cash or non-cash consideration received,
whether for sublicense initiation fee, annual
fee, sublicense milestone payments, or other such non-sale based royalty 
consideration payable by a sublicense as consideration
for or under a sublicense.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><u>Mineral Properties</u></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">Mineral property acquisition costs are capitalized
in accordance with Codification topic 930 &#34;Extractive Activities - 
Mining&#34;. Mineral property pre-exploration and exploration
costs are expensed as incurred. When it has been determined that a mineral 
property can be economically developed as a result of
establishing proven and probable reserves, the costs incurred to develop such 
property are capitalized. The Company did not establish
any reserves on its mineral properties prior to terminating its option under the
Revised and Restated Mineral Property Option Agreement
(see footnote 3).</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><u>Rehabilitation Provisions</u></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">The Company was subject to various government
laws and regulations relating to environmental disturbances which are caused by 
exploration and evaluation activities. The Company
will record the present value for the estimated costs of legal and constructive 
obligations required to restore the exploration
sites in the period in which the obligation is incurred. The nature of the 
rehabilitation activities includes restoration, reclamation
and re-vegetation of the affected exploration sites. The Company has determined 
that there were no rehabilitation provisions at
February 27, 2015 when the option to acquire the mineral claim was 
terminated.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><u>Share-based Compensation</u></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">Codification topic 718 &#34;Stock Compensation&#34;
requires that the cost resulting from all share-based transactions be recorded 
in the financial statements and establishes fair
value as the measurement objective for share-based payment transactions with 
employees and acquired goods or services from non-employees.
The codification also provides guidance on valuing and expensing these awards, 
as well as disclosure requirements of these equity
arrangements. The Company adopted the codification upon creation of the company 
and will expense share based costs in the period
incurred. The Company has not adopted a stock option plan or completed a share-
based transaction; accordingly no stock-based compensation
has been recorded to date.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify"><u>Recent Accounting Pronouncements</u></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">The Company's management has evaluated all
the recently issued, but not yet effective, accounting standards that have been 
issued or proposed by the FASB or other standards-setting
bodies through the filing date of these financial statements and does not 
believe the future adoption of any such pronouncements
will have a material effect on the Company's financial position and results of
operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for the nature of an entity's 
business, major products or services, principal markets including location, and 
the relative importance of its operations in each business and the basis for the
determination, including but not limited to, assets, revenues, or earnings. For 
an entity that has not commenced principal operations, disclosures about the 
risks and uncertainties related to the activities in which the entity is 
currently engaged and an understanding of what those activities are being 
directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6003-
108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -URI 
http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=SL51803626-
108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6720766384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Mineral claim<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this,
'defref_mdsv_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_MineralIndustriesDisclosuresTextBlock', window );">Note 3. Mineral 
claim</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">On March 3, 2012, the Company entered into
a Revised and Restated Mineral Property Option Agreement with 3 individuals (the
&#34;Optionors&#34;) for an exclusive and irrevocable
three year option to acquire a 100% undivided interest in three contiguous 
unpatented mining claims comprising 34 units (the &#34;Claim&#34;
or the &#34;Property&#34;) situated in the Thunder Bay Mining Division in the 
province on Ontario, Canada (the &#34;Agreement&#34;).
The option payments aggregating $30,000 (U.S. Dollars) (the &#34;Option 
Price&#34;) were due: i) $15,000 upon signing but deferred
for eight months, ii) $5,000 on or before March 3, 2013, iii) $5,000 on or 
before March 3, 2014, and iv) $5,000 on or before March
3, 2015 (the &#34;Option Payments&#34;). During the term of the Agreement the 
Company is granted free and unrestricted access
and use of the Property to act as the operator of the Property with the right to
bring buildings, plant, equipment, machinery,
tools, appliances and supplies onto the Property. The Optionors hold title to 
the Property until the full payment of the Option
Price. Upon full payment of the Option Price the Optionors would deliver a duly 
executed transfer of mining claims in respect of
the Property to transfer a 100% undivided interest in the Property to the 
Company free and clear of all encumbrances except for
a retained net smelter return royalty (the &#34;NSR&#34;). The NSR is a 2% 
royalty paid within 30 days of each calendar month
calculated, as defined, from gross Property revenues less permissible 
deductions. The Company had the right, at any time, to reduce
the NSR to a 1% royalty by a One Million Dollar payment to the Optionors.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">Upon the February 27, 2015 termination of the
Agreement had the Company brought any buildings, plant, equipment, machinery, 
tools, appliances and supplies onto the Property
it would have been responsible to remove all such items not later than twelve 
months after termination of the Agreement unless
arrangements are made with the Optionors to retain some or all of the items 
brought onto the Property.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">The Company deferred the first option payment
for an eight month term and made the $15,000 payment on October 27, 2012. Upon 
execution of the Agreement, the Company recorded
the first option payment net of imputed interest as $14,984 and accrued the 
imputed interest ratably over the deferral period.
Annually the Company had the option to retain the mineral claim and make the 
next contractual Option Payment or to terminate the
Agreement. The Company made the March 3, 2013 Option Payment on March 1, 2013 
and the March 3, 2014 Option Payment on February
25, 2014. On February 27, 2015, the Company concluded to terminate the Agreement
and not make the final Option Payment. The aggregate
total of $24,984 previously included in the mineral claim was expensed as a 
discontinued operation.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">Previously in response to the new GPS standards
for unpatented claims issued by the Ontario Ministry of Northern Development and
Mines, the Company expended $1,975 to provide
upgraded geo-referenced location information on its Claim during the quarter 
ended September 30, 2013. An aggregate total of zero
and $1,975 have been expensed for exploration and evaluation of the Company's 
Claim as of March 31, 2015 and 2014, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_MineralIndustriesDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for mineral industries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_MineralIndustriesDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6599175504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Investment in technology license<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this,
'defref_mdsv_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_invest_InvestmentTextBlock', window );">Note 4. Investment in technology
license</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">On August 5, 2015, as amended February 26,
2016, the company entered into an exclusive license agreement (the &#34;License 
Agreement&#34;) with Ocure and Madison-IL Ltd.,
a wholly-owned subsidiary of the Company incorporated in Israel on July 9, 2015 
(the &#34;Subsidiary&#34;). Pursuant to the License
Agreement, Ocure granted to the Subsidiary an exclusive, sub-licensable, 
worldwide, license (the &#34;License&#34;) to Ocure's
semi-occlusive wound dressing for ambulatory treatment of acute and chronic anal
fissure, pursuant to Ocure's patents and patent
applications (the &#34;Licensed Technology&#34;) and to its production, use, 
import, offer for sale, sell, lease, distribute,
or otherwise commercialize the Licensed Technology for uses classified as 
medical devices, or those otherwise approved ultimately
as an OTC (over-the-counter) remedy.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">Under the License Agreement, the Company is
obligated as consideration for the Licensed Technology to provide the Subsidiary
$250,000 for the commercialization of the Licensed
Technology, payable according to the following schedule: $10,000 upon execution 
of the Letter of Intent, $90,000 at the later of
May 11, 2015 or the final signing date of the License Agreement (the 
&#34;Effective Date&#34;), and $50,000 on or before March
4, 2016, and $100,000 on or before April 8, 2016 (collectively, the &#34;First 
$250,000 Tranche&#34;). The License Agreement
Effective Date is November 11, 2015; the date approval of the Chief Scientist of
the Israeli Ministry of the Economy was received.
Upon the 6-month anniversary of the Effective Date, if the Company has paid the 
First $250,000 Tranche, then Ocure will transfer
certain assets, as defined, to the Subsidiary, and the Company will be obligated
to provide the Subsidiary a second $250,000 tranche,
payable as follows: $100,000 on or before August 12, 2016, $100,000 on or before
September 23, 2016, and $50,000 on or before October
28, 2016. The License Agreement terminates, on a country-by-country basis, the 
later of: (a) the date of expiration of the last
to expire of Ocure's rights in Ocure Patents in such country or such other grant
of statutory exclusivity, or (b) the end of a
period of fifteen (15) years from the date of making the first commercial sale, 
as defined, in such country; unless sooner terminated
pursuant to the terms of the License Agreement. As of June 30, 2016 and March 
31, 2016, the Company has advanced $221,850 and $131,850,
respectively, to the Subsidiary and paid Ocure $10,000 in furtherance of the 
commercialization of the Licensed Technology.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">As of June 30, 2016 and March 31, 2016, the
Company has expended and aggregate of $169,606 and $70,998 recorded as the
investment in technology license, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">The Company was in default of its payment schedule
by June 30, 2016 and no assets had been transferred to the Company's subsidiary.
As of the date of filing of this 10-Q, the Company
is also in default of its $100,000 payment that was due August 12, 2016. There 
is no extension agreement or amendment negotiated,
and there is a risk that the License will be cancelled.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_invest_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for investments, including all 
tables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name 
Regulation S-X (SX)<br> -Number 210<br> -Article 6<br> -Section 10<br> 
-Paragraph (c)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6720706624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Due to
related party<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_NotesToFinancialStatementsAbstract', window );"><strong>Notes to
Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_DueToRelatedPartyTextBlock', window );">Note 5. Due to related 
party</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">Due to related parties at June 30, 2016 and
March 31, 2016 consisted of the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times,
Serif; width: 100%; font-size-adjust: none; font-stretch: normal">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" id="hdcell" style="text-align: center"><font style="font-
size: 10pt"><b>June 30,</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 
10pt"><b>March 31,</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt;
text-align: center"><font style="font-size: 10pt"><b>2016</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt;
text-align: center"><font style="font-size: 10pt"><b>2016</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" id="ffcell" style="vertical-align: bottom; text-align: 
right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: 
right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; width: 78%; text-align: justify"><font 
style="font-size: 10pt">Balance at beginning of period</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 8%; text-align: right"><font 
style="font-size: 10pt">213,442</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 8%; text-align: right"><font
style="font-size: 10pt">25,523</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: 
justify"><font style="font-size: 10pt">Funds advanced</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">187,919</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: 
justify"><font style="font-size: 10pt">Funds repaid</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: 
justify"><font style="font-size: 10pt">Funds forgiven</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-
bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-
bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-
</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-
bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-
bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-
</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size:
10pt">Balance at end of period</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-
bottom-width: 2.25pt; text-align: justify"><font style="font-size: 
10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-
bottom-width: 2.25pt; text-align: right"><font style="font-size: 
10pt">213,442</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-
bottom-width: 2.25pt; text-align: justify"><font style="font-size: 
10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-
bottom-width: 2.25pt; text-align: right"><font style="font-size: 
10pt">213,442</font></td>
<td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">On July 3, July 8, July 10, August 12, November
12, November 13, 2014, January 23, February 27, March 5, May 16, June 17, June 
30, July 6, August 13, November 17, 2015, February
13, February 20, March 7, and March 17,2016 a shareholder of the Company 
advanced the Company $2,000, $775, $1,460, $2,000, $2,000,
$1,763, $2,000, $10,000, $3,525, $4,093, $2,755, $1,083, $5,000, $3,000, $2,041,
$961, $5,000, $3,300, and $50,000, respectively,
as a series of unsecured obligations. The funds aggregating $102,756 were used 
to pay operating costs of the Company. The aggregate
obligations bears no interest, has no fixed term and is not evidenced by any 
written agreement. The shareholder is under no obligation
to advance additional funds to the Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">On December 3, December 24, 2015, January 4,
January 6, and January 15, 2016 a shareholder of the Company advanced the 
Company $37,473, $7,500, $7,326, $8,412, and $49,975,
respectively, as a series of unsecured obligations. The funds aggregating 
$110,686 were used to pay operating costs of the Company.
On January 8, 2016, the aggregate advances received and future advances were 
structured as a noninterest bearing unsecured non-recourse
loan due January 31, 2017. The shareholders, if requested by the Company, agreed
to advance additional funds to the Company up
to a maximum of $250,000 subject to certain timing limitation as 
defined.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_DueToRelatedPartyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_DueToRelatedPartyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6608866480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-
term debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DebtDisclosureTextBlock', window );">Note 6. Long-term debt</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">Long term debt at June 30, 2016 and March 31,
2016 consisted of the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times,
Serif; width: 100%; font-size-adjust: none; font-stretch: normal">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" id="hdcell" style="text-align: center"><font style="font-
size: 10pt"><b>June 30,</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 
10pt"><b>March 31,</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt;
text-align: center"><font style="font-size: 10pt"><b>2016</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt;
text-align: center"><font style="font-size: 10pt"><b>2016</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" id="ffcell" style="vertical-align: bottom; text-align: 
right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: 
right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
<td style="vertical-align: top; text-align: justify"><font style="font-size:
10pt">Balance at beginning of period</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: 
justify"><font style="font-size: 10pt">Funds advanced</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">110,000</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: 
justify"><font style="font-size: 10pt">Funds repaid</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-
align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-
align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-
align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-
align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size:
10pt">Balance at end of period</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-
align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-
align: right"><font style="font-size: 10pt">110,000</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-
align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-
align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">On April 18, 2016, the Company entered into
a five year non-interest bearing loan agreement for $110,000. Proceeds were used
to fund the Technology acquisition and operations.
If the loan is not repaid on or before April 15, 2021 the loan amount will be 
subject to default interest on the amount then outstanding
of ten percent (10%) per month during the first 30 days of delinquency, fifteen 
percent (15%) per month during the 31 to 60 days
of delinquency, twenty percent (20%) per month during the 61 to 90 days of 
delinquency (the &#34;Default Interest&#34;). If the
loan amount remains unpaid after 90 days the lender, at its option, will be 
entitled to a default payment of one hundred fifty-nine
percent (159%) of the then outstanding loan amount inclusive of the Default 
Interest.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for information about short-term and
long-term debt arrangements, which includes amounts of borrowings under each 
line of credit, note payable, commercial paper issue, bonds indenture, debenture
issue, own-share lending arrangements and any other contractual agreement to 
repay funds, and about the underlying arrangements, rationale for a
classification as long-term, including repayment terms, interest rates, 
collateral provided, restrictions on use of assets and activities, whether or 
not in compliance with debt covenants, and other matters important to users of 
the financial statements, such as the effects of refinancing and noncompliance 
with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-
112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.19,20,22)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6720731376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Related party transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Note 7. Related 
party transactions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify"><u>Employment Agreements</u></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">On April 2, 2014, Mr. Gene Gregorio was appointed
the Company's President, Chief Executive Officer, Chief Financial Officer and 
sole Director. On April 20, 2014, the Company agreed
to issue Mr. Gregorio 1,000,000 (250,000 presplit) restricted shares of the 
Company's Common Stock, valued at $25,000, based on
the market close, as compensation for his services for an initial term of one 
year (the &#34;April 20<sup>th</sup> Agreement&#34;).
On March 31, 2015, the Company issued Mr. Gregorio the agreed 250,000 restricted
shares of the Company's Common Stock. At March
31, 2015, $1,387 was recorded as a prepaid expense for the period April 1 to 
April 20, 2015.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">In addition, if during the term of the April
20<sup>th</sup> Agreement Mr. Gregorio's direct efforts result in a consummated 
financing for the Company he shall be paid a 5.0%
fee on such financing received by the Company, at his option, as either cash or 
shares of Company's Common Stock at the offering
price. Additionally, the Company will grant Mr. Gregorio a 2 year stock option 
priced at the current market trading price equal
to 5% of the aggregate shares issued to investors within the financing.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">On April 14, 2015, the April 20<sup>th</sup>
Agreement with Mr. Gene Gregorio was extended for a second year under the same 
terms and conditions. Mr. Gregorio will be issued
1,000,000 (250,000 presplit) restricted shares of the Company's Common Stock, 
valued at $25,000, based on the market close, as
compensation for his services for the second year the extended April 
20<sup>th</sup> Agreement. At June 30, 2016, $25,000 was recorded
as an accrued liability for the period April 21, 2015 to April 20, 2016.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">On August 9, 2016, the Company issued Mr. Gregorio
the agreed 1,000,000 (presplit 250,000) restricted shares of the Company's 
Common Stock.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for related party transactions. 
Examples of related party transactions include transactions between (a) a parent
company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity 
and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-
122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-
107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-
107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-
107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-
107864<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-
107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6720761568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Going 
concern<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_GoingConcernTextBlock', window );">Note 8. Going concern</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">These financial statements have been prepared
on a going concern basis which assumes the Company will be able to realize its 
assets and discharge its liabilities in the normal
course of business for the foreseeable future. The Company anticipates future 
losses in the development of its business raising
substantial doubt about the Company's ability to continue as a going concern. 
The ability to continue as a going concern is dependent
upon the Company generating profitable operations in the future and/or to obtain
the necessary financing to meet its obligations
and repay its liabilities arising from normal business operations when they come
due. The Company's operating expenditure plan
for the next fiscal year ending March 31, 2017 will require cash of 
approximately $500,000. Management intends to finance operating
costs over the next twelve months with the issuance of common shares and/or 
related party borrowings.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_GoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_GoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6720711008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Capital stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_CapitalStockTextBlock', window );">Note 9. Capital stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">The Company's capitalization is 300,000,000
shares of common stock, with a par value of $0.001 per share, with 28,400,000 
shares issued and outstanding at March 31, 2016 and
2015. On April 11, 2016, the Company effected a four for one forward stock split
of our i) authorized and ii) issued and outstanding
shares of common stock. All share information has been restated for all periods 
presented giving retroactive effect of the April
11, 2016 four to one forward stock split. Prior to the forward stock split the 
Company had 75,000,000 authorized shares of common
stock, with a par value of $0.001 per share and 7,100 shares issued and 
outstanding at March 31, 2016 and 2015.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">As of June 30, 2016 and March 31, 2016, the
Company has not granted any stock options or stock warrants. As a requirement of
the Ocure License Agreement, the Company will
establish an incentive stock option plan reserving up to 20% of the Company's
issued and outstanding common stock, as of the closing
of the License Agreement.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_CapitalStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>custom: Capital stock text block</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_CapitalStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6598800256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Contingency Liability<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_MalpracticeLossContingencyDisclosureTextBlock', window );">Note 10. 
Contingency Liability</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">The Licensed Technology requires an aggregate
first tranche payment to the Subsidiary of $250,000 by April 8, 2016; an 
aggregate of $231,850 has been advanced to the Subsidiary
as of June 30, 2016. Upon the 6-month anniversary of the Effective Date, if the
Company has paid the First $250,000 Tranche, then
Ocure will transfer certain assets, as defined, to the Subsidiary, and the 
Company will be obligated to provide the Subsidiary
a second $250,000 tranche, payable as follows: $100,000 on or before August 12, 
2016, $100,000 on or before September 23, 2016,
and $50,000 on or before October 28, 2016.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_MalpracticeLossContingencyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for the accrual for malpractice loss
contingencies (general and professional liability) which may include the policy 
used for accruing the loss contingency, the nature and amount of any accrual, 
and any significant estimate used to determine the accrual.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 
50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-
115624<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -URI
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14557-
108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-
108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14615-
108349<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14453-
108349<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-
108349<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> 
-SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-
115624<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14472-
108349<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> 
-SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14394-
108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_MalpracticeLossContingencyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6604127184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Subsequent events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_NotesToFinancialStatementsAbstract', window );"><strong>Notes to 
Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_SubsequentEventsTextBlock', window );">Note 11. Subsequent events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">On August 9, 2016, pursuant to the terms of
the April 20<sup>th</sup> Agreement the Company issued 1,000,000 (250,000 
presplit) shares of the Company's Common Stock at Mr.
Gene Gregorio the Company's President, Chief Executive Officer, Chief Financial 
Officer and sole Director.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">On August 12, 2016, the Company failed to pay
an amount due under the August 5, 2015 Licensing Agreement. The Company has not 
negotiated the terms of any extension and there
is a substantial risk the agreement will be cancelled.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The entire disclosure for significant events or 
transactions that occurred after the balance sheet date through the date the 
financial statements were issued or the date the financial statements were 
available to be issued. Examples include: the sale of a capital stock issue, 
purchase of a business, settlement of litigation, catastrophic loss, significant
foreign exchange rate changes, loans to insiders or affiliates, and transactions
not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6718387632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature
of operations (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_SummaryOfSignificantAccountingPoliciesPoliciesAbstract', 
window );"><strong>Nature Of Operations Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_UseOfEstimates', window );">Use of Estimates and Assumptions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of
America requires management to make certain estimates
and assumptions that affect the reported amounts of assets and liabilities and 
disclosure of contingent assets and liabilities
at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting periods presented.
The Company is required to make judgments and estimates about the effect of 
matters that are inherently uncertain. The Company
regularly evaluates estimates and assumptions related to the useful life and
recoverability of long-lived assets, deferred income
tax asset valuations and loss contingences. The Company bases its estimates and 
assumptions on current facts, historical experience
and various other factors that it believes to be reasonable under the 
circumstances, the results of which form the basis for making
judgments about the carrying value of assets and liabilities and the accrual of 
costs and expenses that are not readily apparent
from other sources. Although, we believe our judgments and estimates are 
appropriate, actual future results may be different; if
different assumptions or conditions were to prevail, the results could be 
materially different from our reported results.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_ProspectiveLicenseAgreementPolicyTextBlock', window );">License 
Agreement</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">On February 27, 2015, we entered into a letter
of intent (the &#34;Letter of Intent&#34;) with Ocure Ltd. (&#34;Ocure&#34;), an
Israeli corporation, pursuant to which the
Company would be obligated to exclusively license certain technology from Ocure 
under terms of a license agreement to be negotiated
between the Company and Ocure. The Letter of Intent terminated when the Company 
did not make the second required payment, however
the Company continued to negotiate with Ocure. On August 5, 2015, as amended 
February 26, 2016, the company entered into an exclusive
license agreement (the &#34;License Agreement&#34;) with Ocure and Madison-IL 
Ltd., a wholly-owned subsidiary of the Company
incorporated in Israel on July 9, 2015 (the &#34;Subsidiary&#34;). Pursuant to 
the License Agreement, Ocure granted to the Subsidiary
an exclusive, sub-licensable, worldwide, license (the &#34;License&#34;) to 
Ocure's semi-occlusive wound dressing for ambulatory
treatment of acute and chronic anal fissure, pursuant to Ocure's patents and 
patent applications (the &#34;Licensed Technology&#34;)
and to its production, use, import, offer for sale, sell, lease, distribute, or 
otherwise commercialize the Licensed Technology
for uses classified as medical devices, or those otherwise approved ultimately 
as an OTC (over-the-counter) remedy.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">Under the License Agreement, the Company is
obligated as consideration for the Licensed Technology to provide the Subsidiary
$250,000 for the commercialization of the Licensed
Technology, payable according to the following schedule: $10,000 upon execution 
of the Letter of Intent (paid February 27, 2015
to Ocure), $90,000 at the later of May 11, 2015 or the final signing date of the
License Agreement (the &#34;Effective Date&#34;),
and $50,000 on or before March 4, 2016, and $100,000 on or before April 8, 2016 
(collectively, the &#34;First $250,000 Tranche&#34;).
The Effective Date will occur upon satisfaction of the Condition Precedent, as 
defined in the License Agreement, and approval of
the Agreement by the Chief Scientist of the Israeli Ministry of the Economy. The
License Agreement Effective Date is November 11,
2015; the date approval of the Chief Scientist of the Israeli Ministry of the 
Economy was received. Upon the 6-month anniversary
of the Effective Date, if the Company has paid the First $250,000 Tranche, then 
Ocure will transfer certain assets, as defined,
to the Subsidiary, and the Company will be obligated to provide the Subsidiary a
second $250,000 tranche, payable as follows: $100,000
on or before August 12, 2016, $100,000 on or before September 23, 2016, and 
$50,000 on or before October 28, 2016. The License
Agreement terminates, on a country-by-country basis, the later of: (a) the date 
of expiration of the last to expire of Ocure's
rights in Ocure Patents in such country or such other grant of statutory 
exclusivity, or (b) the end of a period of fifteen (15)
years from the date of making the first commercial sale, as defined, in such 
country; unless sooner terminated pursuant to the
terms of the License Agreement. As of June 30, 2016 and March 31, 2016, the 
Company has advanced $221,850 and $131,850, respectively,
to the Subsidiary and paid Ocure $10,000 in furtherance of the commercialization
of the Licensed Technology.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">Immediately after the Effective Date of the
License Agreement and for the period ending March 31, 2016 (as amended), the 
shareholders of Ocure and certain individuals designated
by Ocure will have opportunity to purchase up to an aggregate of 7,100,000 
(1,775,000 presplit) shares of the Company's Common
Stock at the par value of $0.001 per share. In addition, the Company will 
establish an incentive stock option plan reserving up
to 20% of the Company's issued share capital, as of the closing. The right to 
purchase an aggregate of 7,100,000 (1,775,000 presplit)
shares of the Company's Common Stock expired unexercised, but by mutual 
agreement the purchase right will be extended under similar
terms.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify">In consideration of the license for the Licensed
Technology and with respect to any inventions, improvement, development or 
enhancement based upon, consists of, comprises, contains
or incorporates the Licensed Technology invented following the Effective Date by
the Subsidiary, its affiliate or sublicensee (the
&#34;New Inventions&#34;), the Subsidiary will pay to Ocure royalties calculated
as 5% of gross sales. In addition, the Subsidiary
will pay to Ocure 20% of any cash or non-cash consideration received, whether 
for sublicense initiation fee, annual fee, sublicense
milestone payments, or other such non-sale based royalty consideration payable 
by a sublicense as consideration for or under a
sublicense.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_OilAndGasPropertiesPolicyPolicyTextBlock', window );">Mineral 
Properties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">Mineral property acquisition costs are capitalized
in accordance with Codification topic 930 &#34;Extractive Activities - 
Mining&#34;. Mineral property pre-exploration and exploration
costs are expensed as incurred. When it has been determined that a mineral 
property can be economically developed as a result of
establishing proven and probable reserves, the costs incurred to develop such 
property are capitalized. The Company did not establish
any reserves on its mineral properties prior to terminating its option under the
Revised and Restated Mineral Property Option Agreement
(see footnote 3).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_RehabilitationProvisionsPolicyTextBlock', window );">Rehabilitation
Provisions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">The Company was subject to various government
laws and regulations relating to environmental disturbances which are caused by 
exploration and evaluation activities. The Company
will record the present value for the estimated costs of legal and constructive 
obligations required to restore the exploration
sites in the period in which the obligation is incurred. The nature of the 
rehabilitation activities includes restoration, reclamation
and re-vegetation of the affected exploration sites. The Company has determined 
that there were no rehabilitation provisions at
February 27, 2015 when the option to acquire the mineral claim was 
terminated.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-
based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">Codification topic 718 &#34;Stock Compensation&#34;
requires that the cost resulting from all share-based transactions be recorded 
in the financial statements and establishes fair
value as the measurement objective for share-based payment transactions with 
employees and acquired goods or services from non-employees.
The codification also provides guidance on valuing and expensing these awards, 
as well as disclosure requirements of these equity
arrangements. The Company adopted the codification upon creation of the company 
and will expense share based costs in the period
incurred. The Company has not adopted a stock option plan or completed a share-
based transaction; accordingly no stock-based compensation
has been recorded to date.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent 
Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">The Company's management has evaluated all
the recently issued, but not yet effective, accounting standards that have been 
issued or proposed by the FASB or other standards-setting
bodies through the filing date of these financial statements and does not 
believe the future adoption of any such pronouncements
will have a material effect on the Company's financial position and results of 
operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_mdsv_ProspectiveLicenseAgreementPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-
space:nowrap;">mdsv_ProspectiveLicenseAgreementPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_RehabilitationProvisionsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-
space:nowrap;">mdsv_RehabilitationProvisionsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_mdsv_SummaryOfSignificantAccountingPoliciesPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-
space:nowrap;">mdsv_SummaryOfSignificantAccountingPoliciesPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Disclosure of accounting policy pertaining to new 
accounting pronouncements that may impact the entity's financial reporting. 
Includes, but is not limited to, quantification of the expected or actual 
impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_OilAndGasPropertiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Disclosure of accounting policy for oil and gas property 
which may include the basis of such assets, depreciation methods used and 
estimated useful lives, the entity's capitalization policy, including its 
accounting treatment for costs incurred for repairs and maintenance activities, 
whether such asset balances include capitalized interest and the method by which
such is calculated, how disposals of such assets are accounted for and how 
impairment of such assets is assessed and recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-
107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_OilAndGasPropertiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Disclosure of accounting policy for stock option and stock
incentive plans. This disclosure may include (1) the types of stock option or 
incentive plans sponsored by the entity (2) the groups that participate in (or 
are covered by) each plan (3) significant plan provisions and (4) how stock 
compensation is measured, and the methodologies and significant assumptions used
to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 1<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-
113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI 
http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-
107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI
http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);"
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Disclosure of accounting policy for the use of estimates 
in the preparation of financial statements in conformity with generally accepted
accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 
50<br> -Paragraph 4<br> -URI 
http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6061-
108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI 
http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6143-
108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI 
http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6132-
108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6729685536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Due to
related Party (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_DueToRelatedPartyTablesAbstract', window );"><strong>Due To Related
Party Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Due to 
related parties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">Due to related parties at June 30, 2016 and
March 31, 2016 consisted of the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times,
Serif; width: 100%; font-size-adjust: none; font-stretch: normal">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" id="hdcell" style="text-align: center"><font style="font-
size: 10pt"><b>June 30,</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 
10pt"><b>March 31,</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt;
text-align: center"><font style="font-size: 10pt"><b>2016</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt;
text-align: center"><font style="font-size: 10pt"><b>2016</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" id="ffcell" style="vertical-align: bottom; text-align:
right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: 
right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; width: 78%; text-align: justify"><font 
style="font-size: 10pt">Balance at beginning of period</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 8%; text-align: right"><font 
style="font-size: 10pt">213,442</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 8%; text-align: right"><font 
style="font-size: 10pt">25,523</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: 
justify"><font style="font-size: 10pt">Funds advanced</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">187,919</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: 
justify"><font style="font-size: 10pt">Funds repaid</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: 
justify"><font style="font-size: 10pt">Funds forgiven</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-
bottom-width: 1pt; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-
bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-
</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: solid; border-
bottom-width: 1pt; text-align: justify">&#160;</td>
<td style="vertical-align: bottom; border-bottom-style: solid; border-
bottom-width: 1pt; text-align: right"><font style="font-size: 10pt">-
</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size:
10pt">Balance at end of period</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-
bottom-width: 2.25pt; text-align: justify"><font style="font-size: 
10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-
bottom-width: 2.25pt; text-align: right"><font style="font-size: 
10pt">213,442</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-
bottom-width: 2.25pt; text-align: justify"><font style="font-size: 
10pt">$</font></td>
    <td style="vertical-align: bottom; border-bottom-style: double; border-
bottom-width: 2.25pt; text-align: right"><font style="font-size: 
10pt">213,442</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_DueToRelatedPartyTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_DueToRelatedPartyTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Tabular disclosure of related party transactions. Examples
of related party transactions include, but are not limited to, transactions 
between (a) a parent company and its subsidiary; (b) subsidiaries of a common 
parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
</head>
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6611930864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-
term debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_LongtermDebtTablesAbstract', window );"><strong>Long-term Debt 
Tables</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_ScheduleOfDebtTableTextBlock', window );">Long term debt</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; 
text-align: justify">Long term debt at June 30, 2016 and March 31,
2016 consisted of the following:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: 
justify; text-indent: 0.5in">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times,
Serif; width: 100%; font-size-adjust: none; font-stretch: normal">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" id="hdcell" style="text-align: center"><font style="font-
size: 10pt"><b>June 30,</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 
10pt"><b>March 31,</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt;
text-align: center"><font style="font-size: 10pt"><b>2016</b></font></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="border-bottom-style: solid; border-bottom-width: 1pt;
text-align: center"><font style="font-size: 10pt"><b>2016</b></font></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" id="ffcell" style="vertical-align: bottom; text-align: 
right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: 
right">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><font style="font-size:
10pt">Balance at beginning of period</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align:
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: justify"><font 
style="font-size: 10pt">$</font></td>
    <td style="vertical-align: bottom; width: 9%; text-align: right"><font 
style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; width: 1%; text-align: 
justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: 
justify"><font style="font-size: 10pt">Funds advanced</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">110,000</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: right"><font style="font-
size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 11.25pt; text-align: 
justify"><font style="font-size: 10pt">Funds repaid</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-
align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-
align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 1pt solid; text-
align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-
align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><font style="font-size:
10pt">Balance at end of period</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-
align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-
align: right"><font style="font-size: 10pt">110,000</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 2.25pt double; text-
align: justify"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; vertical-align: bottom; text-
align: right"><font style="font-size: 10pt">-</font></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData"
style="display: none;" id="defref_mdsv_LongtermDebtTablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_LongtermDebtTablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Tabular disclosure of information pertaining to short-term
and long-debt instruments or arrangements, including but not limited to 
identification of terms, features, collateral requirements and other information
necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6861797296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Nature
of operations (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_NatureOfOperationsDetailsNarrativeAbstract', 
window );"><strong>Nature Of Operations Details Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount', 
window );">Advance for commercialization of the Licensed Technology</a></td>
<td class="nump">$ 221,850<span></span>
</td>
<td class="nump">$ 131,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_FeesPaidForCommercializationLicensedTechnology', window );">Fees 
paid for commercialization Licensed Technology</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_mdsv_FeesPaidForCommercializationLicensedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-
space:nowrap;">mdsv_FeesPaidForCommercializationLicensedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_mdsv_NatureOfOperationsDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-
space:nowrap;">mdsv_NatureOfOperationsDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Discloses the period end balance sheet amount of advances 
for gas exploration, development and production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 932<br> -SubTopic 835<br> -Section 
25<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=68073565&amp;loc=d3e70057-
109498<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6866039072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 
200px;"><strong>Investment in technology license (Details Narrative) - USD 
($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_InvestmentInTechnologyLicenseDetailsNarrativeAbstract', 
window );"><strong>Investment In Technology License Details 
Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount', 
window );">Advance for commercialization of the Licensed Technology</a></td>
<td class="nump">$ 221,850<span></span>
</td>
<td class="nump">$ 131,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_FeesPaidForCommercializationLicensedTechnology', window );">Fees 
paid for commercialization Licensed Technology</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_Investments', window );">Investment in technology license</a></td>
<td class="nump">$ 169,606<span></span>
</td>
<td class="nump">$ 70,998<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_mdsv_FeesPaidForCommercializationLicensedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-
space:nowrap;">mdsv_FeesPaidForCommercializationLicensedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_mdsv_InvestmentInTechnologyLicenseDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-
space:nowrap;">mdsv_InvestmentInTechnologyLicenseDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Discloses the period end balance sheet amount of advances 
for gas exploration, development and production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 932<br> -SubTopic 835<br> -Section 
25<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=68073565&amp;loc=d3e70057-
109498<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-
gaap_AdvancesForGasExplorationDevelopmentAndProductionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData"
style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date 
of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-
122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6718325600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Due to
related Party (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_DueToRelatedPartyDetailsAbstract', window );"><strong>Due To 
Related Party Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DueToRelatedPartiesCurrent', window );">Balance at beginning of 
period</a></td>
<td class="nump">$ 213,442<span></span>
</td>
<td class="nump">$ 25,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_FundsAdvanced', window );">Funds advanced</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">187,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_Repayments', window );">Funds repaid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_FundsForgiven', window );">Funds forgiven</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a"
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_DueToRelatedPartiesCurrent', window );">Balance at end of period</a></td>
<td class="nump">$ 213,442<span></span>
</td>
<td class="nump">$ 213,442<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_DueToRelatedPartyDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_DueToRelatedPartyDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_FundsAdvanced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Funds advanced.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_FundsAdvanced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_FundsForgiven">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_FundsForgiven</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_Repayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Repayments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_Repayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Carrying amount as of the balance sheet date of 
obligations due all related parties. For classified balance sheets, represents 
the current portion of such liabilities (due within one year or within the 
normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-
122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-
107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> 
-SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-
02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
(e.nextSibling.style.display=='none') {
{ e.nextSibling.style.display='none'; }
function toggleNextSibling (e) {
if
e.nextSibling.style.display='block';
} else
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6718319936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-
term debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_LongtermDebtDetailsAbstract', window );"><strong>Long-term Debt 
Details</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LongTermDebtNoncurrent', window );">Balance at beginning of period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_FundsAdvancedLongTermDebtNoncurrent', window );">Funds 
advanced</a></td>
<td class="nump">110,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_FundsRepaidLongTermDebtNoncurrent', window );">Funds 
repaid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_LongTermDebtNoncurrent', window );">Balance at end of period</a></td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_FundsAdvancedLongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_FundsAdvancedLongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_FundsRepaidLongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_FundsRepaidLongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_LongtermDebtDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_LongtermDebtDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Amount after unamortized (discount) premium and debt 
issuance costs of long-term debt classified as noncurrent and excluding amounts 
to be repaid within one year or the normal operating cycle, if longer. Includes,
but not limited to, notes payable, bonds payable, debentures, mortgage loans and
commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6720076640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 
200px;"><strong>Related party transactions (Details Narrative) - USD 
($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_RelatedPartyTransactionsDetailsNarrativeAbstract', 
window );"><strong>Related Party Transactions Details 
Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_AccruedLiabilitiesCurrent', window );">Accrued liability</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 23,618<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" 
id="defref_mdsv_RelatedPartyTransactionsDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-
space:nowrap;">mdsv_RelatedPartyTransactionsDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Carrying value as of the balance sheet date of obligations
incurred and payable, pertaining to costs that are statutory in nature, are 
incurred on contractual obligations, or accumulate over time and for which 
invoices have not yet been received or will not be rendered. Examples include 
taxes, interest, rent and utilities. Used to reflect the current portion of the 
liabilities (due within one year or within the normal operating cycle if 
longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment 
*/</script><script type="text/javascript">
function toggleNextSibling (e) {
if
(e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else
{ e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" 
cellspacing="2" id="idp6718224800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 
200px;"><strong>Capital stock (Details Narrative) - USD 
($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_CapitalStockDetailsNarrativeAbstract', window );"><strong>Capital 
Stock Details Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par 
value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesAuthorized', window );">Common stock, shares 
authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">28,400,000<span></span>
</td>
<td class="nump">28,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-
gaap_CommonStockSharesOutstanding', window );">Common stock, shares 
outstanding</a></td>
<td class="nump">28,400,000<span></span>
</td>
<td class="nump">28,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" 
href="javascript:void(0);" onclick="top.Show.showAR( this, 
'defref_mdsv_StockOptionGranted', window );">Stock options or warrants 
granted</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_CapitalStockDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_CapitalStockDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_mdsv_StockOptionGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mdsv_StockOptionGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>mdsv_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Face amount or stated value per share of common 
stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>The maximum number of common shares permitted to be issued
by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Total number of common shares of an entity that have been 
sold or granted to shareholders (includes common shares that were issued, 
repurchased and remain in the treasury). These shares represent capital invested
by the firm's shareholders and owners, and may be all or only a portion of the 
number of shares authorized. Shares issued include shares outstanding and shares
held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" 
style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" 
onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- 
Definition</a><div><p>Number of shares of common stock outstanding. Common stock
represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
References</a><div style="display: none;"><p>Reference 1: 
http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name 
Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 
S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-
122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> 
-Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> 
-SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI 
http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-
112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ 
Details</a><div style="display: none;"><table border="0" cellpadding="0" 
cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace 
Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>37
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MV"1FO#Y<H''J9XCY]5_C^ %02P,$%     @ R4X027CMV IM @  &0@  !
M  !D;V-0<F]P<R]A<' N>&ULO5;!;MLP#/T5P:?NT#K+AAZ"U,"6%%N!M N6
MK#LS,AT+D25/8HQF7S]:;EVGC=NFA^42FGHD]1YIPF/C!Z.YLR4Z4NC%7:&-
M'['S(LJ)RE$<>YEC ?Z,(89/,^L*('YTZ]AFF9(XM7);H*%X.!B<QWA':%),
M3\LV:92,ZRI?RE(K":2L2:Z5=-;;C,3EG40]CI\"0@1G7J#<.D6[9-!@NJZ
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M3]-K=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5
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M>K=:^8^7-\?XA3VXA,!Q?,YC&(17T#N?=.W[IXG-X1%Y:,B]OHHD*@1?%F.
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MC10QG.RO."<MN[8*IH^;Y"=02P,$%     @ R4X025K#/L,= P  =PD   \
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MGBK9I"&:S22ATQL-DAC-1151B'S<26QQ$JN91'A\8HE/U$PHFDFBF'P(*;J
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MV9,=.!^8,.<_BK=^$IWV<E&SPS">QN*\FWK/Z6+@YULKO?3S^7]02P,$%
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M*&A=.'[S9Y.>5#(<CN</LO[2ZA]02P,$%     @ R4X02<S]N66E 0  L ,
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MB,Y/-LZF0W3@D\ANMI0,_O^LAH3.A>.=/YOTI)+A<#Q_D/67UG\!4$L#!!0
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M"EH7EM_\VJ0GE0*'X_F#K+^T>@=02P,$%     @ R4X02=D,77ZE 0  L0,
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MJ+7M[DQ?^@_.#[3H[]?'=(<5_P!02P,$%     @ R4X025U;@1L5 @  >@8
M !D   !X;"]W;W)K<VAE971S+W-H965T,C,N>&ULC97;CILP$(9?Q>(!EF.
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MCV :$#A+W<U4G]O:: >2]?=*/_UNRK]02P,$%     @ R4X027?V=";Y 0
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MU;=A7! X2SW-U)S;=FD7DG7WYC]^@<K_4$L#!!0    ( ,E.$$F0!HG"(20
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M0)HW=A]0P@>D"JU@HSX//O:0V,P,'1BGA_N+:C2IQ->N\>W6QG)R(A_VBH]
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M(5!Q)_)33<.\ N]L22@<^]W PI8K-O)(2/8,'#@;M%-9(;I@<AC[#T#,7>Z
M8;0Z@)A(V*7ZQ<NKMBL@X5/!"LB>*':BV<Z@ZX"*=,GQ%=S0P7B2"9%;M(X-
M88VX()_W[?81BM^2&I4?X_:.8=\TG8C3;;A*IFUE'3/G_AC/N_:.WHGX&#.[
MH5[J2/:/-IW[.6B_]=.RY<EK%W* )PTB+B8B(:>%QA0:[!_@&B9^)*V"?:H*
M&FC,A='0.N*O<'<Z&K6M]:S%7.!,&^B3E)B#\-)%Z>"<X"[O $K)3%=L*]#1
M%^CHTS/)$W!HE:*9;@L3-%XAL3"G!)S<;)MO6;CL]TPE^';6.9A/I*VJ,AR9
MN/ .H [&##DRC\U+2\H,(T9Y!OM,L01&C*"K24"]9DZR"G I)EL2JV@"MXAM
M&\H</8'I9ZRP8)O1-0XVVFUMHJJ*8@J4I]S!^V$,@)B_;CH\Z?@"\1V"7L1V
M:K6B-*O@(#2MGG$#$/PF;P ESQ?@OFA+ PD/-[,EC XC N"HT%2,,&J$$S**
MS=)CJ=9(QC0#WL67?R.RF?\4[V%%J#[C3_?0 /< ).A.97E,Y<0">IQ+Q5C*
M#\KK@[D[(3;]3JQ2EC>(-DAC!3!)>I@$1!A$.L(C'88'/SD ](:^/CC> H$"
M6RRMR2>#,@B-A!6 >[O:$N#%W,KEPV&286! ?:Q=73?EJ,%,7^AYV1  $%/=
MW*/_'D$U8 0:D>6T2X(05]XO.GW3C!PF5GGXH,;$1NK5X4JM.5BQ*.^!!RL1
M]F8ET3(!W"P#BA-$NVGG+;A<EW8S$=@OV>7U6_W4NNL,KPR$B_:\\#06?5*9
M_>\R5,P 7"/2P7LJ@H8R@(8Q3!%=K\5 OS)&H68FMVX81*H?.L&UWCQ'9H9S
M+*_TFMZ/(L+UCW"68R8"*D.0D++*T_LLA3\M;2** !U@2'H'@-):+[-QF9C1
MD*/1AB-Z1:5','4YQ9@?P$01@[JD-3 U651E01ER#_-BT;%O6ZG&:2S^&U55
M3IXM54^$$PT!&GB+I&!+,C<&;9*$@@4$H+Y$?3*":<W0<L"L:X6TJ'4."BK'
M2/X(D4E39=,6=2*T(#U[G]6Z@Q(W0$2!H[:HP\'G NK,,D[*+75*MLSX+S0T
M:&S$B>X%I([1 F/=!FK&G$)4L(_O/[Z01VBQQ]!X3/A/5\<2O8048/DG9]D&
MV"0&Z<+K(.4#B Q"+2@?6!9K<LJP=-A,'IY=<@66[1[2*0H]VG%%B*A-&HY@
M+05_+2?/0,3*>_P"ZZC3-M?/Y>&$7T407'_6P%OA^%U%=D2)R9YY$);50*,?
M7IMJLL;X;&:$MV#W)C;@91:&@!/ 9C:G5$X(1?MFB5F4DTPH,5C;BTXTLN>A
M(1C.O )]#82ST:N+,*@)JQUH> ,&.Y<F@"2/$B 3OR-?\V8?O,XJ4)]N7SZ"
MA@ *@E8A#!O/"91=#AHI 7(P53%=7".H"@C[PIIU^0'C8"D'HVNJ="N\IS'
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MV>6I4:3G]('R>BNG+?NB8!!'9O"QLS<9!GPJW -*)KF@W@Y#%QC0$_EFB1C
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MF 45V_.E5AA,9*Q ,H7<1M8J>+FQ/O$D2'O;BGF3ETH,9\Y+3 'B* @*J>K
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M#D_JNOG^OP%02P$"% ,4    " #)3A!)GH,0)9H!  !#$@  $P
M    @ $     6T-O;G1E;G1?5'EP97-=+GAM;%!+ 0(4 Q0    ( ,E.$$E(
M=07NQ0   "L"   +              "  <L!  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( ,E.$$E09]C26 $  .L0   :              "  ;D"  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,E.$$EX[=@*;0(
M !D(   0              "  4D$  !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ R4X021U&E7L^ 0  :0,  !$              ( !Y 8  &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ R4X029E<G",0!@  G"<  !,
M         ( !40@  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #)
M3A!)>F#Z2C0"  #I"   #0              @ &2#@  >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( ,E.$$E:PS[#'0,  '<)   /              "  ?$0
M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #)3A!)&**_N&H"  # "
M&               @ $[%   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ R4X02:7X<WM? P  $ \  !@              ( !VQ8  'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( ,E.$$E5,X0MUP$
M &@%   8              "  7 :  !X;"]W;W)K<VAE971S+W-H965T,RYX
M;6Q02P$"% ,4    " #)3A!)6.*G0^("  ">"P  &               @ %]
M'   >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ R4X02?$2
M88V; @  "@H  !@              ( !E1\  'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+ 0(4 Q0    ( ,E.$$D\1&0(@@,  -L/   8
M  "  68B  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #)
M3A!)Y36BMZ4!  "Q P  &               @ $>)@  >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&UL4$L! A0#%     @ R4X022%FUA6C 0  L0,  !@
M         ( !^2<  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0
M   ( ,E.$$G/9I7QI $  +$#   8              "  =(I  !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #)3A!)S/VY9:4!  "P P
M&0              @ &L*P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+
M 0(4 Q0    ( ,E.$$F7@5$RI0$  + #   9              "  8@M  !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ R4X028AL/ BC
M 0  L ,  !D              ( !9"\  'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6Q02P$"% ,4    " #)3A!)-::)-Z,!  "Q P  &0
M@ $^,0  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( ,E.
M$$FOV1VOHP$  +$#   9              "  1@S  !X;"]W;W)K<VAE971S
M+W-H965T,30N>&UL4$L! A0#%     @ R4X024Q%&JRC 0  L0,  !D
M         ( !\C0  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
M    " #)3A!)577 /*0!  "Q P  &0              @ ',-@  >&PO=V]R
M:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( ,E.$$E$WK,6I0$  +$#
M   9              "  :<X  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
M4$L! A0#%     @ R4X02?_/[ 'F 0  J@4  !D              ( !@SH
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " #)3A!)V'0=
M\:0!  "Q P  &0              @ &@/   >&PO=V]R:W-H965T<R]S:&5E
M=#$Y+GAM;%!+ 0(4 Q0    ( ,E.$$G9#%U^I0$  +$#   9
M  "  7L^  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @
MR4X0259/]S&T 0  0@0  !D              ( !5T   'AL+W=O<FMS:&5E
M=',O<VAE970R,2YX;6Q02P$"% ,4    " #)3A!)TWI]Y<\!  #/!   &0
M            @ %"0@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4
M Q0    ( ,E.$$E=6X$;%0(  'H&   9              "  4A$  !X;"]W
M;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ R4X027?V=";Y 0
MZ 4  !D              ( !E$8  'AL+W=O<FMS:&5E=',O<VAE970R-"YX
M;6Q02P$"% ,4    " #)3A!)00N%[)\!  "S P  &0              @ '$
M2   >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( ,E.$$G(
MRZ]F& (  (T&   9              "  9I*  !X;"]W;W)K<VAE971S+W-H
M965T,C8N>&UL4$L! A0#%     @ R4X029 &B<(A)   Z:   !0
M     ( !Z4P  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L%!@     C ", 9PD
' #QQ      $!
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */
var Show = {};
Show.LastAR = null,
Show.hideAR = function(){
Show.LastAR.style.display = 'none';
};
Show.showAR = function ( link, id, win ){
if( Show.LastAR ){
Show.hideAR();
}
var ref = link;
do {
ref = ref.nextSibling;
} while (ref && ref.nodeName != 'TABLE');
if (!ref || ref.nodeName != 'TABLE') {
var tmp = win ?
win.document.getElementById(id) :
document.getElementById(id);
if( tmp ){
ref = tmp.cloneNode(true);
ref.id = '';
link.parentNode.appendChild(ref);
}
}
if( ref ){
ref.style.display = 'block';
Show.LastAR = ref;
}
};
Show.toggleNext = function( link ){
var ref = link;
do{
ref = ref.nextSibling;
}while( ref.nodeName != 'DIV' );
if( ref.style &&
ref.style.display &&
ref.style.display == 'none' ){
ref.style.display = 'block';
if( link.textContent ){
link.textContent = link.textContent.replace( '+', '-' );
}else{
link.innerText = link.innerText.replace( '+', '-' );
}
}else{
ref.style.display = 'none';
if( link.textContent ){
link.textContent = link.textContent.replace( '-', '+' );
}else{
link.innerText = link.innerText.replace( '-', '+' );
}
}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */
/* DefRef Styles */
..report table.authRefData{
background-color: #def;
border: 2px solid #2F4497;
font-size: 1em;
position: absolute;
}
}
..report table.authRefData a {
display: block;
font-weight: bold;
..report table.authRefData p {
margin-top: 0px;
}
..report table.authRefData .hide {
background-color: #2F4497;
padding: 1px 3px 0px 0px;
text-align: right;
}
..report table.authRefData .hide a:hover {
background-color: #2F4497;
}
..report table.authRefData .body {
height: 150px;
overflow: auto;
width: 400px;
}
..report table.authRefData table{
font-size: 1em;
}
/* Report Styles */
..pl a, .pl a:visited {
color: black;
text-decoration: none;
/* table */
..report {
background-color: white;
border: 2px solid #acf;
clear: both;
color: black;
font: normal 8pt Helvetica, Arial, san-serif;
margin-bottom: 2em;
}
}
}
..report hr {
border: 1px solid #acf;
}
/* Top labels */
..report th {
background-color: #acf;
color: black;
font-weight: bold;
text-align: center;
..report th.void {
background-color: transparent;
color: #000000;
font: bold 10pt Helvetica, Arial, san-serif;
text-align: left;
}
..report .pl {
text-align: left;
vertical-align: top;
white-space: normal;
width: 200px;
white-space: normal; /* word-wrap: break-word; */
}
..report td.pl a.a {
cursor: pointer;
display: block;
width: 200px;
overflow: hidden;
}
..report td.pl div.a {
width: 200px;
}
..report td.pl a:hover {
background-color: #ffc;
}
/* Header rows... */
..report tr.rh {
background-color: #acf;
color: black;
font-weight: bold;
}
/* Calendars... */
..report .rc {
background-color: #f0f0f0;
}
/* Even rows... */
..report .re, .report .reu {
background-color: #def;
}
..report .reu td {
border-bottom: 1px solid black;
}
/* Odd rows... */
..report .ro, .report .rou {
background-color: white;
}
..report .rou td {
border-bottom: 1px solid black;
}
..report .rou table td, .report .reu table td {
border-bottom: 0px solid black;
}
/* styles for footnote marker */
..report .fn {
white-space: nowrap;
}
/* styles for numeric types */
..report .num, .report .nump {
text-align: right;
white-space: nowrap;
}
..report .nump {
padding-left: 2em;
}
..report .nump {
padding: 0px 0.4em 0px 2em;
}
/* styles for text types */
..report .text {
text-align: left;
white-space: normal;
}
..report .text .big {
margin-bottom: 1em;
width: 17em;
}
..report .text .more {
display: none;
}
..report .text .note {
font-style: italic;
font-weight: bold;
}
..report .text .small {
width: 10em;
}
..report sup {
font-style: italic;
}
..report .outerFootnotes {
font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.5.0.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>28</ContextCount>
  <ElementCount>93</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>4</SegmentCount>
<ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance 
Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets 
(Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets 
(Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of 
Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations 
(Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Changes in 
Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://madisonventures.com/role/StatementsOfChangesInStockholdersEquityDef
icit</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders' Equity
(Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows 
(Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Condensed financial 
statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/FinancialStatements</Role>
      <ShortName>Condensed financial statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Nature of operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/NatureOfOperations</Role>
      <ShortName>Nature of operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Mineral claim</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/MineralClaim</Role>
      <ShortName>Mineral claim</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Investment in technology 
license</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/InvestmentInTechnologyLicense</Role>
      <ShortName>Investment in technology license</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Due to related party</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/DueToRelatedParty</Role>
      <ShortName>Due to related party</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Long-term debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/Long-termDebt</Role>
      <ShortName>Long-term debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Related party transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related party transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Going concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/GoingConcern</Role>
      <ShortName>Going concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Capital stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/CapitalStock</Role>
      <ShortName>Capital stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Contingency Liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/ContingencyLiability</Role>
      <ShortName>Contingency Liability</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
<Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Nature of operations 
(Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/NatureOfOperationsPolicies</Role>
      <ShortName>Nature of operations (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Due to related Party (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/DueToRelatedPartyTables</Role>
      <ShortName>Due to related Party (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Long-term debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/Long-termDebtTables</Role>
      <ShortName>Long-term debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://madisonventures.com/role/Long-termDebt</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Nature of operations (Details 
Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://madisonventures.com/role/NatureOfOperationsDetailsNarrative</Role>
      <ShortName>Nature of operations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      
<ParentRole>http://madisonventures.com/role/NatureOfOperationsPolicies</ParentRo
le>
      <Position>21</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Investment in technology license 
(Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://madisonventures.com/role/InvestmentInTechnologyLicenseDetailsNarrat
ive</Role>
      <ShortName>Investment in technology license (Details 
Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      
<ParentRole>http://madisonventures.com/role/InvestmentInTechnologyLicense</Paren
tRole>
      <Position>22</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Due to related Party 
(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/DueToRelatedPartyDetails</Role>
      <ShortName>Due to related Party (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      
<ParentRole>http://madisonventures.com/role/DueToRelatedPartyTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Long-term debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/Long-termDebtDetails</Role>
      <ShortName>Long-term debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://madisonventures.com/role/Long-
termDebtTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Related party transactions (Details 
Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      
<Role>http://madisonventures.com/role/RelatedPartyTransactionsDetailsNarrative</
Role>
      <ShortName>Related party transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      
<ParentRole>http://madisonventures.com/role/RelatedPartyTransactions</ParentRole
>
      <Position>25</Position>
    </Report>
    <Report instance="mdsv-20160630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
<LongName>00000026 - Disclosure - Capital stock (Details 
Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://madisonventures.com/role/CapitalStockDetailsNarrative</Role>
      <ShortName>Capital stock (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://madisonventures.com/role/CapitalStock</ParentRole>
      <Position>26</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>mdsv-20160630.xml</File>
    <File>mdsv-20160630.xsd</File>
    <File>mdsv-20160630_cal.xml</File>
    <File>mdsv-20160630_def.xml</File>
    <File>mdsv-20160630_lab.xml</File>
    <File>mdsv-20160630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>43
<FILENAME>0001477932-16-011975-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001477932-16-011975-xbrl.zip
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M_OS:@QGA_0(>''MFZ9FZ3)-@P67A!'B1<\;U!SF]^ ' ]?"V66]29NBN%1[
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MNQ@/5"0#X<G86S&#\AH!?LW@\KW'T\*[H7'5.>LY>BFXD7L56[RQ/$_/>)U
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MC:6P!M("WC<'N.PBJMA)S;ZR_42)@Q6>]%YV>JU&J]72KP?5:^^J00]V;JS
MQX1SO\CII,-XQ?I#D%/I+7Z!':?#,A9GWLLV3T>1$G$G@.GL.:I:XA4F^LSJ
M:97\0'P(JO/E*8\J/3_T8S*.;D^]MCIKDPM$5Q#<0-@*A,QV$F>VH,*_7/V
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M=?(CM>3B4.EL6R[O\5IRR8/)>6VYO,=HR:7-S45MN3S=DJO.CUN+9ZH,A]C
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M:.FQ5X'**-(X0'7S>?(HU]=K''13FDP>;CW9_R'$X[;^O0L>_P102P,$%
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M(,'# N.,J%:0)8+6EHR50.LU8J&4<QYHH?4WA<8!C@F=3-._2!*% =];4)I
MA0T86U3&A,B9(Q.RNDM*"+"U%:HEX9PM2EB]S._#P^7C R0JE/,Q(T;T9.T3
M0P*WSX^.(#":B-')DL >USF%09MSCRPD;2N^LGKJH &F==" ?@ZFRQM@>CU,
MOX+1K1=XE9 P*^@I:4A'QF9'"^$U>[PE *;K1:AZ060A@^AT]1'[BSB)DODS
MN@Y]%E+ (,==BE=>&%P^K1BFTBU)FBR1M4D6)=PF:82"8,BC0M<E42F+<"$,
M)=KT_22/,W*/?1RNO6F$;[ TQ!#+6MZA+X?;V8W?%P3#&Q6Z+F]^IA-7'-&/
M<)(3E-8:0/C3#)9, BJ'(:DV%+7*CZQQ1EK_V"3DX >MD=^*0F$08Q*O,<E8
MZD46J[0D;))" *U)B<;78!Q&'U-O2:^60&&,LDV8$D$*4Y3!JXNH51ZN.HA3
M#5V"TA= \@'7H3<-HS +,1G' 5_I6211@%-2'*35I#3,U6TR9FBCFIPRU07C
M=P8"[E+R>C(^FUQ/'B>7#VA\<X$>_CB^O_SC[?7%Y?W#-^CRSY\FCW]#KRXN
MKR;GDT<@1P0;33;+O*D4'!'3( <GEX9(OF'9N&BC""0E5P7\=]XSB]TU\;)$
MV,5$2PQ8---J2X(AD1*>X-PI%T:K0AH,>=(<!_W70=YDF;QE"JEA=U@D%H9$
M)"5" 9>8?-,9P:#318X?DWO,3U??>:F>3RH%JQEF+?!6NEDJ#8926HB]1'2.
M49:@M%"A7BK-]KHK;Y]1D_&@[CI*,HN.8$T$C;U0.T$$SA<UVG%#^VYHO"W2
M<40F.7P)K_H*8/R2"<K>5"^)YZ,,ITN T3?#]DBA7>!IMFF0K/$28:N\4@)N
M$4HH"8=)*GAR"@54' AU1*_"D-<&@$,R=D1@QS@M=8IA+A+Y(' \TC?7&6<T
M3 '+#R4KKJ%Q@9U\"(O%G'$<G"<Q.WV%8U_.#:6&[1JR&NC=:K(2<3!#E!ZC
MJ,)LJ8&\F&\IWNC H-C@M18HJRO#UE.^@A64P6LF_"14J? -PD7%V5=!407O
M-9"(NG'LBU\+H7BWVF*."EZW0$KJ77,9,+R1 )-4NR9,[A2].SY^<US\'Y'B
M1)V79XLD#?_%:G3.T'\>'QX?G[#$$5HSJ]^CM]^]>5]J,%_6^,_20,BJ#P3\
MRV1S.@]YA-G[WSS&]%??\"M&N,S/]'DMT+N3XB,8;)64X&T\8EG.UT 10(ED
M04,,ZB0WM,"PWABJHF(RVV4Y"F/D0ZJ8W"U_VJAP6A8XE3P1$T67!6GE#5$5
MI^UK@:&@,515T=I@/T5KK57KODX(N<'9[>S1>Y*O?PVS JQRMZB) ^MW-TV
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MX\;4*V&Z-Y .E-KJXJ&%YDZAF&WESB )(DQ87'5K,^5W:/=VQB'L5J8\-T;
M/ZD'N&"C>DVEGH.K=/D XNM9)E ELJ]LWGW[LUX,O"V:V(@:7E'J0#-KL,P8
ME$\B2L36BY+-#A@-A;DQ<?1QRK\<.5"RK*-I@6?.9'$)#Y5DW?S^8/H\!C[[
M\EW^K\+YFX&^K9<N]\?=G&K='RJ-F- ]^T1>E(,4_C?-;]42IL@;Z=QZT;1!
MR-7'DJ;N];V$][F7@,"<93(X[27T\@X<*.<>;. HZ.HU9'U7=V)%$'J*VDE*
MS3*C6B+/=^U$'E[Z3O$*#R*O^I(_>OEKO#?%B_IE])C*MRXXION'7JG72N16
M$\H+#K,O(2M(4K23&7O+*@:Q>"UX6EGD=8FJL2T7 *%&#:;T1X&#W]76,6!J
MPXJ'0(7]:AFZ"RCD0XDM !AEEP8\015 NLEV$9MN22II9#9#J'7>SO#2AX)#
M:$YSQU 1C;AF%+1;H$HRA!L9VS\"%H(3NI7-IK;S&/O P978C:TGI_9?!HZ$
MS'9J8Q^@E#3A!FC-<G\96KSVMC,9^\ DEMT-?!1*]J4&IMZ%_8J5'L:FJR$W
M@%6K NM5^C7\7-C:.W3E=_/KO/0B&*LLI$+?'2?VPUI?Z1:*X>=)*83F+R!P
M"DAK\<G!#D&4H=4+-^[4'*EQ"CE8F+C7+-EYY-C'O,Z1 \'_[69)#1 'R_#<
M8IX<$$H7 O<^65Q$^)%3:/M.(SY/>_*RKKY&>>T+WQK5M1TT=K,R&$,W,5Y#
M"N''Y\\$T,WE2\7/)$C@.K\_2%X2TZ,O5\IQN4BV4SIZZLN-U6_0U/C! EM;
M:%TO5]YJI*L\LB?L4Q0!1@',/MFW8?@>&[/58=YF>R]I;)P,"<:VPXV[+E&?
MH?C@S(2<+U<1?@9 4@*>3X-R0ML[S$'QP'JZ<&G2:.:$5 0NXL/RJ4"G#]NQ
MO*\Q#GJHQ>TA4?\ZK\Y :%+:CD;TP$0&:K=R7(6R_4U?'3B[J&U7)P\ *5])
M RV])0M35'R5_!K=@V"!<(3GSY<PX)@=HU4CM1U]Z@^2NHR[87C%UQ;O8S_L
M97IU>ML!J0&-KTM1#H/;^$RC)K0M:FM%Q8,"RU&2&["J[_U,1+ <*#LV&131
MU-RNWR[ D3C_#KR9J*>P+W>*E[>,>RIHS(W9@2Y'Q:YQ$OR2PAC<X5GR*+R0
M6D!BO?AX"SBPJI!]3=VUHB%U79DP<@<*C8T-#GW-O=*%X0(B'P5F%@9A7_:*
MG0TO# H:<V1AB'$ 0$@NJ"8J'P!_9E^R%:P-0BKKI<M;@-*ZZ5:J'?=P9-DO
M["L==!2K?#5/@=1Z??$@B KUY :LZG*;F(@=J <V!K2^YG9]\3Z?S4"07,^J
M]U)>(Z8$_M@0T:B.A>%N!#0U%N2:<</:&4?L"\?T'Y;VMO8CYHQTE[_S,=7K
M117EX2\ 5'6Y^FC)'7S%N&GDD#B%Q]9SJ%MY[%*<--)I!_CR\S9(N9(4S3E+
MO,(HH%QN]M@H5'-V&+4JL2IRYN-7VLCIB.725'>7KE91)J4?E4).T0S'RUS+
M\FLX5#M0!=-\O*FO&6KJQ@U IR@!5+,)J[ZECIGHA+#14!6@X2H@-?7=/ KL
M%-P55%C>U[W_! CC3WAN6V^HBLIPI55;HM(IN#M?4BMF:#_:S! O3-:J._[L
MC;S-O9>U[ZC-RCX\LNG$Z&*; '*/.UB5%'2H$%JM0RPTV,'@/87S8R0,B"F2
MVZS=4$>N5:>HH1IWK.G*9P_DWR3\OFE,.2$KC<(;TF\F) \\<A7>$6#L:+N3
MQB$89<Y8PH\P^U+8:>3#9;<-O&_:0$'B!1G-M\$O'?R%PJ8H3"DW=&]5N9=:
M8?U0)-])$]%2C3M6D^^=F8!30?)MU8S&ATTSVO3!KK],7GKQHJ*;_QO+(B#8
MG^/U <PTPNSJN/B9B7)<L:C\Z9>-ZD3FDS?N;+M;MB(0Q#7#.$L!JR3:'&UW
M&\.X:0R4SDNP%^>4WBHC?=4&P&&TI4#1"&<4(H+=&N8R:5P;ZY<8S4<)B)>U
M](W:.#]JCO,7&B]D1*]ZA)MQGIAR-RI4<)>X!+ME#3)I7+.&FM&RJ_.I3-R-
M]?BX:1BWU9G?2ZH=?#,2A2LBNY6O93A:G>RD,?50DSL&]@FS<B., A"C;J-Z
MVS2JC,0+"II7;4<<1JM*DWE2G+:[-=(%@K@VH(O2N7J:9&U ?]<ZR\A)/)+1
M_#\.Z*K29 .:TW;W!K10:(<&-$8LGX)]/*BLZ^3L?]]U'-*5I-Z&]E4/<$.Q
M53]:,29@D%U74M&CEN^CV<UNF5 _&5VSKKOT@8!?4OK\?,T]_AZWCK\W9!Y8
M?SOQ5DVWJNM:P8($)#MI+5(5N&,9[7/&&QS!H)K$5[,1I5-M[TW9B=G[/M/E
MTH^?KV=W<([@# 8^2HI++NAD5+ZR_%=V$6C/SBQ:UF="@3HG"5S2<2@X!&^V
MLWJSYU:8->RJ6P$#725T$V.R BRG%12'<Y-Y##+[S]B51M=U.K!VK:<YC'1%
M-@.>H<^JPFB"PD\^H0+062PIQ7V6(UUTH=Z#M9LYC9NCKM8&,M1;L,@W/9D*
MLQ(M\K*02:U4F=K:Q9MF35136V[89_F5=A!6+P"]7F6Z1ZS4BNJ/3CHWD5]*
M(O V^W1F[;I-XU:[A2[=& Q7X+$B?(P1_3'(_7+-25N_)VO7;AH?!GVUZ,[6
MI7W>SZZYX^Q;6IF(C:R1K /O3=Z%T5T+ATW)]D1*97,V#A8@3"/JB_,.Q3)F
M53;^VCW9W,LH(MF<;WMJRQU#JR6K"(SLJ)6G6$]9&<2\V"OJO$DL2T3@A%&]
M,*9E0%U4-HU%C@O73O@*<,<FVG&S,_:YR8A<^3%[L.Y.Y3UJ92]VQ\^*SKR7
MWHS:C)QY60A:HP.K'_)8LTMUR 6.Z2[U_&D5X9S=,[ &$5XQ;X>ZO-3["=-L
M*IXLF4/$-[?>'5H-8VNCW?H$QU9J'&C;?P'R>DO*%;LS"<0L1 ]_+8P\"SZ%
MF_QZSD#6[<1JG*X_D'U$=6W&%=9-J$V^K91:61W%T!.QEDR2.;EG7]^F9\O3
M\U9CX-M,[>1,;013HY.VE0LA2B4(+_&O-+)Z-&+2#CM$=V<A;84Q"N&ZU\Q6
MMGUWX*SH8]C(6?$2W=!9B\QF24J#.0C(:1JSL<FW$1&-4_$P#C[-LA2I"FQ?
MW<9;QU(4DF*)[;K?)INPZVVLKD*Z^'3P/_#![:JX\YY[-KMI8'5MZ*/)MG1#
MN5<,,NH@S.FZQ/NR9*.-U;/LWL.R*:,;;H[9&5WC-L=ASIJ-3^JO[WOIM?,0
MH?/4JJIJ'H@,X395(^]J'I.0PJ)I,;[N"[[8S9,RL^*U=^4<1,V4Q%+O@F^D
MC%O+X]@2P6'\* T(E07:$LPUB!\P 4,!>9M]B54?1C&=51>N#X@J:K )H4NS
MK(;C,HQ;:6JB?7W^"K=T7>G0I%5(R[]N8>CC$E5!).Z.?C<V#TE:'_N4[BX$
M)#8]H;[H-<\X9 HQ/",[4.&N9JCMPN!JQ?O0MBGB5V*/:J16+_%]^283';W7
M<58(&/[D1RFX 7&64,VW1B5BFW:I@USK"E]EQ;@1K*DPG'%')FFRP#'\M3.@
MVY:R361U9V(&.IXF'(6,?2M-"ZZ2P.K^PR14=0TX"M-UFI#$1R%$<PVL:E16
M]Q,F >O0Q4"' =E+\V*>3]3'2K@'55T-K0:>^^B;)PA7Q7QGKO@-^^O!)X ^
M^1]02P$"% ,4    " #)3A!).?4@(W<^  "VRP$ $0              @ $
M    ;61S=BTR,#$V,#8S,"YX;6Q02P$"% ,4    " #)3A!),ZC!+PD)  "H
M3@  $0              @ &F/@  ;61S=BTR,#$V,#8S,"YX<V102P$"% ,4
M    " #)3A!)YD-Z>\$)   A:0  %0              @ '>1P  ;61S=BTR
M,#$V,#8S,%]C86PN>&UL4$L! A0#%     @ R4X025#/"$)=!P  W#T  !4
M             ( !TE$  &UD<W8M,C Q-C V,S!?9&5F+GAM;%!+ 0(4 Q0
M   ( ,E.$$G#7:([N!P  $J  0 5              "  6)9  !M9'-V+3(P
M,38P-C,P7VQA8BYX;6Q02P$"% ,4    " #)3A!)6S9)8[H4  #@, $ %0
M            @ %-=@  ;61S=BTR,#$V,#8S,%]P<F4N>&UL4$L%!@     &
-  8 B@$  #J+      $!
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>